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CHAPTER 1 
INTRODUCTION 
 
Significance 
 
In the US every year, over 50,000 people die following traumatic injury.  It 
is estimated that 30-40% of these deaths are directly due to extensive blood loss 
and shock (Centers for Disease Control and Prevention, 2012; Kauvar and 
Wade, 2005).  Current treatment for hemorrhagic shock includes volume 
resuscitation, the goal of which is to restore perfusion of the vital organs (Perel et 
al., 2013).  However, fluid volume restitution alone is often insufficient to regain 
perfusion pressure, in which case catecholamines or other vasoconstrictors are 
given (Hollenberg, 2011).  Therefore, such treatment is only administered after 
sufficient volume resuscitation in order to avoid exacerbation of ischemia and 
reperfusion injury.  During hypoperfusion, the peripheral tissues become hypoxic 
and undergo anaerobic metabolism.  The byproducts of this process can form 
reactive oxygen species (ROS) upon the reintroduction of blood flow to cause 
further damage to the microvasculature and induce endothelial injury (Verma et 
al., 2002).  While significant treatment advances have been made in recent 
years, morbidity and mortality remain high, especially when resuscitation is 
delayed.  Novel methods of resuscitation that can be employed rapidly and easily 
are required to improve patient survival from traumatic blood loss.      
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Progressive blood loss produces a complex multiphasic response of the 
autonomic nervous system.  During the initial stage of hemorrhage, arterial 
pressure is maintained primarily through the unloading of the arterial 
baroreceptors, which activate sympathetic drive causing vasoconstriction and 
increased heart rate (Korner et al., 1990; Schadt and Ludbrook, 1991).  Once a 
significant amount of blood has been lost (20-30% total volume in humans and 
15% total volume in unanesthetized rats), a reversible decompensatory response 
is initiated during which there is a decrease in sympathetic outflow and rapid fall 
in blood pressure (Hasser and Schadt, 1992; Ludbrook and Ventura, 1996).   
This transient response is hemodynamically similar to vasovagal syncope.  This 
response may be beneficial in that it increases ventricular filling time and cardiac 
output (Barcroft and Edholm, 1945).  The syncopal phase persists until a second 
set of compensatory responses develop that help regain perfusion pressure to 
peripheral organs.  The second compensatory response is characterized by a 
slow restoration of sympathetic drive (Haljamae, 1984).  Without therapeutic 
intervention, this secondary compensatory stage eventually plateaus.  If blood 
loss continues beyond this stage, vascular permeability increases, and vascular 
reactivity declines (Liu et al., 2003).  This last stage is known as decompensation 
and is extremely difficult to treat.  Emergency interventions that prolong the 
secondary compensatory phase and delay decompensation are crucial for 
patient survival from traumatic blood loss.    
Our lab has found that 5-HT1A receptor agonists, including the full agonist, 
8-OH-DPAT, accelerate sympathetic recovery and stimulate sympathetic-
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dependent increases in venous tone without increasing total peripheral 
resistance when given after the onset of hypotensive hemorrhage or hemorrhagic 
shock (Osei-Owusu and Scrogin, 2004; Scrogin, 2003; Scrogin et al., 2000; 
Tiniakov et al., 2007; Tiniakov and Scrogin, 2006).  These effects are prevented 
by ganglionic blockade or sympathetic denervation of the splanchnic vasculature.   
Thus, 8-OH-DPAT administration increases perfusion pressure by mobilizing 
blood from the venous pool in the splanchnic vasculature (Tiniakov et al., 2012; 
Tiniakov and Scrogin, 2009).  This effect persists beyond the duration of drug 
action, suggesting that an initial increase in sympathetic activation mobilizes 
blood stores that remain in the effective circulation even after the direct effects of 
the drug have worn off.  Low dose drug injection in the cisterna magna, directly 
above the floor of the 4th ventricle was found to produce the most robust and 
rapid rise in sympathetic activity in hemorrhaged rats compared to other routes of 
administration (Scrogin, 2003).  Attempts to better define the site of action of 
5HT1A receptor agonists have been hampered by an inability to observe the 
sympathoexcitatory effects of 5-HT1A receptor agonists in anesthetized animals.     
In the course of the studies described above, it was found that selective 
lesion of caudal serotonin neurons attenuated normal ventilatory responses and 
recovery of sympathetic activity following hypotensive hemorrhage.  Destruction 
of serotonin neurons also exacerbated metabolic acidosis, indicating that 
lesioned animals had exaggerated peripheral tissue hypoxia (Kung et al., 2010).   
Excessive tissue hypoxia developed despite high arterial blood O2 levels.   
Evidence that tissue hypoxia after hemorrhage is more severe in lesioned 
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animals despite elevated arterial blood O2 indicates that loss of serotonin cells in 
the caudal brainstem impairs delivery of blood to peripheral tissue.  Nevertheless, 
blood pressure compensation following hemorrhage was similar in lesioned and 
sham-lesioned animals, which led us to speculate that lesioned animals 
maintained blood pressure by increasing peripheral resistance.  These data 
further suggest that serotonin neurons are important for maintenance of cardiac 
output and peripheral oxygenation during low volume states, a phenomenon that 
may be dependent upon sympathetic activation.  Thus, 8-OH-DPAT and 
serotonin neurons have similar effects during hemorrhage.  Specifically, both 
increase sympathetic recovery following hypotensive hemorrhage and improve 
tissue oxygenation, most likely by increasing cardiac output.  Thus, we propose 
that endogenous serotonin may be released during hemorrhage and act on 5-
HT1A receptors expressed on non-serotonergic neurons to mediate sympathetic- 
dependent increases in perfusion.  Therefore, 8-OH-DPAT may act by 
accelerating and further augmenting the normal serotonin-dependent mechanism 
activated by stimuli associated with hemorrhage.     
5-HT1A receptors normally couple to inhibitory Gαi proteins (Fargin et al., 
1989).  Activation of 5-HT1A receptors leads to membrane hyperpolarization 
(Innis et al., 1988; Penington and Kelly, 1990).  Indeed, in euvolemic animals, 8-
OH-DPAT produces profound sympathoinhibition, most likely through activation 
of 5-HT1A receptors expressed on tonically active RVLM cells that excite pre-
ganglionic sympathetic nerves (Kubo et al., 1995; Lewis and Coote, 1993).   
Therefore, the sympathoexcitatory effect of 8-OH-DPAT observed in 
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hemorrhaged animals may be due to disinhibition of a reflex response that is 
activated by some stimulus associated with blood loss, but is not active when 
blood volume is normal.  In accord, the sympathoexcitatory effect of 8-OH-DPAT 
in hemorrhaged animals is attenuated by disruption of afferent input to the CNS 
from peripheral chemoreceptors and arterial baroreceptors (Osei-Owusu and 
Scrogin, 2006).  These data are consistent with the possibility that chemo and/or 
baroreceptor afferents convey information that somehow attenuates the full 
sympathoexcitatory reflex that develops during hemorrhage; and that 5-HT1A 
receptor activation reverses this effect to enable full expression of compensatory 
responses.      
Afferent nerves that emanate from the carotid body transmit information 
on arterial blood gases and pH to the central nervous system through the IXth 
cranial nerve (Berger, 1979).  Chemosensory afferents terminate primarily in the 
commissural subnucleus of the nucleus tractus solitarius (NTS) (Sapru, 1996).  
Excitation of chemosensory afferents by acute hypoxia promotes increased 
ventilation, increased sympathetic activity and bradycardia.  Injection of excitatory 
amino acid neurotransmitters into the commissural NTS promotes similar reflex 
responses (Almado and Machado, 2005).    
Blood pressure is sensed by arterial baroreceptor afferents which arise 
from stretch receptors in the wall of the carotid vessels and the aortic arch.  They 
are activated by vessel stretch, which leads to sympathoinhibition, bradycardia 
and hypotension.  Arterial baroreceptor afferents travel along with the 
chemosensory afferents in the sinus and IXth cranial nerve in rats (Ciriello, 
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1983).  However, nerve terminals of baroreceptor afferents terminate primarily in 
more rostral regions of the NTS in the medial and dorsomedial subnuclei.  
Injection of excitatory amino acids in this region produces responses similar to 
activation of the arterial baroreflex (Viard and Sapru, 2002).   
Disruption of afferent input from both the carotid chemoreceptors and 
arterial baroreceptors by sinoarotic denervation prevents the increase in 
sympathetic drive and heart rate that characterizes the initial normotensive phase 
of hemorrhage (Korner et al., 1990).  This leads to a slight acceleration in the 
onset of the syncopal response to hemorrhage.  Sinoaortic denervation also 
slows the recovery of sympathetic activity, much like serotonin cell lesion (Osei-
Owusu and Scrogin, 2006).  While it is well known that arterial baroreceptor 
unloading contributes to the compensatory response to hemorrhage, the role of 
peripheral chemoreceptors in the sympathetic response to hemorrhage remains 
controversial.  Oxygen pressure within the carotid body declines as blood 
pressure falls during blood withdrawal in the anesthetized cat (Buerk et al., 
1989).  The decline parallels increases in sinus nerve discharge, suggesting that 
the peripheral chemoreceptors are involved in reflex responses to hemorrhage.    
However, during hemorrhage, arterial blood O2 levels rise due to an initial 
increase in ventilation.  Rising acidosis also results in bronchodilation which 
helps to oxygenate blood.  Therefore, it is thought that the decline in perfusion of 
the carotid body is the primary stimulus that increases chemoreflex activation.   
Nevertheless, studies indicate that the blood pressure and heart rate changes 
that develop during blood loss and subsequent compensation are not affected by 
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carotid body artery ligation in the unanesthetized rat, suggesting that 
chemoreceptors may have little effect on compensation from hemorrhage 
(Silveira et al., 2005).  However, our results have also shown that lesion of 
caudal raphe serotonin neurons has no effect on blood pressure and heart rate 
responses to blood loss but does have a significant influence on sympathetic and 
ventilatory drive during hemorrhage; these factors also have a significant effect 
on tissue oxygenation.  It remains to be determined whether peripheral 
chemoreceptors contribute to ventilatory and sympathetic responses to recovery 
from blood loss and whether they modulate the hemodynamic response to 
compensation.     
During hypotensive hemorrhage, loss of tissue perfusion and low pH in the 
carotid body should activate chemoreceptors, while simultaneous hypotension 
should unload arterial baroreceptors.  Both stimuli normally promote reflex 
sympathoexcitation and increased ventilation (Brunner et al., 1982; Kara et al., 
2003).  However, the ventilatory response to hypoxia declines with continued 
hypoxic exposure (Morrill et al., 1975; Tabata et al., 2001).  Sympathetic activity 
also declines, though the response is somewhat delayed (Hunt et al., 2008).   
This effect, known as hypoxic ventilatory decline, is dependent upon the integrity 
of the carotid body; and is associated with increased GABA release in the 
commissural NTS where chemoreceptor afferents terminate (Tabata et al., 2001).   
It is not known whether ventilatory decline contributes to the sympathoinhibitory 
response to severe hemorrhage.  However, we have noted that rats subjected to 
lesion of hindbrain serotonin cells show a significant decline in ventilation that 
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begins to develop at the onset of blood loss, while intact animals show an initial 
increase in ventilation that returns to baseline.  Thus, it is plausible that 
endogenous serotonin release normally counteracts hypoxic ventilatory decline 
during hemorrhage in order to maintain ventilatory drive, which in turn may 
contribute to increased sympathetic drive through central coupling mechanisms.   
Cardiovascular afferents enter the NTS near the dorsal surface of the 
brainstem at the floor of the 4th ventricle in the region where the 
sympathoexcitatory effects of 8-OH-DPAT administration were found to be most 
robust.  The NTS also receives extensive innervation from caudal raphe neurons 
(Schaffar et al., 1988).   Selective lesion of serotonin nerve terminals in the NTS 
produces similar decreases in sympathetic and ventilatory responses during 
hemorrhage as seen with the more widespread caudal raphe serotonin cell lesion 
(Kung and Scrogin, 2011).  Rats subjected to lesion of serotonin nerve terminals 
in the NTS also show a profound reduction in ventilatory and sympathetic 
responses to chemical hypoxia.  In contrast, the same animals show an increase 
in arterial baroreflex gain.  These data suggest that serotonin released in the 
NTS may contribute to compensation after blood loss by facilitating peripheral 
chemoreflex responses.    
The mechanism by which serotonin is released in the NTS to augment 
recovery from hemorrhage remains unknown.  Studies in our lab and by others 
suggest that serotonin neurons in the caudal raphe mediate central 
chemoreception and react to changes in CO2/H+ to promote ventilation (Kung et 
al., 2010; Teran et al., 2014).  Serotonin neurons in the caudal raphe are 
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activated during hypercapnia, and metabolites of serotonin have been shown to 
accumulate in the caudal NTS following hypovolemia (Curtis et al., 2013; Haxhiu 
et al., 2001; Johnson et al., 2005).  Immunohistochemical analysis has shown 
these same serotonin neurons physically wrap around the main blood vessels 
that perfuse the brainstem and have an ideal location to directly sense changes 
in CO2/H+ in the arterial blood supply to the brain (Bradley et al., 2002).  When 
isolated and cultured, these neurons show sensitivity to elevated CO2 and H+ 
(Wang et al., 2001).  Moreover, depletion of serotonin in vivo attenuates the 
ventilatory responses to hypercapnia and peripheral chemoreceptor activation 
(Hodges et al., 2008; Kung et al., 2010; Kung and Scrogin, 2011).  Thus, it is 
possible that during hemorrhage, as blood flow is reduced, peripheral 
chemoreceptors become activated to facilitate sympathetic and ventilatory drive, 
but after prolonged activation these compensatory responses wane (hypoxic 
ventilatory decline).  With sustained blood loss, animals experience metabolic 
acidosis (hypoventilatory hypercapnia), which may stimulate serotonin neurons in 
the caudal raphe to release serotonin in the NTS and thereby activate 5-HT1A 
receptors, which may disrupt the attenuated ventilatory response that develops 
during sustained peripheral chemoreceptor activation.  Studies performed in this 
dissertation investigated whether endogenous serotonin and exogenous 
administration of 8-OH-DPAT activate 5-HT1A receptors in the caudal NTS to 
promote sympathetic compensation from hemorrhage.  In addition, studies were 
performed to determine if this same receptor population is critical for the 
ventilatory response to hypoxic hypercapnia.  A hypoxic hypercapnic stimulus 
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was used here to mimic the hypoxic acidosis that occurs with hemorrhage.  A 
better understanding of the central mechanisms involved in recovery form blood 
loss could contribute to the identification of novel therapeutic targets for treating 
patients with traumatic blood loss. 
Main Hypothesis 
In the current project, studies were performed to examine the OVERALL 
HYPOTHESIS: 5-HT1A receptor activation in the caudal nucleus tractus solitarius 
(NTS) augments recovery from hypotensive hemorrhage by facilitating peripheral 
chemoreceptor activation.  This hypothesis was examined by utilizing the 
following aims. 
Specific Aim 1:  To determine if endogenous serotonin activates 5-HT1A 
receptors in the caudal NTS to facilitate sympathetic drive during compensation 
from hypotensive hemorrhage in unanesthetized rats. 
 Rationale 
Current treatments for hemorrhagic shock can cause reperfusion injury 
and organ damage, making novel treatments critical for improved survival.   
Lesion of caudal serotonin neurons attenuates sympathetic recovery following 
hemorrhage and exacerbates metabolic acidosis and tissue hypoxia (Kung et 
al., 2010).  These data suggest that during severe blood loss, serotonin 
neurons may be critical to the maintenance of peripheral tissue oxygenation 
during hypovolemia.  Selective and discrete lesion of serotonin nerve terminals 
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within the portion of the NTS that receives afferent input from the cardiovascular 
system produces virtually the same disruption of ventilatory and sympathetic 
recovery as the more global caudal raphe lesion (Kung and Scrogin, 2011).   
However, serotonin neurons release multiple neurotransmitters in addition to 
serotonin, and multiple serotonin receptor subtypes are expressed in the NTS.   
It is not known which receptor subtype mediates the ability of endogenous 
serotonin to facilitate compensatory responses to blood loss.  Parallel studies 
performed in the lab found that the selective 5-HT1A receptor agonist, 8-OH-
DPAT, produced the most rapid and robust increase in sympathetic drive and 
blood pressure when administered into the 4th ventricle near NTS subnuclei that 
regulate cardiovascular control.  Evidence that serotonergic innervation of this 
region is necessary for normal sympathetic and ventilatory responses to 
hemorrhage led us to investigate the possibility that endogenous serotonin acts 
on 5-HT1A receptors in the NTS to modulate sympathetic recovery following 
hemorrhage.  Therefore, we utilized a short hairpin RNA (shRNA) targeting the 
rat 5-HT1A receptor to enable discrete and selective down regulation of the rat 
5-HT1A receptor.  This methodology enabled us to determine whether 
endogenous activation of 5-HT1A receptors in the NTS was critical for normal 
compensation from blood loss in the unanesthetized rat. 
Experiments 
A) It was determined if decreased 5-HT1A receptor mRNA levels in the 
caudal NTS attenuated sympathetic drive during recovery from 
hypotensive hemorrhage. 
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B) It was determined if decreased 5-HT1A receptor mRNA levels in the 
caudal NTS augmented metabolic acidosis following hypotensive 
hemorrhage. 
Specific Aim 2:  To determine if the pressor and sympatho-excitatory effects of 
8-OH-DPAT observed in unanesthetized, hemorrhaged-rats is dependent upon 
5-HT1A receptors in the caudal NTS. 
Rationale 
8-OH-DPAT accelerates sympathetic recovery, increases in venous tone 
and attenuates metabolic acidosis when given to rats subjected to hypotensive 
hemorrhage or hemorrhagic shock.  The sympathoexcitatory effect of 8-OH-
DPAT in hemorrhaged animals is severely attenuated after sinoaortic 
denervation, suggesting that sensory afferents of the sinoaortic nerve transmit 
information that attenuates the full extent of reflex responses to hypovolemia, 
and that 8-OH-DPAT unmasks and accelerates the complete reflex response.  
The effects of 8-OH-DPAT are most robust when drug is administered into the 4th 
ventricle, near the NTS, where the arterial baroreceptor and chemoreceptor 
afferents project.  However, 8-OH-DPAT has affinity for other receptors 
expressed in the NTS (e.g. 5-HT7 receptors) so the exact location and receptor 
population which mediates the effects of 8-OH-DPAT are not known.  Therefore, 
we determined if the compensatory responses that are accelerated by 8-OH-
DPAT administration were dependent on 5-HT1A receptors located within the 
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caudal NTS.  We used the same AAV vector described in Specific Aim 1 to 
selectively decrease 5-HT1A receptor expression in the caudal NTS to determine 
the role of these receptors in the sympathetic or pressor response to 8-OH-DPAT 
administration 
Experiments 
A) It was determined if decreased 5-HT1A receptor mRNA in the caudal 
NTS reduced the sympathoexcitatory and pressor effects of 8-OH-
DPAT systemic administration during hypotensive hemorrhage. 
Specific Aim 3:  To determine if acidosis facilitates peripheral chemoreflex 
responses and whether this effect is dependent on 5-HT1A receptors in the 
caudal NTS. 
Rationale 
The ability of 8-OH-DPAT to accelerate the compensatory responses to 
hemorrhage is dependent on the integrity of the sinoaortic nerves that carry 
baroreceptor and chemoreceptor input to the NTS.  Loss of endogenous 
serotonin input in the NTS increases arterial baroreflex gain during hypotension 
but impairs peripheral chemoreceptor activation in response to chemical hypoxia.  
This led us to speculate that the ability of 8-OH-DPAT and endogenous serotonin 
to improve sympathetic recovery from hemorrhage likely depends on peripheral 
chemoreceptor activation rather than arterial baroreflex unloading.  5-HT1A 
receptors typically induce neuronal hyperpolarization.  Thus, 8-OH-DPAT (and 
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endogenous serotonin) may disinhibit full expression of chemoreflex responses 
during hemorrhage by acting on 5-HT1A receptors in the NTS.  We predicted that 
acidosis would promote serotonin release, which in turn, would facilitate 
peripheral chemoreflex response to hypoxia.  Therefore, we examined the role of 
NTS 5-HT1A receptors on ventilatory responses to the simultaneous activation of 
central and peripheral chemoreceptors that is believed to occur during severe 
hemorrhage.  In these studies, chemoreflex activation was induced by altering 
blood gases to simulate the hypoxia and acidosis that develops during 
hemorrhage, without altering blood volume.  We utilized the same AAV vector as 
described in Aim 1 to determine if 5-HT1A receptors in the caudal NTS are 
necessary for augmentation of ventilatory responses to hypoxic hypercapnic gas 
exposure.  In addition, we determined which serotonin cell populations of the 
caudal raphe were activated by the same hypoxic hypercapnic conditions.    
Experiments 
A) It was determined if decreased 5-HT1A receptor mRNA levels in the 
caudal NTS inhibits the ability of acidosis to augment the ventilatory 
response to hypoxia. 
 
B) It was determined if immunoreactive serotonin neurons in the caudal 
raphe are activated by acidosis.
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CHAPTER II 
REVIEW OF RELATED LITERATURE  
Current treatment for hemorrhagic shock 
Severe trauma is the leading cause of death in children and young adults 
(1-44 years of age) in the United States as well as many other developed 
countries (Centers for Disease Control and Prevention, 2012).  In the United 
States alone, this accounts for an average of 50,000 deaths per year and 
costs the government over 400 billion dollars annually (Corso et al., 2006).  
This monetary figure also accounts for the cost of lost productivity since 
traumatic injury results in 30% of all life years lost, more than cancer and 
heart disease combined (Centers for Disease Control and Prevention, 2012).  
Of those traumatic deaths, 30-56% are due directly to blood loss (Kauvar and 
Wade, 2005).  Hemorrhage also is the most common cause of preventable 
death during combat and accounts for 50% of all combat casualties (Clifford, 
2004).  Severely injured trauma patients usually require the resources of a 
designated trauma center within an hour after injury in order to improve their 
chance of survival.  However, nearly 45 million Americans still do not have 
immediate access to a trauma center, and morbidity and mortality remain high 
(Centers for Disease Control and Prevention, 2012).   
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The current treatment for hemorrhagic shock is primarily directed at 
resuscitation with fluid volume to maintain perfusion pressure of the vital organs.  
This consists of an immediate administration of volume expanders that are either 
crystalloids (saline, Ringer’s lactate, etc) or colloids (blood, blood substitutes, 
etc.) (Perel et al., 2013).  While necessary to avoid hypoperfusion, aggressive 
fluid resuscitation can also lead to detrimental complications including 
hemodilution, endothelial damage, and coagulopathy (Cripps et al., 2013).    
When volume resuscitation is unable to maintain proper organ perfusion 
pressure; patients may require the additional administration of vasoconstrictive 
agents such as catecholamines, including norepinephrine, dopamine, 
epinephrine, or non-catecholaminergic vasoactive drugs such as phenylephrine, 
and vasopressin (Hollenberg, 2011).  Although these therapeutic interventions 
can increase vasoconstriction to maintain blood pressure (BP), they can also 
exacerbate ischemic reperfusion (IR) injury.  During hypoperfusion, the 
peripheral tissues become hypoxic and subsequently undergo anaerobic 
metabolism.  Byproducts of this process can form reactive oxygen species (ROS) 
upon the reintroduction of blood flow and oxygen.  Reactive oxygen species can 
promote damage of the microvasculature and induce endothelial injury.  The 
endothelium is important for maintaining the integrity of the vasculature, and with 
disruption of the endothelial layer, introduction of leukocytes and platelets into 
the vessels can promote inflammation leading to organ failure and death (Verma 
et al., 2002).   
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The inflammatory response to hemorrhage and resuscitation also leads to 
complications during recovery.  Within 3 days post-hemorrhage, enhanced gene 
expression of the proinflammatory cytokines, IL-1β, TGF-β, TNF-α, IL-10, IL-6, 
and INF-γ develops (Shenkar et al., 1994).  The increase of cytokine production 
correlates directly with acute lung injury following recovery from blood loss.  The 
production of proinflammatory cytokines also promotes disseminated 
intravascular coagulopathy (DIC), a pathological condition of dysregulated 
coagulation cascade that can occur during hemorrhage.  With administration of 
resuscitation fluids, coagulation factors become diluted and can lead to 
hypocoagulation, which is associated with improper clot and fibrin formation that 
can lead to mortality 24 hours after traumatic injury (Palmer and Martin, 2014).  
Thus, even with restoration of perfusion pressure, inflammation, endothelial 
damage, and coagulopathy can eventually lead to death several days after the 
initial traumatic injury.  While advancements in treatment have been made, 
morbidity and mortality associated with blood loss remain high. 
 
Autonomic responses to hemorrhage  
Progressive blood loss elicits a complex, multiphasic response from the 
autonomic nervous system (Figure 1).  During the initial stages of blood loss, BP 
is maintained primarily through the arterial baroreflex (Korner et al., 1990; Schadt 
and Ludbrook, 1991).  Decreased BP reduces activation of stretch-sensitive 
mechanoreceptors which promotes sympathetically-mediated increases in  
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Figure 1.  Progressive blood loss elicits four distinct phases of autonomic 
nervous system response.  Arterial pressure (AP, top), heart rate, (HR, 
middle), and renal sympathetic nerve activity (RSNA, bottom) of an 
unanaesthetized rat subjected to continued blood withdrawal.  From left to right, 
normotensive phase (white box; I), hypotensive phase (light gray-shaded box; II), 
secondary compensatory phase (medium gray-shaded box; III) and 
decompensation phase (dark gray-shaded box; IV).   
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vasoconstriction and reflex tachycardia that help to maintain organ perfusion with 
oxygenated blood.   
After a significant amount of blood is lost (20-30% of total blood volume in 
humans or 15% total blood volume of a conscious rat), these compensatory 
responses suddenly abate, resulting in a dramatic decline in BP paralleled by a 
rapid fall in sympathetic drive (Hasser and Schadt, 1992; Ludbrook and Ventura, 
1996; Schadt and Ludbrook, 1991).  This drop in BP is reminiscent of a 
vasovagal syncopal or “fainting” and is thought to be evolutionarily beneficial due 
to a resulting increase in ventricular filling time and increased cardiac output 
(CO).   
This transient loss of BP is reversed as a secondary sympathetic 
compensatory phase ensues, characterized by a slow, but even greater increase 
in sympathetic drive than observed in the initial sympathoexcitatory phase 
(Haljamae, 1984).  During the syncopal-like phase of hemorrhage, when 
sympathetic drive is at its nadir, blood pools in the highly compliant venous 
vasculature.  This ultimately “traps” the blood within the veins and limits return of 
venous blood flow back to the heart further decreasing CO.  Therefore, when 
sympathetic drive is re-established, an increase in sympathetically-mediated 
venoconstriction remobilizes blood back to the heart where it can be redistributed 
to the arterial vasculature.  The second sympathoexcitatory phase is 
accompanied by the simultaneous release of vasoconstrictive hormones that 
primarily constrict the arterial side of the vasculature because the majority of their 
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receptors reside in the arterial vasculature (Liu et al., 2003).  Arterial 
vasoconstriction is less hemodynamically favorable since the majority of the 
blood is within the venous vasculature and further constriction of the arterial 
vasculature may actually exacerbate ischemia at the capillary beds (Mellander 
and Lewis, 1963).   
If blood loss progresses, the secondary increase in sympathetic drive 
eventually wanes, and the subsequent decrease in blood flow to the brain further 
attenuates sympathetic drive.  Also at this time, the vasculature becomes more 
permeable and less responsive to catecholamines (Liu et al., 2003).  Increased 
permeability of the vasculature disrupts the osmotic gradient and allows fluid and 
plasma proteins to leak out from the interstitium and augments inflammation by 
promoting the release of lymphatic molecules like macrophages and leukocytes.  
If left untreated, this forth stage eventually progresses to end organ failure and 
death.  Patients that arrive to trauma centers during this final stage are very 
difficult to treat.  Therefore, research efforts have focused on prolonging the 
previous stages of hemorrhage in order to prevent patients from advancing to 
decompensation.   
 
Overview of baro-, chemo- and cardiopulmonary reflexes during 
hypotensive hemorrhage 
The autonomic nervous system is responsible for insuring proper tissue 
oxygenation and organ perfusion pressure and does so utilizing a myriad of 
physiological reflexes.  One such negative feedback system, termed the arterial 
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baroreflex, utilizes stretch-sensitive receptors (baroreceptors) to detect changes 
in pressure to modulate BP.  When there is a rise in mean arterial pressure 
(MAP), detected as increased stretch, baroreceptors are activated and reduce 
sympathetic outflow to the peripheral vasculature and heart, thereby facilitating a 
subsequent fall in BP.  Conversely, when BP is low, these receptors fire less 
frequently and subsequent increases in sympathetic drive and reflex tachycardia 
permit perfusion pressure to rise.  The arterial baroreceptors are most sensitive 
in the physiological range of BP (70 – 150 mmHg) and possess a firing threshold 
of 60 mmHg.  Thus, when BP is less than 60 mmHg, arterial baroreceptors are 
unable to further modulate perfusion pressure because the arterial vessels are 
fully dilated (Seagard et al., 1990).  In addition to the arterial baroreceptors, low-
pressure stretch receptors, termed cardiopulmonary baroreceptors, also respond 
to changes in pressure.  Cardiopulmonary baroreceptors are located in large 
systemic veins, pulmonary vessels, and the atrium of the heart and are primarily 
responsible for regulating blood volume through hormone release (Mancia et al., 
1986).  Because the venous side of the vasculature is highly compliant, 
increases in stretch of the cardiopulmonary receptors are indicative of changes in 
blood volume since the majority of the blood is contained within the large veins.  
Elevations in blood volume are detected as an increase in stretch of the large 
veins.  The subsequent activation of the cardiopulmonary baroreceptors causes 
cardiopulmonary afferents that project to the brain through the vagus nerve to 
initiate a reflex reduction in sympathetic nerve activity.   
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Chemoreceptors include both peripheral chemoreceptors and central 
chemoreceptors which modulate sympathetic activity and control ventilation.  
Both receptors groups are sensitive to changes in pCO2 and pH, but only the 
peripheral chemoreceptors can detect changes in oxygen content in the 
peripheral circulation.  Central chemoreceptors and peripheral chemoreceptors, 
which alter sympathetic drive and ventilation, are necessary to help maintain 
MAP and metabolic homeostasis.   
  
Anatomy of arterial baroreflex 
The primary arterial baroreceptors are specialized stretch receptors 
located on the aortic arch and the carotid sinuses near the bifurcation of the 
internal and external carotid arteries.  As BP rises, the blood vessels passively 
expand and activate the arterial baroreceptors to generate an action potential.  
The action potentials are carried by afferent fibers from the aortic arch and 
carotid sinus to the caudal NTS by the vagus and glossopharyngeal nerves 
respectively (Berger, 1979; Ciriello, 1983).  The release of excitatory amino 
acids, presumably glutamate, coincides with the activation of baro-sensitive 
second order neurons within the NTS to activate excitatory glutatmatergic fibers 
that project to the caudal ventrolateral medulla (CVLM) (Lawrence and Jarrott, 
1994; Talman et al., 1984).   
The second order neurons in the NTS project to the CVLM and release 
glutamate to activate inhibitory neurons that release γ-aminobutyric acid (GABA) 
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to inhibit the rostroventrolateral medulla (RVLM) and suppress tonic sympathetic 
drive.  It is important to note that these inhibitory neurons within the CVLM are 
tonically active and continuously suppress sympathetic drive without 
baroreceptor input.   
The GABAergic afferents from the CVLM extend short axons bilaterally 
just rostral to the RVLM to suppress activity of bulbospinal presympathetic 
excitatory neurons that primarily control tonic sympathetic activity.  The 
bulbospinal neurons have glutamatergic projections to sympathetic preganglionic 
neurons located in the intermediolateral nucleus (IML) of the spinal cord 
(Pilowsky and Goodchild, 2002).  Therefore, when BP increases, the aortic arch 
and carotid sinuses distend to increase action potential generation by the arterial 
baroreceptors.  This in turn, activates second order neurons in the caudal NTS 
which activate the CVLM to increase inhibition of the RVLM.  Decreased activity 
in the RVLM results in decreased sympathetic drive, reduces HR, and ultimately 
decreases BP (Figure 2).  The NTS also contains excitatory projections to the 
nucleus ambiguous (NA) which regulates parasympathetic outflow to the heart.  
Activation of the NA promotes vagal stimulation to the heart to reduce HR.  
Conversely, when BP decreases, the baroreceptors become less active and the 
RVLM becomes disinhibited, which augments sympathetic drive and tachycardia 
to increase BP.   
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Figure 2.  Neural pathways of the arterial baroreflex.  Sagittal view of a rat 
brain illustrating projections involved in the arterial baroreflex (Dampney et al., 
2002).  Arterial baroreceptors generate action potentials in response to increases 
in BP and activate second order neurons within the NTS.  Glutamatergic input to 
the GABAergic neurons in the CVLM facilitates inhibition of the bulbospinal 
neurons in the RVLM.  This ultimately reduces activation of the sympathetic 
preganglionic fibers in the IML and suppresses sympathetic outflow.  Therefore, 
activation of the arterial baroreflex attenuates tonic sympathetic activity to reduce 
vasoconstriction and HR. 
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Physiological role of the arterial baroreflex and hypotensive 
hemorrhage 
Arterial blood pressure is tightly regulated and maintained (between 85-
100 mmHg in humans) to ensure proper oxygenation and nutrient delivery to the 
vital organs as well as provide waste removal.  Arterial baroreceptors are key 
players in maintaining MAP within this narrow range.  The carotid sinus 
baroreceptors are more sensitive than the baroreceptors located in the aortic 
arch, due to the larger pressure within the aortic vessel compared to the carotid 
arteries.  Therefore, maximal carotid sinus sensitivity occurs between 70-150 
mmHg. Thus, minute to minute variations in pressure effectively alter the firing 
rate of the baroreceptors which, in turn, maintains BP within a physiological 
range.  In contrast, aortic baroreceptors detect changes in BP at a higher 
pressure range (100-200 mmHg).  It is important to note that the point at which 
BP is maintained or, “set point,” changes during exercise, chronic hypertension, 
and heart failure.  In addition to changes in pressure, arterial baroreceptors can 
also detect changes in pulse pressure.    
During hemorrhage, the baroreceptors are unloaded as blood is lost and 
pressure wanes.  This results in less activation of the baro-sensitive neurons in 
the NTS that facilitate inhibition of tonic sympathetic activity.  Therefore, 
excitatory bulbospinal neurons within the RVLM are disinhibited and promote a 
robust increase in sympathetic drive and tachycardia to maintain BP.  
Additionally, during blood loss, there is a decrease in pulse pressure.  The 
combination of reduced BP and pulse pressure in hemorrhagic shock results in 
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an even greater response from the baroreceptors.  Vagal activity is also reduced 
to alleviate parasympathetic activation and increase BP (Wehrwein and Joyner, 
2013).   
 
Anatomy of the peripheral chemoreflex 
Peripheral chemoreceptors are composed of specialized cells strategically 
located in carotid bodies in the carotid sinus and the aortic bodies within the 
aortic arch.  Carotid bodies are composed of two main cell types, type I or 
glomus cells are the excitable cells that can directly detect changes in pH, CO2, 
and especially O2 and generate action potentials.  Additionally, the carotid bodies 
contain type II cells (15-20% of the total cell population), which have long 
processes that physically wrap around the glomus cells and play a more 
supportive role, similar to glial cells (Lopez-Barneo et al., 2008).  Although the 
exact mechanism by which glomus cells detect changes in oxygen remains to be 
fully elucidated, the leading hypotheses include the metabolic hypothesis and the 
membrane hypothesis.  First, the metabolic hypothesis suggests that the glomus 
cells respond to even slight changes in O2 content because oxygen-sensing 
proteins within the cytoplasm or mitochondria of the cells become activated 
during decreases in cellular O2.  During hypoxia, heme-containing proteins, such 
as cytochrome oxidase, prevent potassium (K+) channels from opening.  The 
subsequent reduction of K+ influx promotes membrane depolarization, activation 
of voltage gated calcium (Ca2+) channels and ultimately, neurotransmitter 
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release.  Alternatively, the membrane hypothesis proposes that certain K+ 
channels, such as high conductance Ca2+ activated channels and low 
conductance Ca2+ insensitive channels, are able to directly detect changes in O2 
content to activate influx of extracellular Ca2+ through voltage-dependent Ca2+ 
channels (Lopez-Barneo et al., 1988; Peers, 1990).  Whether indirectly or directly 
activated, the influx of Ca2+ promotes membrane depolarization to facilitate the 
final step in oxygen sensing, and neurotransmitter release.   
While numerous neurotransmitters have been associated with peripheral 
chemoreceptor activation, the most prevalent active neurotransmitters released 
in the synapse are acetylcholine and adenosine triphosphate (ATP).  Upon Ca2+ 
influx, neurotransmitters are released from the glomus cell into the synapse and 
activate the afferent nerve fibers that project to the medulla.  Additionally, the 
carotid body is a highly dopaminergic structure, and it is thought that dopamine 
(DA) is released in an autocrine fashion to reduce activation of the carotid body 
in a negative feedback loop (Lopez-Barneo et al., 2008). 
Chemoreceptor afferent fibers then relay this information through the 
carotid sinus and glossopharyngeal nerves that synapse in a more caudal portion 
of the NTS, separate from where baroreceptor afferents project in the 
commissural NTS (Figure 3).  These sensory afferents release excitatory amino 
acid neurotransmitters, such as glutamate, to facilitate direct activation of the 
RVLM to increase sympathetic drive.  Additionally, the NTS promotes increases  
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Figure 3.  Neural pathways of the peripheral chemoreceptors.  Sagittal 
image of a rat brain illustrating projections involved in the peripheral 
chemoreceptor activation (Dampney et al., 2002).  Peripheral chemoreceptors in 
the carotid and aortic bodies are activated by pH, CO2 and decreased O2 
(hypoxia).  Activation of the peripheral chemoreceptors stimulate second order 
neurons in the caudal NTS.  Excitatory chemo-sensitive neurons in the NTS 
directly activate excitatory input into the RVLM to stimulate sympathetic drive.  
Additionally, activation of the peripheral chemoreceptors increases activity in the 
rVRG to enhance ventilation by downstream stimulation of the phrenic motor 
nucleus (PMN).  Therefore, activation of the peripheral chemoreflex augments 
tonic sympathetic activity and facilitates ventilation. 
 
 
 
 
 
29 
 
 
 
 
in ventilation through direct projects to the rostal ventrolateral respiratory group 
(rVRG) of nerves which facilitate phrenic nerve activity (Mifflin, 1992). Lastly, 
second order neurons in the NTS that receive afferent input from peripheral 
chemoreceptor afferents also project to the NA to promote parasympathetic 
outflow to the heart. 
 
Physiological role of the peripheral chemoreflex and hypotensive 
hemorrhage 
 Although peripheral chemoreceptors become activated by increases in 
CO2 and decreases in pH; they are primarily activated by hypoxia.  Glomus cells 
within the carotid body can be activated either indirectly by O2-sensitive proteins 
or directly by K+ channels to promote membrane depolarization.  Depolarization 
causes Ca2+ influx through voltage dependent Ca2+ channels, which facilitate the 
release of excitatory amino acid neurotransmitters that excite the sensory 
afferents that project to second order neurons in the NTS.  Upon activation of the 
NTS, direct projections from the NTS to the RVLM augment sympathetically 
mediated increases in vasoconstriction.  Additionally, ventilation is increased by 
activation of neurons of the phrenic motor nucleus in the cervical spinal cord.  
Furthermore, peripheral chemoreceptor activation facilitates coronary 
vasodilation and bradycardia through vagal activation of the parasympathetic 
system.  Thus, the traditional peripheral chemoreflex response is associated with 
increased sympathetically mediated vasoconstriction, increased ventilation, and 
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bradycardia.  The carotid bodies are a highly vascularized structure that receive 
an enormous amount of blood flow (10 times the flow per unit mass compared to 
the rest of the cerebral circulation), but have a relatively low metabolic demand 
(1-2 ml/100g/min O2 consumption) (Barnett et al., 1988; De Burgh Daly et al., 
1954; Obeso et al., 1989).  Therefore, during hemorrhage, the reduced blood 
flow past the carotid bodies is sensed as reduced blood oxygen content and 
promotes the peripheral chemoreflex to boost sympathetic drive and increase 
ventilation to ameliorate reductions in BP.  During hemorrhage, bradycardia is 
masked by input from the arterial baroreceptors that suppress vagal input to the 
heart. 
 
 Peripheral chemoreceptor and baroreceptor interactions 
Peripheral chemoreceptor activation results in increased ventilation, 
exaggerated vasoconstriction, and varying effects on HR.  In contrast, activation 
of the arterial baroreflex elicits vasodilation, bradycardia, and reduced BP.  Since 
baroreceptors and chemoreceptors have opposing effects on ventilation and 
sympathetic nerve discharge, it is plausible that these reflexes antagonize each 
other.  Specifically, there is evidence that elevated BP associated with arterial 
baroreceptor activation attenuates the sympathetic and ventilatory responses 
that result during peripheral chemoreceptor activation.  Conversely, peripheral 
chemoreceptor activation is potentiated by hypotension (Heistad et al., 1974; 
Mifflin, 1993).   
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Central chemoreceptors 
In contrast to peripheral chemoreceptors, central chemoreceptors are cells 
located in the brainstem that are exclusively sensitive to changes in CO2 and H+ 
ion content.  Activation of central chemoreceptors facilitates sympathoexcitation 
and augments ventilation during respiratory or metabolic acidosis via projections 
to the neural circuitry in the brainstem and spinal cord involved in sympathetic 
and ventilatory drive.    
The partial pressure of arterial blood CO2 content (PaCO2) is tightly 
controlled and maintained near 40 mmHg in humans.  The pH of the arterial 
blood is closely regulated and typically ranges between 7.35-7.45.  Even slight 
disturbances in the cellular environment produce dramatic alterations in 
ventilation in order to maintain homeostasis.  In humans, ventilation can increase 
by as much as 50% in response to slight increases in PaCO2 (1.5 mmHg) or 
decreases in pH (0.01) (Smith et al., 1988).  Increases in CO2 and H+ ions 
promote a robust increase in ventilation, which buffers the blood by causing the 
release of CO2 in the lungs.  This occurs because bicarbonate (HCO3) and H+ 
ions are quickly converted by carbonic anhydrase (CA) into water and CO2.  
Moreover, CO2 is easily able to permeate lipid membranes, unlike H+ ions, which 
are unable to diffuse across the blood-brain barrier (BBB).  Thus, H+ ions require 
a transport mechanism, such as the Na+/H+ exchanger to relay plasma pH 
information to the brain, but this process takes significantly longer than CO2 
diffusion (Adler et al., 1990).  Alternatively, CO2 can readily cross the BBB and be 
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converted back into H+ ions to acidify brain tissues and activate the central 
chemoreceptors (Figure 4).   
Besides possessing the intrinsic ability to detect changes in CO2/H+ ions, 
the central chemoreceptors also must possess a direct connection to the 
respiratory central pattern generator (CPG) to induce increased ventilation in 
response to increased demand for buffer.  The central pattern generator refers to 
the semi-autonomous neural network within the pons and medulla that drives 
ventilatory function.  The CPG contains the ventral respiratory group (VRG) 
composed of a bilateral group of inspiratory and expiratory neurons that have 
been divided into the rostral ventral respiratory group (rVRG), caudal ventral 
respiratory group (cVRG), Pre- Bötzinger complex (PreBötC) and Bötzinger 
complex (BötC).  Activity of the VRG is regulated by afferent input from the NTS 
and pontine nuclei (Kölliker-Fuse nucleus and parabrachial nucleus) that regulate 
phase transitions between inspiration and expiration (Abdala et al., 2009; Alheid 
and McCrimmon, 2008; Smith et al., 2009; Smith et al., 2013).  Behavioral 
responses also influence the CPG through input from the cortex, cerebellum, 
basal ganglia, and hypothalamus (Pattinson et al., 2009a; Pattinson et al., 
2009b).  The VRG contains projections to motor neurons that control the upper 
airway muscle and innervate the diaphragm and thoracic respiratory muscles.    
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Figure 4.   Schematic representation of how CO2 and H+ ions in 
plasma activate central chemoreceptors.  CO2 is able to readily cross the 
blood brain barrier (BBB).  Conversely, H+ ions require the aid of a transporter, 
such as the Na+/H+ exchanger to cross the BBB more slowly.  During 
hemorrhage, when peripheral tissue becomes hypoxic and undergoes anaerobic 
metabolism, H+ ions can be converted in the blood by carbonic anhydrase to 
CO2, which can quickly cross the BBB and be converted back into H+ ions to 
acidify brain tissue and activate the central chemoreceptors.  Simultaneously, 
ventilatory drive increases such that most of the H+ is blown off in the lungs as 
CO2.  The remaining H+ accumulates in the blood which eventually perfuses the 
brain.  Thus, during blood loss, central chemoreceptors would presumably be 
activated more so by the local metabolic production of H+ and H+ transport, rather 
than PaCO2 which remains low during the hyperventilatory response to 
hemorrhage.    
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During homeostasis, inspiratory drive is initiated in the PreBötC and 
facilitated by the rVRG.  Inhibitory GABAergic and glycinergic interneurons from 
PreBötC suppress expiratory drive from the BötC and cVRG.  The PreBötC also 
provides excitatory glutamatergic input to the rVRG. The rVRG contains the main 
cluster of bulbospinal premotor neurons that relay inspiratory drive to the phrenic 
motor neurons that innervate the diaphragm to control and initiate inspiration 
(Smith et al., 1991).  Bulbospinal neurons in the rVRG are also inhibited by 
interneurons in the cVRG and BötC regions.  Conversely, expiration is driven by 
BötC through the inhibition of PreBötC and rVRG.  The BötC activates cVRG, 
which contains bulbospinal expiratory neurons that excite thoracic and lumbar 
motor neurons to facilitate expiration by engaging the abdominal muscles.  
Although the rhythmic drive to motor neurons can persist without sensory 
feedback; these respiratory networks are heavily influenced by central 
chemoreceptors. 
The exact location of the central chemoreceptors is not entirely clear and 
remains a topic of debate.  Central chemoreceptors were thought to be confined 
to the ventrolateral surface of the medulla because direct application of acidic 
solutions to the CVLM and RVLM augmented ventilation while selective blockade 
of neurotransmission in these regions via lesion, cooling, or chemicals reduced 
the ventilatory and sympathetic responses to hypercapnia (Hanna et al., 1979).  
More recently, additional sites of central chemosensation within the brainstem 
have been identified.  These include the NTS (Dean et al., 1990), locus 
coeruleus (Pineda and Aghajanian, 1997), serotonin neurons within the 
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medullary raphe (Wang et al., 1998), glutamatergic neurons in  the retrotrapezoid 
nucleus (RTN) (Mulkey et al., 2004), and orexinergic neurons in the 
hypothalamus (Williams et al., 2007).  Although several potential central 
chemoreceptor sites have been investigated, attention has been primarily 
focused on the serotonergic neurons in the medullary raphe and glutamatergic 
neurons of the RTN.  The evidence supporting the involvement of serotoninergic 
neurons of the medullary raphe in the central chemoreflex will be explored further 
in the section entitled “serotonin and central chemoreception,” located on page 
64. 
The RTN is a nucleus located near the ventral surface of the rostral 
medulla and is known to mediate tonic ventilatory drive, but is also thought to 
modulate ventilation in response to changes in CO2 (Mulkey et al., 2004).  Within 
the RTN exists a bilateral cluster of glutamatergic, non-purinergic neurons 
(~1000 neurons total) that can be identified by their unique expression of the 
transcription factor, paired-like homobox2b (Phox2b).  This transcription factor is 
known to regulate neuron formation and differentiation in brain regions important 
to cardiorespiratory function (Dauger et al., 2003; Tiveron et al., 2003).  
Subsequently, mutations within the Phox2b transcription factor gene result in 
autonomic dysfunction and are linked to congenital central hypoventilation 
syndrome.  Moreover, mice that lack Phox2b neurons within the RTN experience 
pronounced hypoventilation and reduced chemoreflex responses (Dubreuil et al., 
2008).   
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The small subset of neurons proposed to be central chemoreceptors in the 
RTN have been extensively studied in vitro and in vivo over the last decade.  
Brainstem slice recordings have shown that these particular neurons are 
stimulated by acidification and inactivate when pH is increased (Lazarenko et al., 
2009; Mulkey et al., 2004; Stornetta et al., 2006).  Additionally, focal acidification 
of the RTN via microdialysis produced a 25% increase in ventilation in awake 
rats (Li et al., 1999).  Moreover, rats exposed to increasing concentrations of CO2 
gas were found to have increased c-Fos expression in the RTN indicating that 
these neurons are activated during hypercapnia (Sato et al., 1992).  Recently, a 
more selective activation of these neurons was found to promote increases in 
ventilation in vivo.  Studies by Abbott et al. utilized a lentiviral delivery system to 
express light-activated cation channel, Channel Rhodopsin 2 (ChR2) in RTN 
neurons in rats.  Channel expression was driven by a Phox2-responsive 
promoter enabling the use of photostimulation to selectively activate only the 
neurons within the RTN that expressed Phox2b.  Results of these experiments 
concluded that direct excitation of these neurons augments breathing frequency 
and amplitude in vivo (Abbott et al., 2009).   
The RTN also projects to the VRG to facilitate ventilation directly.  Tract 
tracing methods have elucidated connections of the RTN to the ventrolateral 
medulla, caudal and lateral portions of the NTS, and the dorsolateral pons.  
Specifically, the RTN has direct projections to regions associated with the CPG 
including the PreBötC (Rosin et al., 2006).  If glutamatergic neurons within the 
RTN are intrinsically sensitive to changes in CO2/H+, then they are also able to 
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initiate alterations in ventilation directly through these connections to maintain 
PaCO2 within a normal physiological range.  Interestingly, the RTN receives 
synaptic input from other putative chemoreceptors located in the medullary raphe 
and NTS (Takakura et al., 2006).  Therefore, it is possible that 
additional/alternative central chemoreceptors, such as the serotonergic neurons 
in the medullary raphe, and/or input from cells in the NTS that are responsive to 
peripheral chemoreceptor activation facilitate RTN central chemosensitivity in 
vivo.    
 
Nucleus tractus solitarius  
The nucleus tractus solitarius (NTS) is an important sensory integration 
center located in the dorsal medulla within the brainstem.  The NTS is the initial 
site to which a multitude of sensory afferents, including the arterial baroreceptors, 
project.  The NTS is involved in a vast range of autonomic functions from 
sensations of tastes and intestinal mobility to cardiovascular and ventilatory 
function.  In general, the NTS contains important second order neurons that 
receive sensory inputs critical in initiating the autonomic responses that maintain 
cardiorespiratory homeostasis in the face of pathological or environmental 
changes. 
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Anatomical features of the NTS  
The NTS is composed of multiple subnuclei that are orientated rostro-
caudally along the solitary tract.  The solitary tract is the bundle of cranial nerves 
(facial, glossopharyngeal, and vagus) that carry visceral sensory information to 
the CNS (Berger, 1979; Ciriello, 1983; Mifflin, 1992).  Therefore, sensory 
information is organized in this rostro-cadual orientation such that the more 
rostral regions convey information from gustatory and somatic processes, while 
the more caudal region receives input from cardiovascular, renal, digestive and 
respiratory organs.  The more caudal portion of the NTS is known to be involved 
in compensation from hypotensive hemorrhage and will be the primary focus of 
this section. 
As previously mentioned, the NTS receives afferent projections from the 
arterial baroreceptors and peripheral chemoreceptors.  The arterial baroreceptors 
project to the more medial portion of the NTS to modulate sympathoexcitation via 
projections to the CVLM.  Additionally, the peripheral chemoreceptors project to 
the more caudal regions of the NTS to modulate cardiorespiratory parameters in 
response to changes in O2 through direct projections to the RVLM and VRG (see 
section, overview of baro-, chemo- and cardiopulmonary reflexes during 
hypotensive hemorrhage on page 20). 
 Additionally, the NTS can modulate cardiac function through 
glutamatergic projections to cardiac vagal pre-ganglionic neurons (CVPN) 
located in the dorsal motor nucleus of the vagus (DMN) and NA.  Activation of 
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CVPNs initiate negative chronotropic, ionotropic, and dromotropic effects 
depending on their origin.  Specifically, CVPNs located in the DMN have negative 
dromotropic, ionotropic and chronotropic effects on the heart (Nosaka et al., 
1982; Stuesse, 1982; Takanaga et al., 2003).  Interestingly, DMN CVPNs do not 
appear to be modulated by arterial baroreceptor input, unlike CVPNs located in 
the NA.  The CVPNs of the NA facilitate bradycardia in response to arterial pulse 
pressure changes and are reduced during the inspiratory phase of ventilation. 
The NTS also projects to the paraventricular nucleus of the hypothalamus 
(PVN).  The PVN is an integration center for autonomic and endocrine function 
that is particularly important in maintaining cardiovascular homeostasis.  The 
PVN is known to regulate BP in response to stress, primarily through activation of 
the hypothalamic-pituitary-adrenal (HPA) axis (Badoer and Merolli, 1998; 
Herman et al., 1996).  The PVN also has direct projections to regions important 
for cardiorespiratory responses to hemorrhage, including the RVLM, spinal cord, 
phrenic motor nucleus, PreBötC, and the dorsomedial, medial, and commissural 
portions of the NTS (Affleck et al., 2012; Kc et al., 2002a; Saper et al., 1976).   
Interestingly, exposure to hypoxia enhances c-Fos expression in NTS 
neurons that project to the PVN, and these projections were found to be mostly 
catecholaminergic (King et al., 2012).  Hypotensive hemorrhage and hypercapnia 
have also been shown to increase activation of the PVN (Badoer and Merolli, 
1998; Kc et al., 2002b).  Moreover, lesion of the PVN has been shown to block 
the pressor response to chemical hypoxia in the unanesthetized rat (Olivan et al., 
2001).  Based on these findings, it appears that the PVN plays a pivotal role in 
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peripheral and/or central chemoreceptor activation, possibly through the input 
received from the NTS. 
Additionally, NTS provides direct catecholaminergic and peptidergic 
projections to the central nucleus of the amygdala (CeA), a subnucleus of the 
amygdala found to be important in the modulation of BP during exposure to 
fearful stimuli (Zardetto-Smith and Gray, 1990).  In turn, the CeA provides 
inhibitory GABAergic projections that synapse onto second order baroreceptor 
neurons within the NTS.  Thus, CeA activation in response to fear/anxiety can 
attenuate arterial baroreceptor activation to promote increases in BP (Saha, 
2005).  The CeA also modulates BP during stress via direct projections to C1 
adrenergic regions in the RVLM that promote sympathoexcitation (Saha et al., 
2005). 
As mentioned previously, the NTS can augment ventilation through direct 
projections to the VRG.  Additionally, the NTS projects to pontine nuclei to 
modulate ventilation.  The pontine ventilator nuclei are located in the parabrachial 
area at the junction between the midbrain and the pons and are composed of 
three regions: the Kölliker-Fuse nucleus (KFN), lateral parabrachial nucleus 
(LPBN) and the medial parabrachial nucleus (MPBN).  Both the KFN and the 
LPBN receive projections from the caudal NTS and are involved in 
cardiorespiratory functions (Herbert et al., 1990).  Lesion of either the KFN or 
LPBN has no effect on normal breathing in room air, but elicits an impaired 
ventilatory response to hypoxia and hypercapnia in the unanesthetized rat.  
Interestingly, KFN and LPBN lesions also produce altered behavior of the rats 
41 
 
 
 
 
during hypercapnic gas exposure.  Specifically, control animals were observed to 
spend more time sniffing, moving, gasping, and generally were more active than 
animals subjected to KFN and LPBN lesion (Mizusawa et al., 1995).  Since the 
ventilatory response in either region has been shown to be heavily impaired by 
anesthetics, it appears as though consciousness and higher brain function is 
important in the ventilatory response to changes in CO2.  Moreover, 
consciousness may be necessary for behavioral responses to sensory 
information generated by changes in blood gases that are integrated within the 
NTS.    
  
 Neurotransmission in the NTS 
As mentioned previously, the more caudal portion of the NTS receives 
input from the arterial baroreceptor and the peripheral chemoreceptor afferents 
carried by the solitary tract.  Neurotransmitter release from these afferent 
projections modulate sympathetic drive and ventilation.  Although it is known that 
an excitatory amino acid neurotransmitter is released from these afferents, 
numerous additional neurotransmitters, gases, and peptides are also thought to 
be involved in modulating the arterial baroreflex and peripheral chemoreflex 
responses.   
Many investigators have found evidence that glutamate acts as the 
primary excitatory amino acid neurotransmitter released from the baroreceptor 
afferents to activate second order neurons within the NTS.  Microinjection of the 
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NMDA glutamate receptor antagonist, (2R)-amino-5-phosphonovaleric acid (AP-
5) into the NTS of conscious rats did not change baseline BP but did reduce 
baroreflex gain in response to phenylephrine-induced hypertension (Machado, 
2001; Machado and Bonagamba, 1992).  The utilization of alternative glutamate 
receptor antagonists that were specific for metabotropic glutamate receptors or 
non-NMDA glutamate receptors (AMPA or Kainate receptors) ultimately revealed 
that glutamate had varying effects on BP depending on the specific glutamate 
receptor population that was manipulated and whether the animal was 
anesthetized.  In general, glutamate neurotransmission modulates beat-to-beat 
BP control through a non-NMDA glutamate receptor population, whereas 
activation of the arterial baroreceptors by larger changes in BP facilitate 
glutamate binding of the NMDA glutamate receptors.   
Similarly, Substance P (SP) has been identified as one of the main 
neurotransmitters released in the NTS in response to baroreceptor activation 
(Helke et al., 1980).  Aortic nerve afferent fibers release SP in the NTS in 
response to increased BP (Potts and Fuchs, 2001).  Moreover, NTS 
microinjections of exogenous SP or SP antagonist were found to enhance and 
blunt the arterial baroreflex respectively, but only in response to loading 
(activation) of the baroreceptors (Seagard et al., 2000).  Selective destruction of 
cells in the NTS that express the primary SP receptor, neurokinin-1 (NK-1), using 
a SP-conjugated saponin toxin, impaired baroreflex sensitivity (Riley et al., 2002).  
Thus, SP also appears to contribute to arterial baroreceptor activation through 
NK-1 receptors in the NTS. 
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Retrograde tracing studies have also identified a population of inhibitory 
interneurons in the NTS that are activated by the arterial baroreflex and project to 
the CVLM to modulate RVLM activity.  These neurons are located more rostrally 
and are distinct from the interneurons in the NTS that are tonically active.  At 
least a portion of these baro-sensitive interneurons are GABAergic (Izzo et al., 
1992).  Several investigators have studied the role of these GABAergic neurons 
in the NTS and found that their selective activation facilitates the pressor effect 
associated with inhibition of the arterial baroreflex (Sved and Sved, 1990).  
Similarly, this response was reversed with direct injection of an antagonist to the 
GABAA receptors, gabazine (Zubcevic and Potts, 2010).  Therefore, GABA 
appears to be the primary neurotransmitter involved in baroreflex inhibition. 
Glutamate is also thought to be the primary excitatory amino acid released 
in the NTS to facilitate ventilatory and BP effects during peripheral 
chemoreceptor activation.  Peripheral chemoreceptors are also activated by 
systemic KCN injection that elicits a transient hypoxic state in the carotid body 
cells.  Consequently, increased ventilation and BP, as well as bradycardia, result 
in response to simultaneous activation of sympathetic and parasympathetic 
systems.  Similar responses in conscious rats have been observed following 
microinjections of L-Glutamate directly into the NTS (Colombari et al., 1998).  It 
appears that glutamate modulation of HR develops through NMDA glutamate 
receptor activation since direct microinjection the NMDA receptor glutamate 
antagonist, AP-5, eliminates the bradycardia associated with peripheral 
chemoreceptor activation (Accorsi-Mendonca et al., 2009). 
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The pressor effect of peripheral chemoreceptor activation is also 
dependent on glutamate neurotransmission, but this process is thought to be 
mediated through a non-NMDA ionotropic glutamate receptor population in the 
NTS.   When Machado et al. microinjected the non-selective AMPA and Kainate 
antagonist, 6,7-dinitroquinoxaline-2,3-dione (DNQX), in the NTS and 
administered KCN to activate the peripheral chemoreceptors, there was only a 
partial attenuation of the pressor effect associated with peripheral chemoreceptor 
activation.  This suggests that an alternative glutamate receptor subtype or 
another excitatory neurotransmitter besides glutamate is also involved in the 
pressor response to peripheral chemoreceptor activation (Machado and 
Bonagamba, 1992).    
Interestingly, separate studies found that NTS microinjections of ATP 
mimicked peripheral chemoreceptor activation, similar to results seen with direct 
injection of L-Glutamate (de Paula et al., 2004).  Moreover, when the non-
selective purinergic receptor antagonist, suramin, was administered, a significant 
attenuation of the bradycardiac response to chemical hypoxia was observed 
(Paton et al., 2002).  More recent studies microinjected both a non-selective 
ionotropic glutamate receptor antagonist, kynurenic acid, and purinergic receptor 
P2X2 antagonist, pyridoxalphophate-6-azophrenyl-2’,4’-disulfonic acid (PPADS), 
during chemical hypoxia.  The result was significantly impaired sympathoxcitatory 
and pressor responses to peripheral chemoreceptor activation.  In summary, 
NTS microinjection studies suggest that ATP and glutamate may be co- 
transmitters involved in peripheral chemoreceptor activation in the NTS.  It 
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appears that glutamate, and possibly ATP, facilitate the pressor effect of 
peripheral chemoreflex activation through increases in sympathetic drive via non-
NMDA and purinergic receptors.  Additionally, it is likely that glutamate binds 
NMDA receptors in the NTS to mediate the bradycardic component of peripheral 
chemoreceptor activation through subsequent cardiac vagal activation.   
Increased sympathetic and ventilatory drive during peripheral 
chemoreceptor activation can be modulated by a myriad of neurotransmitters.  
Noradrenergic structures in the brain, including the A1 and A2 regions of the 
medulla, show increased c-Fos expression in response to chemical hypoxia and 
activation of the carotid sinus nerve (Buller et al., 1999; Erickson and Millhorn, 
1994; Smith et al., 1995; Teppema et al., 1997).  The role of norepinephrine (NE) 
in peripheral chemoreceptor activation was further supported by in vivo studies 
that found excitation or inhibition of these same regions could modulate 
cardiorespiratory responses to peripheral chemoreceptor activation (Hayward, 
2001; Perez et al., 1998).  Anatomically, the caudal NTS projects to other central 
noradrenergic structures, and noradrenergic cells identified in the NTS make up 
the A2 nucleus (Dahlstrom and Fuxe, 1964; Jacobowitz and Palkovits, 1974).  
Microinjection of NE into the caudal NTS produces a dose-dependent decrease 
in the pressor response to KCN injection in awake rats, suggesting that NE 
exerts an inhibitory effect on the pressor/sympathoexcitatory response to 
peripheral chemoreceptor activation (Silva de Oliveira et al., 2007).  Both α1 and 
α2 adrenergic receptors are expressed in the NTS, but the expression of α1 
adrenergic receptors is more prevalent in the medial NTS, while α2 adrenergic 
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receptors are expressed primarily in the more caudal portions of the caudal NTS 
(Young 1985).  Microinjection of the selective α1AR agonists, phenylephrine or 
methoxamine, near the medial NTS elicits a dose-dependent increase in BP and 
HR.  In contrast, dose-dependent decreases in BP and HR are produced by 
microinjection of α2AR agonist, clonidine, in the same region (Kubo et al., 1987; 
Tsukamoto et al., 2002; Zandberg et al., 1979).  Similar results are seen with 
microinjection of clonidine in the commissural NTS of rats.  Moreover, the effects 
of clonidine can be reversed by microinjection of α2AR antagonist yohimbine 
(Bhuiyan et al., 2009).  In general, α1- and α2-adrenergic receptors are thought to 
have an inhibitory/modulatory role on both the arterial baroreflex and peripheral 
chemoreflex.   
It is also important to note that the physiological response to hypoxia-
induced peripheral chemoreceptor activation is biphasic.  The initial 
augmentation of ventilation is followed by a decline or “roll off” in ventilation 
termed hypoxic ventilatory decline (HVD).  It is likely that glutamate contributes to 
the immediate increase in ventilation during hypoxia exposure, but the 
mechanism by which HVD occurs remains to be fully elucidated.  One 
neurotransmitter thought to be involved in HVD is GABA.  The NTS receives 
GABAergic innervation from other brain regions, such as the PVN; but the major 
source of GABA in the NTS is from interneurons.  Most GABAergic interneurons 
are excited by second order neurons that become activated by afferent fibers 
from the solitary tract.  Consequently, GABA’s role in the inhibition of the NTS is, 
to some degree, regulated by excitatory drive.  It has been proposed that with 
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prolonged peripheral chemoreceptor activation, and thus increased glutamate 
accumulation, GABA synthesis increases to facilitate HVD.  Data from 
microdialysis studies of Tabata et al. showed that rats exposed to sustained 
hypoxia had significantly elevated GABA concentrations in the NTS 15 minutes 
after the start of gas exposure.  Animals in which the carotid bodies have been 
denervated do not accumulate GABA upon exposure to hypoxia.  Therefore, it is 
plausible that with prolonged peripheral chemoreceptor activation GABA levels 
increase, and, as a consequence, ventilatory drive becomes suppressed.    
  Separate studies have found that increased GABA concentrations in the 
commissural NTS correlates with impaired peripheral chemoreceptor activation.  
Specifically, microinjection of the GABA reuptake inhibitor, nipecotic acid, 
reduces the ventilatory, BP, and sympathetic responses to peripheral 
chemoreceptor activation.  Furthermore, this effect is reversed by GABAA 
receptor antagonist, bicuculline.  Similar to the results seen with blockade of 
GABA reuptake, microinjection of GABAA receptor agonist, muscimol, attenuates 
the autonomic responses to peripheral chemoreceptor activation.  Together, 
these studies provide significant evidence that GABA neurotransmission is 
facilitated by excitatory second order neurons in the NTS to reduce the peripheral 
chemoreflex response during sustained hypoxia.   
Another neurotransmitter that may contribute to HVD, is DA.  It has been 
well established that glomus cells of the carotid bodies are highly dopaminergic 
structures that utilize DA release to inhibit peripheral chemoreceptor activation in 
an autocrine fashion (Gonzalez et al., 1994; Prabhakar, 1994).  Additionally, DA 
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is found in peripheral chemoreceptor afferent fibers that terminate in the NTS.  
Like GABA, DA has also been shown to accumulate in the NTS during sustained 
hypoxia, and its accumulation is dependent on intact carotid sinus nerves (Goiny 
1991).  Dopamine is thought to activate D2-like receptors in the caudal NTS (Qian 
et al., 1997; Yokoyama et al., 1994).   The D2 receptors are inhibitory and have 
been co-localized within the NTS with synaptophysin, a presynaptic vesicle 
protein.  Thus, DA release in the NTS can attenuate excitatory glutamatergic 
synaptic transmission via the activation of presynaptic D2 receptors located in the 
caudal NTS.  Furthermore, DA release during sustained hypoxia may enhance or 
coincide with HVD.    
Previous studies from our laboratory and others have found that serotonin 
also plays a critical role in the physiological responses to peripheral 
chemoreceptor activation.  The NTS receives extensive serotonin innervation 
from the nodose ganglion as well as the caudal raphe nuclei (Nosjean et al., 
1990; Thor and Helke, 1987a).  Earlier studies found that serotonin turnover was 
increased in the NTS of rats that received systemic injection of phenylephrine, 
and that this effect was abolished by sinoaortic denervation (Bhaskaran and 
Freed, 1988).  It was also previously shown that low dose microinjection of 
serotonin in mediocaudal and commissural NTS produced cardiovascular 
responses typically associated with baroreceptor activation, specifically 
decreased HR and BP.  In a study from Orer et al., the selective serotonin 
neurotoxin, 5,7-DHT, was utilized to lesion serotonin nerve terminals in the NTS.   
They showed a moderate, but significant increase in BP in unanesthetized, freely 
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moving rats (Orer et al., 1991).  Previous studies from our laboratory utilized the 
same neurotoxin to selectively destroy the serotonergic nerve terminals in the 
dorsomedial medulla (including the NTS) in rats.  Loss of serotonin innervation in 
the NTS enhanced arterial baroreceptor reflex gain but reduced the sympathetic 
and ventilatory response to peripheral chemoreceptor activation by systemic 
KCN injection (Kung and Scrogin, 2011).  Although several serotonin receptor 
subtypes have been identified in the NTS, 5-HT1A, 5-HT2, and 5-HT3 receptors 
have been the most extensively studied to date.  In general, that 5-HT2 and 5-
HT1A receptors in the NTS are thought to mediate the depressor effect of arterial 
baroreflex activation, while 5-HT3 receptors located on vagal afferent fibers 
facilitate hypertensive responses during baroreflex activation induced by 
systemic phenylephrine (Itoh et al., 1992; Itoh and Bunag, 1991; Merahi et al., 
1992).  Interestingly, partial and full 5-HT1A receptor agonists have been shown 
to increase ventilation in rats following spinal cord injury and in intact cats and 
rats, although the location of these effects remains obscure (Garner et al., 1989; 
Mendelson et al., 1990; Teng et al., 2003).   
 
Overview of central serotonergic system 
Serotonin, or 5-Hydroxytryptamine, is a monoamine neurotransmitter 
biochemically synthesized from tryptophan via tryptophan hydroxylase (TPH).  
The majority of serotonin (approximately 90%) is produced and stored in 
enterochromaffin cells located in the lining of the gut, while the remaining 
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serotonin is synthesized in the CNS.  Serotonin modulates numerous 
physiological and behavioral functions, such as mood, sleep, appetite, 
vasoconstriction, and pain processing.  Serotonin has the capacity to regulate so 
many biological functions owing to the widespread distribution of its molecularly 
diverse receptor subtypes throughout the CNS.   
 
 Anatomy of serotonergic system 
The majority of serotonin innervation in the CNS originates from a group of 
neurons termed the raphe nuclei.  This cluster of nuclei is located medially 
throughout the rostrocaudal extent of the brainstem.  Although the raphe nuclei 
are made up of a heterogeneous population of neurons, the main constituents of 
the region are serotonergic.   
There are two major divisions of raphe nuclei (Figure 5).  The more rostral 
group of raphe nuclei (B5-B8) are located in the midbrain and rostral pons and 
project almost exclusively to the forebrain to modulate pathways involved in 
mood, appetite, and sleep.  The caudal raphe nuclei (B1-3) are located within the 
caudal pons and medulla oblongata and project within the brainstem as well as to 
regions within the spinal cord to regulate cardiorespiratory function and pain 
processing.  In 1964, Dalhstrom and Fuxe identified and divided serotonin nuclei 
within the raphe into 9 groups (B1-9) (Dahlstrom and Fuxe, 1964).   
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Figure 5.  Sagittal view of a rat brain depicting serotonin innervation 
throughout the CNS.  The more rostral serotonin nuclei, B5 (pontine median 
raphe), B6 (pontine dorsal raphe), B7 (midbrain dorsal raphe), and B8 (midbrain 
median raphe) project rostrally towards the forebrain to mediate functions related 
to mood, sleep, and appetite.  The more caudal raphe, B1 (raphe pallidus), B2 
(raphe obscurus), and B3 (raphe magnus have projections within the medulla 
and spinal cord which modulate cardiorespiratory function and pain processing 
(Cooper JR, 2003).   
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The rostral group is composed of three nuclei and is responsible for 85% 
of all serotonin innervation within the brain. The caudal linear nucleus (CLi) is the 
most rostral of the raphe nuclei, but contains relatively few serotonin neurons 
compared to the other raphe nuclei.  The dorsal raphe (DR-B7) is the next most 
rostral of the nuclei.  The DR contains the largest number of serotonin neurons, 
the majority of which are located in the rostral portion of the DR and also utlize 
SP as a co-transmitter with serotonin (Hornung, 2003). The most caudal nucleus 
of the rostral group is the median raphe (MR-B8). The majority of serotonin 
synthesizing neurons are located in the midline (>80%), while the lateral 
extensions of the MR rarely express serotonin.  Caudal extensions of the DR and 
MR located in the pons are termed B6 and B5 respectively.  Both the DR and MR 
receive glutamatergic afferent projections from the limbic system in the forebrain 
including the cingulate cortex, ventral tegmental area, and several nuclei of the 
hypothalamus (Behzadi et al., 1990; Peyron et al., 1998).  While the rostral raphe 
nuclei project to a myriad of regions in the forebrain, there is very little overlap of 
projections from the DR and MR.  The DR projections provide afferent input to 
the amygdala, hypothalamus, olfactory bulb, cortex, and basal ganglia (Van de 
Kar 1979).  In contrast, the MR project to more midline structures which include 
the hippocampus, caudal raphe nuclei, laterodorsal tegmental nucleus, dorsal 
raphe nucleus, interpeduncular nucleus, medial mammillary body, and other 
medial sites (Vertes 1999).  In general, the rostral raphe project throughout the 
forebrain to mediate many behavioral functions, such as arousal, aggression, 
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and anxiety (Monti, 2011; Pucilowski and Kostowski, 1983; Zangrossi and Graeff, 
2014).   
The caudal raphe are composed of the raphe magnus (RM-B3), which is 
the largest serotonergic group of the caudal raphe, the raphe obscurus (RO-B2), 
and the raphe pallidus (RP-B1, smallest group of serotonergic neurons).  The 
caudal raphe project to other regions within the brainstem and to the spinal cord 
to regulate a variety of autonomic functions.  The RM is mainly involved in pain 
processing as it has projections (most of which are serotonergic) to the dorsal 
horn of the spinal cord.  Studies have identified an excitatory projection from the 
periaqueductal gray (PAG) region to the RM which promotes the release of 
opioid neurotransmitters in the spinal cord to cause analgesia (Mason, 2001).  
The RO has been shown to augment ventilation and has reciprocal projections 
with the PreBötC and hypoglossal motorneurons. Glutamate injections into the 
RO or direct activation of the RO by optogenetic means both result in a dramatic 
increase in ventilation (Depuy et al., 2011; Ptak et al., 2009).  The RP has been 
shown to be involved in regulating tachycardia and increased BP in response to 
emotional stressors and provides excitatory input to the sympathetic neurons that 
innervate brown adipose tissue to stimulate thermogenesis (Morrison et al., 
2012; Pham-Le et al., 2011).   
The NTS receives extensive serotonin innervation from all three of the 
caudal raphe, the DR, and peripherally from the nodose ganglia, in which the cell 
bodies of the vagal sensory afferent nerves are located (Gaudin-Chazal et al., 
1982; Nosjean et al., 1990; Schaffar et al., 1988; Thor and Helke, 1987b).  The 
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highest density of serotonin innervation is located in the commissural and 
dorsomedial band of the parvocellular subdivision of the NTS and to a lesser 
degree in the remaining portion of commissural NTS and lateral and medial 
subdivisions of the NTS.  Only sporadic serotonin immunoreactive fibers are 
observed in the ventrolateral subnucleus and remainder of the parovocellular 
portions of the NTS (Maley and Elde, 1982).  It is also important to note that 
projections from the caudal raphe also release SP as a co-transmitter with 
serotonin in the NTS, dorsal motor nucleus of the vagus (DMX), area postrema, 
hypoglossal nucleus and the ventral horn of the cervical spinal cord (Thor and 
Helke, 1987a; Thor et al., 1988).  There are considerably fewer serotonin and SP 
double-labeled varicosities from the nodes and petrosal ganglia in the NTS 
compared to the spinal cord or hypoglossal nucleus.  Instead, serotonin and SP 
are more likely to be co-localized in varicosities arising from the RM, RO, and RP 
(Thor and Helke, 1989). 
 
Serotonin receptors  
To date, 7 classes of serotonin receptors have been identified, each with 
multiple receptor subtypes (14 total).  The majority of serotonin receptors are G-
protein coupled receptors (GPCRs), with the exception of the ionotropic 5-HT3 
receptor.  The first group of serotonin receptors are the 5-HT1 family, comprised 
of 5 receptor subtypes (5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, and 5-HT1F), which are 
typically inhibitory in nature.  Specifically, these receptors preferentially couple to 
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Gαi/o to inhibit adenylyl cyclase (AC) as well as to activate K+ channels that 
promote hyperpolarization.  The 5-HT1A receptor is the most extensively studied 
receptor of this family due to its wide CNS distribution and prominent role in 
various mood disorders.  Both, the 5-HT1A and 5-HT1B receptors have been 
localized to the NTS, but the exact role of these receptors within the NTS 
remains unknown (Manaker and Verderame, 1990). 
 The 5-HT2 receptor family is composed of 3 receptor subtypes (5-HT2A, 5-
HT2B, and 5-HT2C) and promotes depolarization by preferentially coupling to 
Gαq/11 to activate phospholipase C (PLC) and increase inositol phosphatase 3 
(IP3) levels.  This leads to increased Ca2+ to promote vascular constriction and 
neurotransmission.  Cells of the NTS express both 5-HT2A and 5-HT2C receptors.   
The 5-HT2A receptors have been shown to be involved in the depressor and 
bradycardic responses of arterial baroreflex function (Comet et al., 2007; 
Pompeiano et al., 1994). 
The ionotropic 5-HT3 receptor is composed of 5 subunits (5-HT3A/B/C/D/E), 
but must contain at least one 5-HT3A subunit to be functional.  Upon ligand 
binding, the channels are permeable to cations such as, Na+, Ca2+, and K+ and 
typically promote depolarization and facilitate neurotransmission.  The 5-HT3 
receptor is highly expressed within the NTS on vagal afferent terminals (Leslie et 
al., 1990; Pratt and Bowery, 1989).  Activation of these receptors promotes 
release of glutamate within the NTS to facilitate vagal excitatory input to the NTS 
(Jeggo et al., 2005).   
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 The remaining receptors, 5-HT4, 5-ht5, 5-ht6, and 5-HT7 are less well 
characterized, but it is recognized that 5-ht5 receptors couple to Gαi, while the 
rest couple to Gαs and activate AC, and thus protein kinase A (PKA) to facilitate 
depolarization.   The NTS also expresses 5-HT4 and 5-HT7 receptors.  Although 
these receptors have not been as extensively studied, some laboratories have 
found that activation of the 5-HT4 receptor in the NTS results in an attenuated 
bradycardic response to cardiopulmonary reflex activation in anesthetized rats 
(Edwards and Paton, 1999).  Additionally, 5-HT7 receptors located in the NTS 
have been shown to increase cardiac vagal drive in anesthetized rats (Kellett et 
al., 2005).   
 
Major function of serotonin  
Serotonin has been investigated over many decades and has been 
identified as a key neurotransmitter in a variety of physiological functions 
including appetite, mood, arousal, thermoregulation, and autonomic functions.  
Although the role of serotonin in cognitive and emotional functions has been well 
documented, its role in cardiovascular function has not been as well 
characterized.  Injection of serotonin directly into the NTS results in a dose-
dependent increase in BP that can be blocked by local and systemic injection of 
serotonin antagonists.  Additionally, administration of a selective serotonin 
reuptake inhibitor (SSRI) augments the serotonin-dependent increase in BP 
(Wolf et al., 1981).  Similar results were reproduced in unanaesthetized rats 
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(Callera et al., 1997).  More recently, a study by Curtis et al., found increased 
serotonin metabolite accumulation in the caudal NTS of rats exposed to 
polyethylene glycol (PEG) induced hypovolemia (Curtis et al., 2013).    
 
Serotonin and 5-HT1A receptors in hemorrhage 
General functions of serotonin in hemorrhage  
Several laboratories have provided evidence that central release of 
serotonin is involved in the sympatholytic phase of hemorrhage resulting in a 
dramatic fall in BP.  Studies performed in anesthetized cats and rats found that 
depletion of serotonin resulted in a delayed hypotensive response to 
hypovolemic shock.  Furthermore, central administration of a non–selective 
serotonin receptor antagonist, methysergide, produced similar effects (Blum and 
Spath, 1986; Elam et al., 1985; Morgan et al., 1988).  Direct injections of the 5-
HT1A receptor antagonist, WAY-100635, in the RVLM resulted in a delayed 
hypotensive and sympathoinhibitory responses to blood loss in anaesthetized 
rats.  Thus, central serotonin release was thought to contribute to syncopal-like 
responses to blood loss through activation of 5-HT1A receptors located in the 
RVLM (Dean and Bago, 2002).  However, additional studies have provided 
conflicting evidence for the role of central serotonin to sympathoinhibitory 
responses that follow blood loss.  Unanesthetized animals subjected to prior 
depletion of serotonin demonstrated normal phasic responses to blood loss, 
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suggesting that anesthesia likely contributed to previous observations that 
implicated serotonin release in sympathoinhibition (Evans et al., 1992).   
More recent studies from our laboratory have investigated the role of the 
serotonin neurons of the caudal raphe in hypotensive hemorrhage.  Utilizing the 
immediate early gene, c-Fos, as a marker for neuronal activation, serotonin 
neuronal activation was assessed during hemorrhage in unanesthetized, freely 
moving rats.  Serotonin neurons within the caudal raphe, including the RO and 
RM, were activated during hypotensive hemorrhage but not during hydralazine-
induced hypotension (Kung et al., 2010).  Studies from our laboratory also found 
that selective destruction of the caudal hindbrain serotonin neurons resulted in an 
attenuation of sympathetic and ventilatory recovery from hypotensive 
hemorrhage rather than attenuated sympathoinhibition to blood loss as had been 
observed in previous studies.  In addition, rats subjected to serotonin depletion 
showed greater metabolic acidosis as a result of hypotensive hemorrhage 
despite normal BP and HR responses.  Metabolic acidosis is indicative of 
peripheral tissue hypoxia.  Thus, oxygen delivery to peripheral tissue was 
reduced by serotonin depletion.  Oxygen delivery is dependent upon CO and 
arterial blood oxygenation.  Interestingly, the partial pressure of O2 in arterial 
blood (PaO2) was significantly higher in serotonin depleted animals.  These data 
suggest that the rats depleted of serotonin had impaired oxygen delivery to the 
peripheral tissues, possibly due to reduced CO.  Since BP is determined by CO 
and TPR, the data further suggest that after serotonin lesion normal BP 
responses to blood loss are maintained by detrimental increases in peripheral 
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resistance rather than more hemodynamically favorable increases in CO.  
Together, these studies suggested that endogenous serotonin release from the 
caudal raphe contributes to sympathoexcitation and increased ventilation during 
compensation from hypotensive hemorrhage, and that in the absence of 
serotonin BP may be maintained by a potentially more dangerous increase in 
TPR that further reduces tissue perfusion.   
The mechanism by which serotonin neurons in the caudal raphe become 
activated during blood loss remains unknown.  The recovery of sympathetic and 
ventilation following blood withdrawal was found to rise in parallel with the 
PaCO2, suggesting that central chemoreceptor activation may contribute to 
compensation from blood loss.  Moreover, rats subjected to serotonin depletion 
were found to have reduced sympathetic and ventilatory responses to hyperoxic-
hypercapnic gas exposure.  Hyperoxia prevents activation of peripheral 
chemoreceptors.  Therefore, these data suggest an important role for serotonin 
neurons in central chemoreceptor responses to acidosis in unanesthetized 
animals.       
 Following the initial study by Kung et al., evidence supported the view that 
serotonin neurons in the caudal hindbrain facilitated chemosensory input in the 
brainstem to modulate sympathetic and ventilatory drive.  But it was unclear 
where serotonin was acting to mediate these effects.  The NTS is an important 
sensory integration center in the brainstem and receives extensive serotonin 
innervation from the caudal raphe neurons.  Therefore, additional studies were 
conducted to selectively destroy serotonin nerve terminals in the dorsomedial 
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medulla, including regions of the NTS.  Serotonin nerve terminal lesion in the 
dorsal midline brainstem also reduced sympathetic and ventilatory responses to 
compensation from hypotensive hemorrhage in unanesthetized, freely moving 
rats (Kung and Scrogin, 2011).  Additionally, the lesion reduced the sympathetic 
and ventilatory responses to peripheral chemoreceptor activation by systemic 
KCN injections but enhanced arterial baroreflex gain during pharmacologically 
induced hypotension.  Results from the serotonin nerve terminal lesion study 
were consistent with the previous studies, and further supported the view that 
serotonin facilitates sympathetic and ventilatory recovery during blood loss by 
facilitating chemoreflexes within the NTS.   
  
5-HT1A receptor activation in hemorrhage 
Although previous studies have identified a sympathoexcitatory role for 
central serotonin release in the NTS during hypotensive hemorrhage, the 
receptor population mediating these effects remains unknown.  The previously 
mentioned studies found that administration of the non-selective serotonin 
receptor antagonist, methysergide, delayed the hypotensive phase of 
hemorrhage (Elam et al., 1985; Morgan et al., 1988).  However, methysergide 
also acts as an agonist at 5-HT1A/B/D receptors (Hoyer et al., 1994).  Studies from 
our laboratory found that injection of methysergide into the lateral 
cerebroventricle delayed the hypotension, bradycardia, and sympathoinhibition 
associated with progressive blood loss in unanesthetized rats (Scrogin et al., 
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2000).  It was also found that the partial 5-HT1A receptor agonist, buspirone, and 
the more selective 5-HT1A receptor agonist, 8-OH-DPAT mimicked the effects of 
methysergide in a dose-dependent manner (Osei-Owusu and Scrogin, 2004).   
Systemic injection of the potent 5-HT1A receptor antagonist, WAY-100635, dose-
dependently blocked the ability of methysergide to delay the sympathoinhibitory 
effect of hemorrhage, whereas a selective 5-HT2 receptor antagonist had virtually 
no effect.    
To better localize the 5-HT1A receptor population that mediated these 
effects, 8-OH-DPAT was injected in various rostro-caudal locations along the 
ventricular system of rats subjected to hypotensive hemorrhage.  Injections into 
the 4th ventricle produced the most robust responses with the shortest latency.  
The results suggested that 5-HT1A receptors located in the hindbrain contributed 
to compensation from blood loss (Scrogin, 2003).  The portion of the NTS that 
receives cardiovascular and chemoreceptor afferents forms the ventral floor of 
the 4th ventricle.  This area also expresses 5-HT1A receptors.  Denervation of the 
baroreceptor and chemoreceptor afferents that innervate the NTS was found to 
attenuate the sympathoexcitatory and pressor effects of 8-OH-DPAT compared 
to intact controls (Osei-Owusu and Scrogin, 2006).  This implies that 
baroreceptor, and/or peripheral chemoreceptor input into the NTS is necessary 
for sympathoexcitatory and pressor responses elicited by 5-HT1A receptor 
activation in a hypovolemic rat.  This is intriguing because the 
sympathoexcitatory and pressor effects of 8-OH-DPAT are only observed in a 
hypovolemic rat.  Activation of 5-HT1A receptors actually induces 
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sympathoinhibition in euvolemic rats.  Therefore, it is plausible that 5-HT1A 
receptors modulate a pathway that is quiescent in the euvolemic rats but is 
activated during severe blood loss.   
Subsequent studies utilizing a more severe shock model (~50% estimated 
blood volume withdrawn) showed that 8-OH-DPAT administration increased 
mean circulatory filling pressure (MCFP) in hemorrhaged rats (Tiniakov and 
Scrogin, 2006).  Mean circulatory filling pressure is the mean pressure that exists 
when CO stops and the blood redistributes throughout the vasculature.  Thus, 
MCFP is a measure of how full the circulatory system is and is determined by 
blood volume and venous tone, since the veins are more compliant than the 
arterial vasculature.  Given that the amount of blood withdrawn during 
hemorrhage was not different between 8-OH-DPAT and saline-control treated 
rats, it was assumed that 8-OH-DPAT increased MCFP through increased 
venous tone.  An increase in venous tone should cause an increase in venous 
return and BP if right arterial pressure is maintained.  In fact, systemic 
administration of 8-OH-DPAT to hypovolemic animals was also found to improve 
metabolic acidosis following severe blood, indicating that 5-HT1A receptor 
activation improves oxygen delivery to peripheral tissue in the hemorrhaged 
animal.  Indeed, it was determined that 8-OH-DPAT administration in 
hemorrhaged rats increased BP exclusively by increasing CO.  Neither HR nor 
TPR were affected by 8-OH-DPAT administration.  Thus, 8-OH-DPAT may 
selectively promote venoconstriction to ultimately increase venous return and CO 
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and ameliorate the progression of metabolic acidosis in hypovolemic rats 
(Tiniakov et al., 2007).   
It is also plausible that 8-OH-DPAT may mobilize blood stores within the 
venous vasculature to increase MCFP.  The splanchnic vasculature holds 33% of 
blood volume in euvolemic animals (Greenway and Lister, 1974).  Due to the 
high compliance of the splanchnic venous vasculature, a relatively large portion 
of this blood remains unstressed and contributes very little to central venous 
pressure.   Sympathetic-mediated constriction of the splanchnic veins can result 
in up to 60% of blood re-mobilization back into the circulation to increase 
perfusion pressure (Reilly et al., 2001).  Our laboratory also showed that bilateral 
denervation of the splanchnic sympathetic nerves in the rat did not alter the initial 
pressor effect of 8-OH-DPAT but did abolish the ability of 8-OH-DPAT to 
increase MCFP and improve acid-base balance.  Interestingly, denervation 
greatly shortened the pressor effect of 8-OH-DPAT, as did ganglionic blockade.   
Together, the data indicate that 8-OH-DPAT, when given following hemorrhagic 
shock, promotes a sympathetic-dependent increase in the splanchnic venous 
tone that increases CO and thereby reduces metabolic acidosis (Tiniakov et al., 
2012).  Endogenous serotonin released from the caudal hindbrain raphe 
produces very similar effects to administration of the 5-HT1A receptor agonist, 8-
OH-DPAT in hypovolemic animals.  These findings suggest that 8-OH-DPAT and 
endogenous serotonin release may both facilitate sympathetic and ventilatory 
compensation through activation of 5-HT1A receptors located within the NTS. 
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Serotonin and central chemoreceptors 
As discussed previously, the serotonergic neuronal population within the 
mid-line medullary raphe are considered putative central chemoreceptors.  
Central chemoreceptors are defined by their intrinsic sensitivity to PaCO2/H+ and 
direct connection to a respiratory network that mediates ventilation.  Over the 
years, there have been various (often conflicting) results from studies 
investigating whether serotonin neurons of the caudal raphe are central 
chemoreceptors or modulate chemosensitivity.   
In general, serotonin has not been shown to be necessary for homeostatic 
ventilatory rhythmogenesis in adults, but it does increase the frequency and 
amplitude of phrenic nerve bursts during hypercapnia (Corcoran et al., 2013).  
Hypercapnia has also been shown to induce c-Fos expression in raphe serotonin 
neurons (Haxhiu et al., 2001; Johnson et al., 2005), and to augment serotonin 
release within the dorsomedial medulla (Kanamaru et al., 2013).  Hypercapnia 
was shown to increase the firing rate of serotonin neurons in the raphe of freely 
moving cats (Veasey et al., 1995).  Moreover, numerous laboratories have 
shown that rodents display reduced chemosensitivity when serotonin neurons 
have been genetically altered (Barrett et al., 2012; Buchanan and Richerson, 
2010; Hodges et al., 2011; Hodges et al., 2008; Penatti et al., 2011a), 
pharmacologically lesioned (Nattie et al., 2004), or selectively silenced (Ray et 
al., 2011).  Dietary restriction of tryptophan also reduces central chemosensitivity 
(Penatti et al., 2011b).  Together, these studies indicate that serotonin modulates 
or facilitates central chemoreflex activation. 
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One compelling piece of evidence that serotonin neurons are central 
chemoreceptors is their ideal location for the direct assessment of how efficiently 
the lungs oxygenate the blood supply.  The PaCO2 is an excellent reflection of 
the aveolar ventilation, and immunohistochemical analysis has shown that 
serotonin immunoreactive caudal raphe neuronal dendrites physically wrap 
around the major arterial blood vessels in the brain (Bradley et al., 2002).  
Therefore, it is plausible that these neurons are able to penetrate the blood 
vessels to directly and accurately assess PaCO2 and H+ in the arterial blood 
supply to the brain.  This idyllic location of serotonin neurons is comparable to 
the peripheral chemoreceptors located in carotid and aortic bodies, which enable 
them to directly measure the oxygen content of the blood immediately after 
departing the heart. 
Furthermore, when the same serotonin neurons are removed and 
cultured, they are found to be directly sensitive to changes in CO2 and H+ (Wang 
et al., 1998; Wang et al., 2001).  Specifically, they are more active when CO2 is 
elevated and pH is decreased.  Conversely, when pH increases or CO2 
decreases, these neurons become quiet.  This intrinsic ability to be activated by 
changes in CO2 and pH strongly suggest that these neurons are chemosensitive.   
Caudal raphe serotonin neurons not only provide afferent projections to 
numerous components of the respiratory network including, PreBötC and 
hypoglossal motorneurons, but they have also been shown to directly stimulate 
respiratory motor output.  Patch clamp recording studies by Ptak et al., found that 
focal administration of a glutamate receptor agonist in the RO caused an 
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increase in firing rate of the serotonin neurons that was proportionate to an 
increase in firing of the hypoglossal nerve (Ptak et al., 2009).  And for the first 
time, a study has recently shown that specific activation of serotonin neurons via 
optogenetic-mediated activation in vivo caused an increase in phrenic nerve 
bursting frequency and amplitude (Depuy et al., 2011).   
Serotonin receptor subtypes involved in this central chemoreceptor 
response have been linked to 5-HT2A/C, 5-HT4A, and 5-HT1A receptor activation.  
When 5-HT2 receptor agonists are administered via the cerebroventricles, a 
subsequent increase in ventilation occurs which can be reversed by 5-HT2 
receptor antagonist administration (Ray et al., 2011).  Similarly, a 5-HT4A receptor 
agonist has been shown to increase respiratory motor output.  Systemic 
administration of 8-OH-DPAT also restores ventilation after fentanyl-induced 
apnea (Manzke et al., 2003; Zhuang et al., 2012).  As mentioned, 5-HT1A 
receptors are inhibitory, and their ability to promote ventilation suggests a 
potential role for 5-HT1A receptor-mediated disinhibition of respiratory centers 
through suppression of GABAergic or glycinergic interneurons (Corcoran et al., 
2014).   
Despite evidence from the aforementioned studies, some investigators do 
not believe that serotonin neurons play a role in central chemoreception in vivo 
because serotonin neurons in the RO were unresponsive to hyperoxic 
hypercapnia in anaesthetized rats (Depuy et al., 2011).  Similarly, other studies 
have found that intact medullary serotonin neurons are not chemosensitive by in 
vivo recordings in anaesthetized rats (Mulkey et al., 2004; Takakura and Moreira, 
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2013).  However, it has been well documented that the hypercapnic ventilatory 
response (HCVR) is significantly impaired by isoflurane and other anesthetics.  In 
fact, studies from Depuy et al., found that 8% CO2 only increased ventilation by 
35% in anesthetized rats.  In contrast, studies performed in unanaesthetized rats 
found 7% CO2 produce a dramatic 250% increase in ventilation (Davis et al., 
2006; Hodges et al., 2008).   
Similarly, arguments have been made against serotonin neurons as 
central chemoreceptors because they are less sensitive to CO2 during sleep.  
Therefore, some have suggested that the responses of serotonin activation are 
due to arousal rather than central chemosensitivity.  However, it has long been 
known that HCVR is reduced during slow wave sleep and further reduced during 
REM, but the mechanism is unknown (Bulow, 1963).  Additionally, the firing of 
serotonin neurons is highest during wakefulness, and virtually absent during 
REM sleep.  Combined with the fact that serotonin neurons are important for 
arousal from sleep during elevated CO2, it plausible that consciousness is 
necessary for serotonin neurons to be fully active and augment the HCVR.   
Another argument against the medullary raphe as central chemoreceptors 
includes a study by Mulkey et al.,that utilized TASK knockout mice.  It had been 
previously determined that TASK1/3 channels are the acid sensitive ion channels 
directly linked to chemosensitivity of the medullary raphe in vitro.  Therefore, 
when TASK channel knockout mice were found to have a normal HCVR, it was 
presumed that serotonin neurons in the medullary raphe were not central 
chemoreceptors.  However, there are several plausible explanations for why 
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these results do not exclude serotonin neurons as central chemoreceptors.  
Specifically, brain slice recordings were performed in P7-P12 mice despite the 
fact serotonin neurons are not fully developed until P21 (Wang and Richerson, 
1999).  It is well known that age affects chemosensitivity and that in earlier 
stages of development chemosensation is mediated more by central 
chemoreceptors in the LC and NTS (Conrad et al., 2009; Stunden et al., 2001).   
More importantly, TASK channels become inactive with most anesthetics, and 
thus serotonin neurons may not be chemosensitive when studied in an 
anesthetized animal model (Conway and Cotten, 2012; Patel et al., 1999; Talley 
and Bayliss, 2002).    
In light of the most recent studies, there is a compelling amount of 
evidence suggesting that medullary serotonin neurons may act as central 
chemoreceptors or at least contribute to part of the ventilatory response to 
hypercapnia.  Additionally, serotonin neurons are most active during 
wakefulness, and silenced during sleep.  Therefore, studies examining the 
contribution of serotonin neurons to the central chemoreflex in awake animals 
are necessary for a better understanding of the ventilatory response to 
hypercapnia.  
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CHAPTER III 
5-HT1A RECEPTORS IN THE NUCLEUS TRACTUS SOLITARIUS FACILITATE 
SYMPATHETIC RECOVERY FOLLOWING HYPOTENSIVE HEMORRHAGE 
 
Abstract 
 Serotonin neurons in the caudal raphe are activated in response to 
hypotensive hemorrhage.  Moreover, selective destruction of the same neuronal 
population results in attenuated sympathetic and ventilatory responses to blood 
loss.  The caudal raphe provide extensive serotonin innervation of the nucleus 
tractus solitarius (NTS), the lesion of which also attenuates ventilatory and 
sympathetic responses to hemorrhage and peripheral chemoreceptor stimulation.  
Multiple serotonin receptor subtypes are expressed in the NTS, but it is not 
known which receptor subtype mediates compensatory responses during blood 
loss.  However, our prior studies found that systemic administration of the 5-HT1A 
receptor agonist, 8-OH-DPAT, improves recovery from hypotensive hemorrhage 
by stimulating sympathetically-mediated venoconstriction and CO.  Thus, we 
hypothesize that serotonin released in the NTS during hemorrhage activates 5-
HT1A receptors that facilitate sympathetic recovery.  We utilized viral mediated 
knockdown of the rat 5-HT1A receptor in the caudal NTS to examine the role of 5-
HT1A receptors on compensation following hemorrhage.  Genes encoding a
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5-HT1A shRNA or scrambled version of the same sequence were incorporated 
into adeno-associated viral (AAV) vectors and injected into the caudal NTS of 
rats.  Five weeks after viral injection, rats treated with the vector encoding the 5-
HT1A shRNA showed decreased recovery of renal sympathetic nerve activity 
following hemorrhage compared to controls (-6.4 ± 12.9 vs. +42.6 ± 15.6% of 
baseline, 30 min after start of hemorrhage, P<0.05).  They also showed greater 
lactate levels 60 min after the start of hemorrhage (2.77 ± 0.5 vs 1.34 ± 0.2 
mmol/L, P<0.05).  The 5-HT1A mRNA expression in the commissural NTS was 
directly correlated with renal sympathetic nerve activity and inversely correlated 
with lactate 50 minutes after hemorrhage termination (P< 0.01, P< 0.05 
respectively).  These data indicate that serotonin released in the caudal NTS 
during hemorrhage activates 5-HT1A receptors to facilitate sympathetic-mediated 
compensation and tissue perfusion following severe blood loss.   
 
Introduction 
Progressive blood loss elicits a complex, multiphasic response of the 
autonomic nervous system, but the mechanisms that regulate these responses 
remain ambiguous.  Initially, blood pressure is maintained primarily through 
sympathetically-mediated increases in vasoconstriction and tachycardia (Korner 
et al., 1990; Schadt and Ludbrook, 1991).  After significant blood loss, these 
compensatory responses suddenly abate, resulting in a rapid and dramatic 
decline in BP (Hasser and Schadt, 1992; Ludbrook and Ventura, 1996).  As 
blood loss continues, a secondary, sympathoexcitatory phase ensues, in which 
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venoconstriction mobilizes blood pooled in the highly compliant venous 
vasculature.  The resulting increase in venous return increases CO and 
maintains BP (Haljamae, 1984).  This phase can only be temporarily sustained in 
the absence of volume resuscitation and with continued blood loss, eventually 
gives way to decompensation, characterized by a decline of sympathetic drive 
and a more permeable and less responsive vasculature (Liu et al., 2003).  
Elucidating the pathways that contribute to the secondary sympathoexcitatory 
response to blood loss could lead to novel methods of therapy to manipulate and 
prolong the sympathetically-mediated venoconstriction, and thereby slow the 
progression to decompensation. 
Serotonergic neurons in the caudal raphe of rats become activated during 
blood loss (Kung et al., 2010).  Selective lesion of those same serotonin neurons 
results in attenuated sympathetic and ventilatory recovery following hypotensive 
hemorrhage.  Rats subjected to lesion of caudal raphe serotonin neurons also 
develop greater metabolic acidosis with hemorrhage, despite having elevated 
arterial blood oxygen and normal BP recovery (Kung et al., 2010).  Together, 
these data suggest that serotonin neurons in the caudal raphe are necessary for 
normal compensation from blood loss, quite possibly by orchestrating a beneficial 
hemodynamic pattern in which perfusion pressure recovers more by 
venoconstriction and increased venous return rather than by arterial constriction 
which may further exacerbate tissue hypoxia.    
Caudal medullary serotonin neurons have numerous projections within the 
medulla and brainstem, including the NTS (Schaffar et al., 1988).  These 
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projections densely innervate the medial and commissural subnuclei of the NTS, 
where baroreceptor and peripheral chemoreceptor afferents terminate.  We 
found that lesion of the serotonin nerve terminals in the dorsomedial brainstem 
(including the medial and commissural NTS) significantly impaired sympathetic 
and ventilatory recovery from blood loss in conscious rats.  The lesion also 
attenuated ventilatory and sympathetic responses to peripheral chemoreflex 
activation (Kung and Scrogin, 2011).  Given the similar effects of caudal 
serotonin cell body lesion and discrete lesion of serotonin nerve terminal lesion in 
the dorsomedial brainstem in hemorrhaged animals, it is plausible that 
endogenous serotonin acts in the NTS during hemorrhage to augment 
sympathetic drive and ventilation, possibly by enhancing peripheral 
chemoreceptor responsiveness. 
It is not known which serotonergic receptor population mediates these 
compensatory effects.  A myriad of serotonin receptor subtypes are expressed in 
the NTS including the 5-HT1A receptor (Edwards and Paton, 1999; Gustafson et 
al., 1996; Leslie et al., 1990; Manaker and Verderame, 1990; Pompeiano et al., 
1994).  Previous experiments have shown that the selective 5-HT1A receptor 
agonist, 8-OH-DPAT, elicits a sympathetically mediated increase in BP when 
administered centrally or systemically to conscious, hypovolemic rats (Scrogin, 
2003).  This pressor effect is due almost exclusively to an increase in venous 
tone with virtually no effect on peripheral resistance (Tiniakov et al., 2007).  
Furthermore, the sympathoexcitatory effect of 8-OH-DPAT is dependent on intact 
sinoaortic nerve afferents which terminate in the medial and commissural 
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subnuclei of the NTS (Osei-Owusu and Scrogin, 2006).  Since, 8-OH-DPAT 
appears to mimic the hemodynamically beneficial effects of endogenous 
serotonin release during blood loss, we predicted that 5-HT1A receptor activation 
in the NTS would be necessary for normal compensation from hypotensive 
hemorrhage.   
Therefore, in the current study we tested the hypothesis that 5-HT1A 
receptors in the caudal NTS are necessary for normal recovery of sympathetic 
activity following severe hemorrhage.  Moreover, we determined whether 5-HT1A 
receptor activation in the NTS contributes to peripheral tissue oxygenation.   
Here we used an AAV vector to selectively reduce gene expression of the 5-HT1A 
receptors within the NTS to test these hypotheses.    
 
Methods 
Short hairpin RNA sequence screening 
Five short hairpin RNA (shRNA) sequences targeting various regions of 
rat 5-HT1A receptor mRNA were cloned into a humanized Renilla reniformis 
green fluorescent protein (hrGFP) expression vector (courtesy of Dr. Nichole 
Dudek).  The plasmid contained a mouse RNA polymerase III U6 promoter 
upstream of the shRNA sequence, and a hrGFP marker gene driven by a 
separate Cytomegalovirus (CMV) promoter.  The 5 shRNA sequences and the 
control shRNA sequence targeting the rat tryptophan hydroxylase 2 (TPH2) gene 
are provided in Table 1.   
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Table 1.   shRNA sequences screened in HEK 293 cells.   
 
The sequences for the 5 shRNA sequences targeting various portions of the rat 
5-HT1A receptor (5-HT1A shRNA #1-5) and the control shRNA targeting the rat 
TPH2 gene (TPH2shRNA).   
 
 
 
 
 
 
 
 
 
 
 
shRNA Sequence 5’  3’ 
5-HT1A shRNA #1 GTGAAAGGAAGACGGTGAA 
5-HT1A shRNA #2 CCGAGTGGGCAACTCCAAA 
5-HT1A shRNA #3 GCTCAATCCGGTTATTTAT 
5-HT1A shRNA #4 GAGGTGCACCGAGTGGGCAACTCCAAAGA 
5-HT1A shRNA #5 GGCTATCACCGACCCTAT 
TPH2 shRNA CCACCATTGTGACGCTGAA 
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The full length rat 5-HT1A receptor gene (gift from Dr.  Paul Albert) was cloned 
into the mammalian expression vector mCherry-C1-I74T3 (donated by Dr. Roger 
Y. Tsien) by Dr. Dudek to produce a rat 5-HT1A receptor mCherry fusion protein 
(mCherry-5-HT1AR) that was used to examine efficiency of shRNA-mediated 
knockdown.     
Human embryonic kidney (HEK) 293 cells were grown at 37°C in 
Dulbecco’s Modified Eagle Medium (DMEM; Hyclone™, ThermoScientific) with 
high glucose (4.5g/L), L-Glutamine, and Sodium Pyruvate.  Medium was 
supplemented with 1.2g Sodium Bicarbonate, 1% nonessential amino acids, 10% 
fetal bovine serum (FBS; Cellgro), 100 units/mL penicillin (Cellgro) and 100µg/ML 
streptomycin (Cellgro) in the presence of 5% CO2.  HEK 293 cells were grown in 
six-well plates (9.6 cm2) to 80% confluency, then were co-transfected with 0.4µg 
mCherry-5-HT1AR and 1.2 µg of the shRNA-hrGFP encoding plasmid using the 
transfection reagent, TurboFect (ThermoScientific) according to manufacturer’s 
guidelines.  Three days post transfection, the efficacy of each shRNA sequence 
was determined via fluorescent microscopy by comparing the intensity of red 
fluorescence of cells treated with each shRNA sequence to fluorescence of cells 
treated with a control shRNA vector.  Fluorescence intensity was determined 
using Image J software (NIH, USA).  Afterwards, cells were lysed and harvested 
in Trizol™ (Invitrogen). 
5-HT1A receptor protein and mRNA expression were determined by 
Western blot and semi-quantitative PCR respectively (methods described below).   
The most efficient shRNA sequence and a scrambled version of the same 
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sequence without homology to any known sequence in the rat genome were 
incorporated into serotype 2/8 adeno-associated viral (AAV) vectors through an 
outside vendor (Gene Transfer Vector Core, University of Iowa, USA).     
Semi Quantitative Reverse Transcriptase-Polymerase Chain Reaction  
Total RNA was isolated from transfected cell lysates (Trizol, Invitrogen) 
and reverse transcribed into cDNA (First Strand cDNA Synthesis, Fermentas) 
according to the manufacturer’s guidelines.  Specific primers for GAPDH and 5-
HT1A receptor were used to amplify cDNA from extracted RNA (Table 2; 
Integrated DNA Technologies).  PCR reactions were prepared with PCR buffer, 
200µM dNTPS, 1mM MgSO4, 1-4µL cDNA, 20µM forward primer, 20µM reverse 
primers, 1U KOD Hot Start Polymerase then up to 50µL with PCR water 
(Novagen).  PCR cycling conditions for 5-HT1A receptor were as follows: 94°C for 
1 min, followed by 30 cycles of 94°C  for 15s/45° for 30 s/ 72°C for 45 s and a 
final extension period of 10 min at 72°C.  Similar PCR cycling conditions were 
used for GAPDH: 94°C for 1 min, followed by 32 cycles of 94°C for 15s/58° for 30 
s/ 72°C and a final extension at 72°C for 10 min.  PCR products were run on a 
1% agarose gel at 100 volts along with a 1Kbp DNA molecular weight marker 
(GeneScript USA Inc).  Images were acquired with a Kodak Image Station 
4000mm Pro.  Band density was calculated using Image J (NIH, USA) and 
individual 5-HT1AR bands were normalized to the GAPDH band.   
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Table 2.   Reverse transcriptase PCR primers. 
Gene 
Symbol 
T 
(°C) 
Cycle 
Forward Primer (5’3’) Size 
(bp) Reverse Primer (5’3’) 
GAPDH 58 32 
CAA GGT CAT CCA TGA CAA CTT TG 
500 
GTC CAC CAC CCT GTT GCT GTA G 
5-HT1A 45 30 
TCC AGA ATG TGG CCA ACT AT 
510 
CCT TCT TTT CCA CCT TCC TG 
 
Forward and reverse primers specific for rat glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and 5-HT1A receptor.  Primer specific temperature 
used for annealing phase of RT-PCR (T), number of cycles of PCR performed, 
and product length are also shown.   
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Immunoblotting  
Total protein was extracted from transfected HEK 293 cell lysates 
according to manufacturer’s guidelines (Trizol, Invitrogen).  Protein concentration 
was determined by BCA assay (Pierce) using bovine serum albumin (BSA) as 
standard.  Protein (10µg) was then separated by electrophoresis on a 10% 
sodium dodecyl sulfate (SDS)-polyacrylamide gel for 1.5 hours at 150 volts, then 
transferred to a nitrocellulose membrane (BioRad) for 2 hours at 100 volts.  The 
membrane was blocked in 5% nonfat dry milk and 0.1% Tween-20 in Tris- 
buffered saline (TBST) for 1 hour, prior to overnight incubation with a custom 
rabbit anti-5-HT1A receptor antibody (1:10,000, Pacific Immunogical), or mouse 
anti-actin (1:40,000, MP Biomedicals Inc.) in 1% nonfat dry milk at 4˚C.   
Membranes were washed with TBST (3 times for 10 minutes) and incubated with 
HRP-conjugated anti-mouse and anti-rabbit secondary antibodies (1:2000 and 
1:5000 respectively, Pierce) for 1 hour at room temperature.  The membrane was 
washed a final time with TBST (3 times for 10 minutes) then protein bands were 
developed with Super-Signal West Pico substrate (Themo) and exposed on 
autoradiographic film.  The band density was quantified with Image J (NIH, USA), 
and normalized to actin.   
Animals 
Experiments were performed on 44 Male Sprague-Dawley rats (275 to 
300 g; Harlan, Indianapolis, IN), which were acclimated to the institutional animal 
facility under standard conditions (22°C ambient temperature, 12:12 hour light 
cycle) with food and water available ad libitum for at least 1 week prior to 
79 
 
 
 
surgery.  All experimental protocols were approved by the Institutional Animal 
Care and Use Committee and conducted in compliance with the Principles of 
Laboratory Animal Care, as adopted and promulgated by the United States 
National Institutes of Health. 
Surgical procedures 
AAV Vector injections 
Prior to surgery, AAV vectors were diluted in viral storage buffer (400nM 
NaCl, 20 mM Tris base) to 1x1012 vg/ml and dialyzed in 0.9% saline (Slide-a-
Lyzer, ThermoScientific) according in manufacturer’s guidelines.  Briefly, 10-25 
µL of virus was dialyzed for 10-25 min in 500 mL 0.9% saline on ice.  After 
dialysis, heparin (1000 units/ml) was added in a 1:7 ratio (heparin: virus v/v) to 
facilitate the initial internalization step of viral infection (Smith et al., 2004).  Rats 
were anesthetized with ketamine/xylazine (85/13mg/kg, im) and placed in a 
stereotaxic apparatus with the nose bar positioned 11 mm below a flat skull 
plane.  Throughout the surgery, animals were monitored and supplemental doses 
of ketamine (10 mg/supplemental injection, im) were administered as necessary 
to maintain a surgical plane of anesthesia.  The back of the skull was exposed 
and a small portion of the occipital bone was removed in order to visualize the 
dorsal surface of the brainstem at the level of calamus scriptorus.  A glass 
micropipette pulled to an outer diameter of 20-40 µm, was filled with virus 
encoding the 5-HT1AR shRNA or scrambled version of the same sequence.    
Using an oil pressure injection system, AAV vectors were infused bilaterally (750 
nL/site) at a rate of 200 nL/min, 0.5 mm ventral to calamus scriptorus at two 
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rostrocaudal planes along the NTS: +0.5 and 0 mm relative to calamus 
scriptorus.  Injections were made 0.7 mm lateral from the midline for the rostral 
set of injections, and 0.25 mm lateral from the midline for the caudal set of 
injections for a total of 4 injections targeting the commissural and medial NTS.   
Prior to the injection, the glass pipette remained in the tissue for 5 minutes after 
insertion to allow the tissue to equilibrate.  Similarly, following each injection, the 
injector remained in tissue for 5 minutes after infusion to ensure that the virus 
had completely exited the injector tip before removal so as to avoid viral spread 
to alternative brain regions dorsal to the injection site.  Following injection, the 
neck muscle and skin were closed in separate layers and rats were given 
buprenorphine (50µg/kg, sc) every 8 hours, for 2 days post-surgery along with 
ampicillin (150 mg/kg sc) twice per day for 3 days.  Animals were then allowed to 
recover for four weeks prior to hemorrhage experiments. 
Vascular catheter and renal sympathetic recording electrode implantation 
The day before hemorrhage experiments, rats were anesthetized with 
isoflurane (5% for induction and 1.5-2.5% for maintenance) in 100% O2 (1L/min) 
and instrumented with bilateral femoral arterial catheters (PE-50 fused with PE-
10 tubing) to enable simultaneous blood withdrawal and direct measurement of 
arterial pressure.  A third catheter was inserted in the femoral vein to enable 
blood sampling for venous blood gas determinations and for systemic injections.   
All catheters were externalized at the nape of the neck and secured with 3-0 silk 
suture.  After catheter implantation, a segment of the left renal sympathetic nerve 
was isolated through a left flank incision.  A fiber bundle was placed on a bipolar 
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electrode made from Teflon-coated stainless steel (bare diameter = 0.005 in; A-M 
Systems, Everett, WA) and isolated in Kwiksil silicon (World Precision 
Instruments).  The electrode lead wires were tunneled under the skin to exit at 
the nape of the neck.  Rats were given ampicillin (150 mg/kg sc) antibiotic and 
ketoprofen (5mg/kg sc) for analgesia and allowed to recover overnight.  
Experiments were conducted the day after surgery.    
Experimental Protocols 
Hypotensive hemorrhage  
All rats were subjected to hypotensive hemorrhage conducted as 
described previously (Kung and Scrogin, 2011).  Briefly, arterial lines were 
connected to a withdrawal pump and an arterial pressure transducer through an 
overhead swivel system while the rats rested, unrestrained in their home cage.   
The recording electrode and venous line were connected to appropriate sampling 
lines through the same overhead swivel system.  Rats were habituated for at 
least one hour, after which blood withdrawal commenced at a rate of 3.2 
mL/min/kg for 6 minutes, and then 0.52 mL/min/kg for an additional 4 minutes, to 
provide a total withdrawal of 21% of estimated blood volume over 10 minutes.    
Data acquisition began 20 minutes prior to the start of blood withdrawal and 
continued throughout the course of hemorrhage and for an additional 50 minute 
recovery period following termination of blood withdrawal.  Femoral venous blood 
samples (150 µL) were taken 20 minutes prior to hemorrhage, and 10 and 60 
minutes after the start of blood withdrawal to measure hematocrit, venous blood 
gases and acid-base status with an i-STAT 1 analyzer (i-STAT, East Windsor, 
82 
 
 
 
NJ).  Plasma protein concentrations were determined by a handheld clinical 
refractometer (ATAGO U.S.A. Inc.).  At the end of the experiment, rats were 
given hexamethonium chloride (30 mg/kg iv) to block post-ganglionic sympathetic 
activity and allow determination of background noise in the renal sympathetic 
recording electrode.  A subset of the rats were then quickly anesthetized with 
sodium pentobarbital (100mg/kg, iv), and decapitated.  Brains were quickly 
extracted and flash frozen in cold isopentane and stored at -80°C for later qPCR 
assessment of receptor gene expression.  The remaining rats were anesthetized 
with sodium pentobarbital (100mg/kg iv) then quickly perfused transcardially with 
90 ml of sodium nitrate (0.1M) in 6.7 mM phosphate buffer followed by 90 ml 4% 
paraformaldehyde in 0.1 M phosphate buffer saline (PBS).  Brains were then 
removed and post-fixed for 1 hour.  The brainstem was blocked and post-fixed 
overnight.  The following day, brains were transferred to 30% sucrose solution 
and stored at 4°C until sectioning.  Brains were sectioned on a freezing 
microtome in 40 µm sections and collected serially into 6 wells filled with 
cryoprotectant (30% sucrose and 30% ethylene glycol in 0.1 M PB) and stored at 
-20° until immunohistochemical analysis was performed. 
Spontaneous baroreflex sensitivity 
Five minute segments of baseline BP and HR data were recorded prior to 
hemorrhage and analyzed with Nevrokard SA-BRS software version 3.2.4 to 
determine spontaneous baroreflex gain using the sequence method (Padley et 
al., 2005).  Spontaneous baroreflex gain was determined as the average slope of 
linear regressions obtained from at least 3 sequences.  Sequences included in 
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the analysis had to satisfy the following constraints: three or more consecutive 
interbeat intervals (IBI) with variation in the same direction, >0.5 ms that 
correlated (r2 > 0.85) with systolic, diastolic, or mean arterial BP variations of 
>0.5 mmHg, with a three-beat delay.  Parameters used to select sequences were 
set based on evidence obtained from our prior work that they retrieved the most 
sequences (Henze et al., 2008).  A 128-point fast-Fourier transformation with a 
smoothed Hamming window was used to conduct cross-spectral analysis on IBI 
and BP.  The relationship between IBI and BP variability was determined as the 
square root of the ratio of IBI and BP power spectra, with 50% overlap and zero 
padding of eight.  Values were reported as the α-index in the low-frequency (LF, 
0.06 – 0.6 Hz) and high-frequency (HF, 0.6- 3.0 Hz) domains (Pinna et al., 2002).  
BP variability was determined in the time domain as the standard deviation of 
systolic, mean, or diastolic BP.  Blood pressure variability was also determined in 
the LF domain.  HR variability in the LF and HF domains was analyzed using the 
IBI power spectra criteria described above (Kuwahara et al., 1994).  Group 
means for each variable were compared by Student’s t-test. 
Data acquisition  
Arterial pressure, HR, and renal sympathetic nerve activity (RSNA) were 
recorded on a Macintosh G4 Powerbook with PowerLab data acquisition 
software (Chart version 5.2.1; ADinstruments, Colorado Springs, CO).   Arterial 
pressure was measured with a disposable pressure transducer (Transpac IV; 
Abbott Labs, North Chicago, IL) and a PowerLab bridge Amplifier 
(ADinstruments).  Heart rate was calculated using peak-to-peak detection of the 
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pulse pressure wave.  Sympathetic activity was sampled (4,000 Hz) and 
amplified (10,000x) with a PowerLab Bioamplifier (ADinstruments).  The raw 
signal was filtered (1-1,000 Hz), rectified, and integrated over a 20-ms time 
constant.  Background noise, determined as the signal that remained after 
hexmethonium chloride injection, was subtracted from all values.  Only data from 
recordings with a signal to noise ratio greater than 2:1 were included in the data 
analysis.    
Tissue Microdissection  
Brains were transferred to a Leica CM 3050 S Cryostat (-15 to -17°C).  
Five hundred µm thick sections were cut and 0.75 and 1 mm diameter 
micropunches were taken from areas of interest determined using the stereotaxic 
rat brain atlas of Paxinos and Watson (Watson, 1982).  Bilateral punches were 
taken from the commissural- and medial NTS (mNTS) as well as the hypoglossal 
nucleus -14.3 to -13.8, -13.3 to -12.3, and -14.8 to -13.3 mm relative to Bregma 
respectively.  Micropunches from RO were obtained by two midline punches from 
-13.3 to -11.3 mm from Bregma.   Dorsal raphe samples were obtained from a 
single punch -9.3mm to -6.8mm from Bregma.  The tissue was homogenized 
immediately in 1.0 mL TRIzol® Reagent (Invitrogen) using a glass mortar and 
pestle on ice.  Samples were transferred to microcentrifuge tubes for RNA 
extraction.    
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Tissue RNA Isolation and cDNA synthesis 
Total RNA was extracted according to manufacturers’ protocols 
(Invitrogen) with the addition of GlycoBlue™ Coprecipitant (15mg/mL) to facilitate 
nucleic acid precipitation (Invitrogen).  RNA purity and concentration were 
assessed using a NanoDrop 8000 Spectrophotometer (Thermo Scientific).  
Samples were treated with DNAse I enzyme (1U/1µg RNA) (Fermentas) to 
remove remaining genomic DNA and cDNA was synthesized (First Strand cDNA 
Synthesis Kit, Fermentas) according to the manufacturers’ instructions using 200 
ng of total RNA from each sample.  Each sample was processed in duplicate 
except that the reverse transcription enzyme was omitted in one of the duplicates 
as a negative control. 
Quantitative Real-Time PCR  
Messenger RNA levels of the target 5-HT1A receptor were determined 
from tissue obtained from the virus injection site, i.e., mNTS and commissural 
NTS, as well as the RO, which is the caudal raphe nucleus with the greatest 
density of serotonergic projections to the NTS.  This latter analysis was 
performed in order to rule out the possibility that any observed physiological 
effect of treatment was due to retrograde transport of virus and subsequent 
knocked down of 5-HT1A autoreceptors.  Samples of DR were also assessed as a 
positive control for 5-HT1A gene expression.  The α-adrenergic2A receptors 
(αAR2A) were also assessed in mNTS and commissural NTS to assess potential 
off target or compensatory effects of 1ARshRNA expression.  Real-time 
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quantitative PCR (qPCR) was performed on amplified cDNA using the CFX96 
TouchTM Real-Time PCR Detection System (Bio-Rad).  Template cDNA (2ng) 
corresponding to the transcripts of interest were amplified using primers (500nM) 
for both the sense and antisense strands.  SsoAdvancedTM SYBR® Green 
Supermix (2X) diluted to 1X with DEPC-treated water was added to all samples.   
Samples were run in triplicate and in parallel with a negative control in which 
water was substituted for template.   The following general PCR protocol was 
used with various annealing/extension temperatures: 95°C for 30 sec, 40 cycles 
of 95°C for 5 sec and 56-63°C for 30 sec.  Melt curves from 65°C to 95°C were 
included to confirm that only a single product was formed for each primer pair.   
CFX Manager Software was used to determine relative mRNA expression levels 
using the 2-ΔΔCT method (Livak and Schmittgen, 2001).  Results are presented as 
relative mRNA expression normalized to relative GAPDH mRNA and compared 
with average group values obtained from rats injected with the scrambled shRNA 
that were run in the same cohort (defined as 1.0-fold).  Forward and reverse 
primers were screened and designed using http://bioinfo.ut.ee/primer3-0.4.0/ and 
are shown in Table 3.  The Basic Local Alignment Search Tool (BLAST) from the 
NCBI website: (http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn& 
BLAST_PROGRAMS=megaBlast&PAGE_TYPE=BlastSearch) was applied to 
ensure that all amplified sequences shared no sequence homology with any 
other cDNA in the database.   Efficiency of each primer pair was determined by 
the slope of the standard curve and kept between 90 and 110%. 
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Table 3.   Primers for qPCR analysis. 
 
Forward and reverse primers are shown for GAPDH, 5-HT1A (5-HT1A), and α-
adrenergic2A receptor (ARD2A).  Annealing temperature (T), primer efficiency, 
and product length are also shown. 
 
 
 
 
 
 
 
 
 
 
 
 
Gene 
Symbol 
T 
(°C) 
Primer 
Efficiency 
(%) 
Forward Primer (5’ 3’) 
Reverse Primer (5’ 3’) 
Size 
(bp) 
GAPDH 56/61 99/96 
GAC ATG CCG CCT GGA GAA AC 
94 
AGC CCA GGA TGC CCT TTA GT 
5-HT1A 56 89 
AAG AAG AGC CTG AAC GGA 
171 
CAG AGG AAG GTG CTC TTT GG 
ADR2A 63 98 
CGG CAA TAG CAG CTG GAA CG 
129 
TTG CCA AAC ACG GTG AAC AG 
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Immunohistochemistry 
Serotonin immunoreactivity in caudal raphe nuclei was determined in a 
subset of rats injected with AAV vectors to rule out an effect of infection of caudal 
raphe serotonin cells with virus as a cause of observed physiological effects.  
One out of every six 40 µm sections were washed with 0.05 M potassium 
phosphate buffered saline (KBPS, 6 times for 10 minutes) then incubated in 
rabbit anti-serotonin primary antibody (1:80,000 in 0.4% Triton X-100 in KBPS; 
Immunostar) for one hour at room temperature followed by a 48 hour incubation 
at 4°C.  Sections were then washed with 0.05 M KPBS (10 times for 6 minutes) 
then incubated in goat anti-rabbit Dylight-649 (1:500, Jackson ImmunoResearch) 
for 3 hours at 37°C.  Following secondary antibody incubation, sections were 
washed a final time (10 times for 6 minutes), mounted on gelatin-coated slides, 
and coverslipped using Fluromount mounting media (Sigma).  Once 
coverslipped, sections were immediately stored at 4° for 14 days prior to imaging.   
Statistical Analysis 
 Two-way ANOVA with repeated measures were used to determine the 
effects of viral injection on cardiovascular and sympathetic measures as well as 
blood gas variables over time.  Holm-Šidák post-hoc tests were used to 
determine group differences at specific time points (i.e. every minute for the first 
10 minutes, then every 5 minutes until the end of the recovery period).  P values 
of <0.05 were considered significant.  Effect of viral injections on gene 
expression was determined by unpaired Student’s t-tests.  When group data 
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failed the Shipiro-Wilk normality test, the Mann-Whitney U Rank Sum Test was 
used instead.  All qPCR results are expressed as the group mean ± SEM.    
Results 
shRNA screening 
Images of mCherry and hrGFP positive HEK293 cells are shown after 
transfection with 5 unique sequences targeting various portions of the rat 5-HT1A 
receptor gene (1ARshRNA #1-5) or an shRNA sequence targeting the rat 
tryptophan hydroxylase 2 gene (TPHshRNA) as a control (Figure 6).  Of the 5 
sequences screened, only 1ARshRNA #2 significantly decreased expression of 
the 5-HT1A mCherry fusion protein as shown by reduced fluorescence intensity 
compared to cells transfected with TPHshRNA control (P < 0.01).   
Semi-quantitative PCR also showed a decrease in 5-HT1A receptor 
message in cells transfected with 1AshRNA #2 (Figure 7A; P < 0.05).  Our 
custom designed polyclonal rabbit 5-HT1A rabbit antibody identified a ~46 Kd 
protein that was present in HEK293 cells transfected with the full length rat 5-
HT1A receptor, but not in untransfected cells (Figure 7B).  This size is consistent 
with the expected size of the unmodified rat 5-HT1A receptor.  Whole cell lysates 
from cells transfected with the full length 5-HT1A receptor and 1AshRNA#2 
showed almost no labeled protein of this size, while cells transfected with the 
receptor and the shRNA sequence targeting TPH continued to express the 
identified protein.  1AshRNA#2 produced a 97% knockdown of 5-HT1A receptor 
protein compared to the TPHshRNA (P <0.01).  Together, these experiments  
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Figure 6.  In vitro screening of shRNA sequences targeting the rat 5-HT1A 
receptor.  HEK-293 cells co-transfected with Cherry-5-HT1AR and one of 5 
different 1ARshRNA sequences or a control sequence targeting the tryptophan 
hydroxylase gene, TPHshRNA (left).   Each sequence was compared to its own 
separate control.   Average fluorescent intensity (FI) of mCherry determined from 
each plate are also shown (right).  Independent experiments were repeated 3 
times on separate occasions.  Values are group means ± SEM.  Student’s t-test 
was used to analyze FI of ScramshRNA vs 1ARshRNA#1-5.  Only 1ARshRNA 
#2 had a significant reduction in FI compared to TPHshRNA [df = 4, t = 7.60, **P 
<0.01]   
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Figure 7.  The 5-HT1A receptor shRNA #2 reduces 5-HT1A receptor mRNA 
and protein expression in vitro.  A) The cell lysates from HEK 293 cells 
transfected with 1ARshRNA #2 and TPHshRNA were used to determine relative 
5-HT1A R mRNA levels via semi-quantitative RT-PCR (normalized to GAPDH).  
Representative blot of protein obtained from cells transfected with TPHshRNA 
and 1ARshRNA #2 (left) and mean densitometry data of 5-HT1AR mRNA from 6 
independent experiments (right), Student’s t-test was used to compare 
TPHshRNA vs 1ARshRNA,*P<0.05.  B) Immunoblot illustrating custom 5-HT1AR 
antibody specificity in untransfected (UT) and transfected HEK-293 cells.  C) 
Representative immunoblot of 5-HT1AR protein levels in cells transfected with 
1ARshRNA #2 or TPHshRNA transfected cells (top) and mean densitometry data 
(bottom) of 5-HT1AR protein from 3 independent experiments which show 
reduced 5-HT1AR protein expression in cells treated with 1ARshRNA #2 vs 
TPHshRNA.  Student’s t-test [df = 4, t = 4.71, **P <0.01].    
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identified one shRNA vector (1ARshRNA #2) that was found to efficiently knock 
down 5-HT1A receptor expression in cultured cells. 
Four weeks after in vivo injection of viruses encoding hrGFP and the 
efficient 1ARshRNA sequence or a scrambled version of the sequence, the  
hrGFP transgene was highly expressed in the NTS of injected rats (Figures 8 
and 9).  Evidence of hrGFP expression in the caudal raphe regions was 
identified, but was not extensive (Figure 9).  However, there was no apparent 
hrGFP expression in serotonin-positive cells of the caudal raphe region.  Nor was 
there hrGFP expression in or around the DR, an area enriched with 5-HT1A 
receptor (data not shown).  Approximately 50% and 30% reductions in 5HT1A 
receptor mRNA levels were found in the commissural NTS and mNTS 
respectively in rats injected with 1ARshRNA compared to ScramshRNA (Figure 
10A-C, P < 0.01).  The αAR2A receptor levels did not differ between groups in 
either the commissural NTS or mNTS injection sites (Figure 10D). 
 
Effects of 5-HT1A receptor knockdown on cardiovascular variables 
during hypotensive hemorrhage 
Treatment had no effect on body weight (358 ± 5 vs. 368 ± 5 g for 
ScramshRNA and 1ARshRNA respectively) prior to the start of hemorrhage.  All 
rats subjected to acute hypovolemic hemorrhage showed a characteristic 
multiphasic response to blood withdrawal (Figures 11 and 12).  Specifically, both 
groups displayed a short normotensive phase characterized by augmented  
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Figure 8.  AAV injection sites.  A) Schematic, modified from from 
Mitchell et al.  1975, shows dorsal view of the rat brain stem modified with 
numbers to indicate location of injection sites of AAV.   B) Location of 
injection sites relative to calamus scriptorus (top), and schematic, modified 
from Scott et al, 2000, showing coronal brainstem sections and location of 
injection in medial NTS (middle panel) and commissural NTS (lower 
panel).   C) Fluorescent micrographs demonstrating neuronal infection 
(hrGFP expression) in rats injected with AAVs encoding either the 
scrambled shRNA (left) or an shRNA targeting the rat 5-HT1A receptor 
(right).  mNTS, medial NTS; cNTS, commissural NTS; AP, area postrema; 
DMVX, dorsal motor nucleus of the vagus; XII, hypoglossal nucleus.   
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Figure 9.  Representative coronal rat brain sections after 
immunohistochemical label of serotonin.  Green fluorescence indicates 
hrGFP expression or AAV infection and red fluorescence represents serotonin 
(5-HT) expression.  Cells infected with virus encoding the ScramshRNA or the 
1ARshRNA were surrounded by 5-HT-positive nerve terminals in the 
commissural NTS (left panels).  5-HT immunoreactive cells of the RO (center 
panels) and those of the RM (right panels) were not infected with virus.   
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Figure 10.   5-HT1A receptor shRNA selectively and discretely reduces 
relative 5-HT1A receptor gene expression at the target site in vivo.  
Representative qPCR amplification curves for ScramshRNA (blue) and 
1ARshRNA (red) samples from RO (A) and commissural NTS (cNTS, B) show 
knockdown in cNTS but not RO.  C) Relative 5-HT1AR mRNA levels were 
normalized to GAPDH and calcuated as fold change from the average 5-HT1AR 
expression of the corresponding brain regions in the rats injected with 
ScramshRNA.   Values are group means ± SEM.  Student’s t-test was used to 
assess differences in 5-HT1A receptor mRNA levels between ScramshRNA vs 
1ARshRNA in different brain regions.  5-HT1A receptor expression was 
significantly decreased in the commissural NTS [df = 17, t = 6.66, P < 0.01] and 
mNTS [df = 17, t = 4.71, P < 0.01], but not in the hypoglossal nucleus [df = 16, t = 
0.60, P = 0.56], RO [df = 15, t = 1.23, P = 0.24] or DR [df = 13, t = 0.29, P = 
0.78].   D) Relative mRNA expression of αAR2A receptor in cNTS and  mNTS.  
Values are group means ± SEM.  Mann-Whitney U and Student’s t-test revealed 
no significant differences on the relative αAR2A receptor population in the cNTS 
[U = 22, t = 62, p = 0.54] and mNTS [df = 13, t = - 1.04, p = 0.32] respectively in 
1ARshRNA vs ScramshRNA rats.   
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Figure 11.   Representative sample recordings during hypotensive 
hemorrhage in ScramshRNA- and 1ARshRNA-injected rats.  Representative 
sample recordings (2.5 seconds) of arterial pressure (AP), raw renal sympathetic 
nerve activity (RSNA) and integrated activity (int.  RSNA) in individual 
ScramshRNA (A) and 1ARshRNA injected rats (B).   Data are shown prior to 
hemorrhage (baseline), 3 minutes after start of hemorrhage (peak 
compensation), and 8, 20 and 60 minutes after start of hemorrhage, and after 
injection with the ganglionic blocker hexamethonium chloride (Hex).   
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Figure 12.  Mean arterial pressure (MAP), heart rate (HR) and renal 
sympathetic nerve activity (RSNA) during hemorrhage and subsequent 
recovery in ScramshRNA- and 1ARshRNA-injected rats.  The MA, HR and 
RSNA during hemorrhage (gray shaded area) and subsequent recovery in rats 
injected with AAV encoding ScramshRNA or 1ARshRNA.  Values are group 
means ± SEM.  Number of subjects for ScramshRNA were 8 for RSNA and 16 
for MAP and HR measurements respectively.  Group number for rats treated with 
1ARshRNA were 6 for RSNA and 15 for MAP and HR respectively.    
Two-way ANOVA with repeated measures that examined the effect of ShRNA 
treatment and Time on cardiovascular variables revealed an interaction between 
ShRNA treatment and Time [F (1,144) = 3.06, P < 0.001] on RSNA responses.   
Post-hoc Holm-Sidak analyses performed at each time point revealed a 
significant reduction of RSNA among 1AshRNA-treated rats compared to 
ScramshRNA-treated controls throughout recovery, but not during hemorrhage 
itself.  *P <0.05 and ** P< 0.01  vs. ScramshRNA treated rats. 
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sympathetic activity and reflex tachycardia.   After withdrawal of approximately 9-
12 ml/kg of estimated blood volume, a rapid decline in BP, HR, and RSNA 
developed in both groups.   After termination of blood withdrawal, BP and HR 
recovered over the next 10-15 minutes before reaching a plateau.  Treatment 
with the 1ARshRNA did not affect either baseline BP or HR, or the response to, 
and subsequent recovery from blood withdrawal (Figure 11).  Among animals 
treated with the ScramshRNA, RSNA recovered following termination of blood 
withdrawal in parallel with BP and HR.  The RSNA of rats treated with 
ScramshRNA exceeded baseline levels and stabilized at a plateau approximately 
40-50% above baseline.  In contrast, RSNA of rats treated with 1ARshRNA did 
not fully return to baseline levels and stabilized at levels approximately 20% 
below baseline for the remainder of the experiment.  Rats treated with the 
1ARshRNA had reduced RSNA (relative to their own baseline) compared to rats 
treated with the ScramshRNA during recovery (P<0.01).    
Spontaneous baroreflex activity did not differ between the two treatment 
groups (Table 4).  Similarly, hematocrit and protein plasma levels were 
comparable between groups throughout the experiment (Table 5).  Lactate levels 
were significantly elevated in the 1ARshRNA group compared to the 
ScramshRNA group 60 minutes after the start of hemorrhage (Figure 13, P 
<0.01), but there were no further differences in the acid-base balance or blood 
gas variables between groups (Table 6).   
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Table 4.  Spontaneous baroreflex sensitivity data from baseline recordings in 1ARshRNA and 
ScramshRNA injected rats 
 
Spectral analyses were performed in the low frequency (LF) and high frequency (HF) domains.  Number of 
animals is shown in parentheses.  Systolic (SBP), mean (MBP), and diastolic (DBP) blood pressure.   Data are 
group means ± SEM.  Student’s t-test were used to compare group means for ScramshRNA and 1ARshRNA 
treated groups.   No significant differences were identified.
shRNA 
treatment  
Up 
Sequences 
(ms/mmHg) 
Down 
Sequences 
(ms/mmHg) 
All 
Sequences 
(ms/mmHg) 
Alpha        
(LF) 
Alpha        
(HF) 
LF Power 
(mmHg2) 
BP SDNN 
LF RRI    
(nu) 
HF RRI   
(nu) 
LF - to - HF 
ratio 
Scram (10)           
SBP 1.89  ± 0.32 1.49  ± 0.21 1.76  ± 0.26 0.83  ± 0.10 1.98  ± 0.37 13.95 ± 1.54 4.54 ± 0.47    
MBP 2.18  ± 0.32 2.06  ± 0.26 2.13  ± 0.27 0.90  ± 0.11 2.36  ± 0.38 11.88 ± 1.07 4.21 ± 0.43 43.22 ± 5.42 41.76 ± 4.82 1.35 ± 0.32 
DBP 2.30  ± 0.28 1.93  ± 0.25 2.13  ± 0.25 0.91  ± 0.12 2.20  ± 0.30 11.29 ± 0.68 4.21 ± 0.40    
1AR (6)           
SBP 2.28  ± 0.18 1.88  ± 0.62 2.55  ± 0.14 0.61  ± 0.04 2.87  ± 0.51 13.55 ± 2.52 4.33 ± 0.48    
MBP 2.54  ± 0.13 2.46  ± 0.22 2.20  ± 0.32 0.65  ± 0.06 3.18  ± 0.39 11.84 ± 2.02 4.09 ± 0.42 27.71 ± 6.50 57.76 ± 7.50 0.65 ± 0.28 
DBP 2.56  ± 0.15 2.03  ± 0.11 2.25  ± 0.10 0.67  ± 0.06 2.67  ± 0.29 11.29 ± 1.88 4.09 ± 0.40       
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Table 5.  Hematocrit and plasma protein concentrations before and after 
hypotensive hemorrhage in ScramshRNA and 1ARshRNA rats 
 
 
 n 
Hematocrit 
(%) 
Plasma Protein 
(g/dL) 
SCRshRNA 11   
0 min  43 ± 1 6.3 ± 0.15 
10 min  33 ± 1** 4.7 ± 0.1** 
60 min  33 ± 1** 4.9 ± 0.1** 
1ARshRNA 11   
0 min  41 ± 2 6.2 ± 0.1 
10 min  31 ± 2** 4.6 ± 0.1** 
60 min   30 ± 2** 4.9 ± 0.1** 
 
Values are group means ± SEM.  Two-way ANOVA with repeated measures 
were used to examine the effect of ShRNA treatment and Time on hematocrit 
and protein plasma.  No interactions were found.  The main effect of Time were 
followed up by Holm-Šidák post-hoc analysis.  Both plasma protein 
concentrations [F (2,21) = 246, P<0.001] and hematocrit levels [F (2, 21) = 531, 
P < 0.01] fell by 10 minutes after start of hemorrhage and both remained below 
baseline by 60 minutes after start of hemorrhage **P < 0.01 vs 0 minutes within 
group. 
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Table 6.   Effects of hemorrhage on venous blood gas variables and acid-
base status in ScramshRNA- and 1ArshRNA-injected rats 
 
 
 
Values are group means ± SEM.  Two-way ANOVA with repeated measures 
were used to compare ShRNA Treatment and Time on blood gas variables and 
acid-base status.  There were no group differences observed at any time point.   
Main effects of Time only on pH [F (2, 25) = 57.91, P< 0.001], pCO2 [F (2,25) = 
36.33, P < 0.001], pO2 [F (2,25) = 19.88, P < 0.001] and BE [F (2,25) = 121.82, P 
< 0.001] were all due to reductions in all variables with hemorrhage and/or 
subsequent recovery by 60 min.  The main effects of Time were followed up by 
post-hoc analysis using Holm-Šidák, * P < 0.05 vs 0 min within group, ** P < 0.01 
vs 0 min within group, † P < 0.05 vs 10 min, and ‡ P < 0.01 vs 10 min within 
group.    
 
  n pH 
pCO2     
(mmHg) 
pO2       (mmHg) 
BE       
(mmol/L) 
SCRshRNA 13     
0 min  7.49 ± 0.01 43.31 ± 0.44 34.85 ± 1.58 10.00 ± 0.66 
10 min  7.44 ± 0.01* 42.35 ± 0.82  26.62 ± 1.38* 4.46 ± 0.55* 
60 min  7.46 ± 0.01**,† 46.19 ± 0.54**,‡ 31.69 ± 1.14*,‡ 9.00 ± 0.78**,‡ 
1ARshRNA 13     
0 min  7.50 ± 0.01 42.52 ± 0.66 34.85 ± 1.49 10.08 ± 0.70 
10 min  7.44 ± 0.01* 41.89 ± 0.96 27.92 ± 1.14* 4.08 ± 1.06* 
60 min   7.45 ± 0.01**,† 46.40 ± 0.76**,‡ 31.85 ± 1.64*,‡ 8.00 ± 1.12**,‡ 
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Figure 13.  Lactate levels at baseline, after hemorrhage termination and           
recovery.  Data were analyzed by 2-way ANOVA with ShRNA treatment and 
repeated measures of Time as factors.  There were significant effects of shRNA 
treatment [F (1,25) = 5.16, P< 0.05] due to higher lactate levels overall in 
1ARshRNA treated rats.  A main effect of Time [F (2,25) = 62.1, P < 0.01] was 
due to the rise in lactate with hemorrhage, and the subsequent fall with recovery.    
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5-HT1A receptor knockdown correlates with sympathetic recovery 
and acid-base status following hypotensive hemorrhage 
 5-HT1A mRNA expression in 1ARshRNA-treated rats ranged from 20-80% 
of levels found in rats treated with ScramshRNA.  To determine if the degree of 
5-HT1A receptor knockdown was related to sympathetic compensation from 
hemorrhage, RSNA and lactate levels determined 60 min after the start of 
hemorrhage were correlated with 5-HT1A mRNA gene expression.  Significant 
positive correlations between 5-HT1A receptor mRNA and RSNA in both 
commissural NTS and mNTS injection sites were observed (Figure 14A; 
Spearman coefficient = 0.90 and 0.79, r2 = 0.82 and 0.63, P < 0.01).  Lactate was 
negatively correlated with 5-HT1A receptor mRNA in the commissural NTS, but 
not in the mNTS (Figure 14B; Spearman coefficient -0.82 vs -0.23, r2 = 0.67 vs 
0.05, P= 0.01 vs P= 0.42).   
 
Discussion 
In the present study, we investigated the role of 5-HT1A receptor 
expression in the commissural NTS and mNTS on compensation from 
hypotensive hemorrhage in unanesthetized rats.  We found that rats with 30-50% 
knockdown of 5-HT1A receptors in the commissural NTS and mNTS showed an 
attenuated recovery of sympathetic activity following a moderate level and rate of 
blood loss (~21% of estimated blood volume over 10 minutes), but showed no 
differences in BP or HR responses to hemorrhage.  The extent of 5-HT1A  
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Figure 14.  Relationship of 5-HT1A  receptor mRNA levels in the 
commissural NTS to sympathetic recovery and and lactate levels.  5-HT1A  
receptor gene expression in the commissural NTS is directly related to 
sympathetic recovery and inversely related to lactate levels.  A) A Spearman 
correlation between relative 5-HT1A receptor mRNA expression and RSNA 60 
min after the start of hemorrhage in commissural NTS (cNTS; left) and mNTS 
(right).  B) Spearman correlation data between the relative mRNA levels of 5-
HT1AR and lactate production 60 minutes after the start of hemorrhage in the 
cNTS (left) and  mNTS (right).   
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receptor knockdown was also related to the level of lactic acidosis and RSNA 
activity 50 minutes after termination of hemorrhage.  This relationship was most 
robust when receptor expression in the more caudal commissural subnucleus of 
the NTS was examined.  Together, the data indicate that sufficient expression of 
5-HT1A receptors in the commissural NTS is necessary for normal sympathetic 
compensation following moderate blood loss, and that this receptor population 
contributes to oxygen delivery to peripheral tissue during compensation from 
hypotensive hemorrhage. 
These results extend our previous findings that selective destruction of the 
serotonin neurons in the caudal raphe attenuates sympathetic recovery following 
hypotensive hemorrhage and exaggerates metabolic acidosis.  Such lesions 
reduced serotonin innervation of the caudal NTS by 50% and the RVLM by 
almost 90%.  Despite the use of the same protocol for hemorrhage, the caudal 
raphe lesioned animals from the prior study showed more severe lactic acidosis 
as well as reduced arterial blood pH.  In contrast, animals subjected to 5-HT1A 
receptor knockdown in the current study did not show significant deficits in pH 
buffering.  Clinical evidence indicates that pH does not correlate with lactate until 
lactate values exceed 5.0 mM, as was seen in the caudal raphe lesion study 
(Mizock and Falk, 1992).  It is not known why the animals in this experiment 
experienced less severe tissue hypoxia than in our prior study given that the 
blood withdrawal protocols were the same.  However, in the prior study, animals 
were also implanted with diaphragmatic EMG electrodes, which required a more 
invasive surgical procedure that could have potentially affected ventilation, 
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possibly resulting in an impaired buffering through expiration of CO2.  
Nevertheless, lactate is the first and best indication of deficits in tissue perfusion, 
and the present data indicate that 5-HT1A receptors in the NTS contribute to 
neural responses that facilitate tissue perfusion following hemorrhage.    
Alternatively, the greater metabolic acidosis seen with caudal raphe 
serotonin cell lesion may indicate that serotonin acting on additional receptor 
populations beyond the 5-HT1A receptors of the NTS may also contribute to 
sympathetic-dependent changes in tissue perfusion.  A more recent study from 
our laboratory would suggest that this is not likely the case since discrete lesion 
of serotonin nerve terminals in the caudal NTS also attenuates sympathetic 
recovery to the same extent found in the present study.  However, blood gases 
and acid base balance were not examined in the NTS lesion study. 
 Rats injected with 1ARshRNA displayed the normal, multi-phasic 
response to blood loss, suggesting that 5-HT1A receptors in the NTS are probably 
not involved in the initial sympathoexcitatory response or in the sympatholytic 
phase of hypotensive hemorrhage.  Rather, 5-HT1A receptor activation in the NTS 
appears to be necessary for normal secondary sympathoexcitatory 
compensation from blood loss.  The presence of exaggerated lactic acidosis 
during this secondary sympathoexcitatory phase in 1ARshRNA-treated rats 
indicates that a deficit in oxygen delivery to peripheral tissue developed following 
termination of blood withdrawal in these animals.  Furthermore, the correlation of 
lactic acid as well as sympathetic recovery with the extent of 5-HT1A receptor 
knockdown suggests that sympathetic drive aids in peripheral tissue 
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oxygenation.  Reduced oxygen delivery results from reduced oxygen in arterial 
blood and/or deficits in perfusion of peripheral tissue.  In this study, we did not 
measure arterial blood gases.  However, in the caudal serotonin cell lesion study 
PaO2 was actually increased in lesioned animals, indicating that peripheral tissue 
hypoxia observed in this prior study was due to reduced perfusion rather than to 
a deficit in blood oxygenation.  Here, we focused on blood gases measured in 
venous blood since they better reflect peripheral metabolic acidosis.  No group 
differences were found in either PvO2 or PvCO2 at any point, suggesting that 
arterial blood oxygen may have been similar between groups during and after 
hemorrhage.  While we cannot rule out the possibility that tissue O2 extraction 
differed between groups and thus that PaO2 differed between groups, given our 
prior results that extensive caudal serotonin cell lesion did not impair blood 
oxygenation, it seems more likely that the greater tissue hypoxia observed in 
1ARshRNA-treated rats was due to reduced perfusion of peripheral tissue.    
Our findings that BP responses were not different between groups despite 
evidence of perfusion deficits suggests that serotonin acts on 5-HT1A receptors in 
the NTS to maintain CO.  In the absence of these mechanisms, other potentially 
more damaging mechanisms of vasoconstriction may contribute to the 
maintenance of the BP.  Toung et al, performed elegant studies that examined 
the degree to which circulating vasoconstrictor hormones and sympathetic 
activity contribute to arterial and venous constriction during blood loss.  They 
noted that sympathetic activity contributes substantially more to venous 
constriction, while increases in angiotensin II and vasopressin contribute to BP 
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maintenance primarily by increasing arterial vasoconstriction (Toung et al., 
2000).   Together, these data suggest that endogenous serotonin released during 
hemorrhage acts on 5-HT1A receptors in the NTS to maintain CO through 
increased venoconstriction; this hypothesis remains to be tested.  Nevertheless, 
this hypothesis is further supported by our prior studies which showed that 
administration of the 5-HT1A receptor agonist, 8-OH-DPAT, into the 4th 
cerebroventricle of unanesthetized rats increased venous tone, CO and indices 
of tissue oxygenation.  Moreover, these effects were found to be dependent upon 
sympathetic activity. 
It is unclear how 5-HT1A receptors in the caudal NTS contribute to 
sympathoexcitation following hemorrhage.  The decrease in 5-HT1A receptor 
mRNA levels had no effect on any index of spontaneous arterial baroreflex 
sensitivity.  Therefore, it is unlikely that deficits in baroreflex sensitivity 
contributed to the attenuated sympathetic response in 1ARshRNA-treated rats 
during hemorrhage.  Indeed, our prior study showed that serotonin nerve terminal 
lesion actually improved baroreflex sensitivity.  The current study further extends 
these earlier findings by demonstrating that the enhanced baroreflex sensitivity 
that accompanies deficits in serotonin innervation of the dorsomedial portion of 
the caudal brainstem are likely not due to deficits in 5-HT1A receptor activation.     
Of interest were findings that the 5-HT1A receptor gene expression in the 
commissural NTS correlated better with lactate levels or sympathetic recovery 50 
minutes after termination of hemorrhage than did receptor expression in the 
mNTS.  The commissural NTS receives a far greater density of nerve terminals 
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from peripheral chemoreceptors than the medial NTS, which itself receives more 
arterial baroreceptor terminals than the commissural NTS (Finley and Katz, 1992; 
Housley et al., 1987; Mifflin, 1992).  Our prior work showed that the 
sympathoexcitatory effect of 5-HT1A receptor agonist administration in 
hemorrhaged animals was severely attenuated following sinoaortic denervation, 
indicating that 5-HT1A receptor-mediated increases in sympathetic activity after 
hemorrhage are dependent on arterial baroreceptors and/or peripheral 
chemoreceptor input (Osei-Owusu and Scrogin, 2006).  Together, these findings 
are highly suggestive of the possibility that 5-HT1A receptors facilitate peripheral 
chemoreceptor afferent activation of sympathetic drive during hemorrhage.    
 A limitation of this study is the possibility that our results are due to 
unintentional effects of viral injection due either to down regulation of 5-HT1A 
receptor populations remote from the site of injection or by altering gene 
expression of entirely different receptors that could influence sympathetic drive 
during hemorrhage.  Post-mortem assessments of 5-HT1A receptor gene 
expression confirmed that knockdown of the receptor was localized to the 
injection sites.  We did not observe significant reductions in gene expression 
ventral to the injection site in the hypoglossal nucleus.  Nor did we observe 
decreases in 5-HT1A receptor gene expression in sites remote from the injection 
that are enriched in 5-HT1A receptor such as the DR.  We also assessed the 
possibility that retrograde transport of the virus and subsequent expression of the 
shRNA in serotonin cells that project to the NTS from the RO and RM might have 
contributed to deficits in compensation during hemorrhage by reducing 
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expression of 5-HT1A autoreceptors.  While we noted some hrGFP expression 
around the serotoninergic cells of the RO and RM, we did not see co-localization 
of hrGFP and serotonin label in either of these regions.  Furthermore, 5-HT1A 
receptor gene expression in the RO, which provides the densest serotonergic 
projections to the caudal NTS, was not affected by 1ARshRNA treatment.    
We also explored the possibility that the attenuated sympathetic recovery 
exhibited by rats injected with virus encoding the 1ARshRNA was due to 
compensatory gene expression of other receptors within the NTS.  Previous 
investigations have found that αAR2A receptors in the caudal NTS facilitate 
central integration of the peripheral chemoreflex (Hayward, 2001).  Therefore, we 
examined gene expression of the rat αAR2A in the NTS and found no effect of 
treatment.    
Results from this first study were incorporated into a working model that 
illustrates the major findings of Aim 1 (Figure 15). In summary, results from the 
current study identified a role for 5-HT1A receptor activation in the sympathetic 
recovery that follows hypotensive hemorrhage.  Additionally, we found that 5-
HT1A receptor activation in the caudal NTS facilitates peripheral tissue perfusion.  
Although the mechanism by which 5-HT1A receptor activation promotes recovery 
from blood loss remains unknown, it is recognized that activation of 5-HT1A 
receptors hyperpolarizes neurons.  Thus 5-HT1A receptor activation may disinhibit 
neurons that normally suppress recovery of sympathetic drive during 
compensation from hypotensive hemorrhage.  We speculate that as blood loss 
progresses, serotonin is released in the NTS where it activates 5-HT1A receptors, 
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which in turn, disinhibit inhibitory interneurons that suppress sympathetic drive to 
the venous vasculature that mobilizes blood stores.  The precise mechanism(s) 
that stimulate serotonin release in the NTS remain unknown.  
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Figure 15. Diagram of 5-HT1A receptor activation during hypotensive 
hemorrhage.  Results from Aim 1 identified a role for 5-HT1A receptor activation 
in the sympathetic recovery from hemorrhage and facilitates peripheral tissue 
oxygenation.  Since activation of 5-HT1A receptors produces hyperpolarization of 
neurons, it is plausible that 5-HT1A receptor activation may disinhibit GABA 
neurons that normally suppress recovery of sympathetic drive during 
compensation from hypotensive hemorrhage.  Therefore, during blood loss 
serotonin is released in the NTS where it activates 5-HT1A receptors, which in 
turn, disinhibit GABA interneurons that suppress sympathetic.  The precise 
mechanism(s) that stimulate serotonin release in the NTS remain unknown.  
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CHAPTER IV 
5-HT1A RECEPTORS IN THE NUCLEUS TRACTUS SOLITARIUS ARE 
RESPONSIBLE, IN PART, FOR THE SYMPATHOEXCITATORY AND 
PRESSOR EFFECTS OF 8-OH-DPAT ADMINISTRATION DURING 
HYPOTENSIVE HEMORRHAGE 
 
Abstract 
 In prior work outside of this dissertation, we demonstrated that 
administration of the full 5-HT1A receptor agonist, 8-OH-DPAT, promotes a 
sympathetically-mediated increase in BP in rats subjected to hypotensive 
hemorrhage or more severe hemorrhagic shock.  The sympathoexcitatory effect 
of 8-OH-DPAT was found to be more pronounced when the drug was 
administered centrally into the 4th cerebroventricle and was dependent upon 
intact sinoaortic nerve innervation.  Arterial baroreceptors and peripheral 
chemoreceptor afferents of the sinoaortic nerves innervate the dorsomedial 
brainstem in the caudal NTS near the site where 8-OH-DPAT was found to have 
the most pronounced hemodynamic effects.  These findings led us to 
hypothesize that 8-OH-DPAT activates 5-HT1A receptors located in the caudal 
NTS to mediate its BP and sympathoexcitatory effects in hypovolemic rats.  In 
this study, we injected the 5-HT1A shRNA AAV or the scrambled AAV control
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virus into the caudal NTS of male Sprague Dawley rats to test this hypothesis.  
After 4 weeks, rats treated with the 1ARshRNA-encoding AAV showed a slowed 
pressor response to 8-OH-DPAT compared to rats injected with virus encoding 
the scrambled shRNA (68 ± 4 vs 87 ± 3 mmHg, 10 min after start of hemorrhage, 
P<0.01).  5-HT1A receptor gene expression in the commissural NTS, but not the 
medial NTS or underlying hypoglossal nucleus, was inversely correlated with the 
latency of BP to recover to 75% of baseline after 8-OH-DPAT injection.  
Successful knockdown of the 5HT1A receptor also attenuated the 
sympathoexcitatory effect of 8-OH-DPAT (-41.6 ± 13.6 vs 77.1 ± 22.0 % of 
baseline, 1 minute after 8-OH-DPAT administration, P < 0.05).  The 
sympathoexcitatory response to 8-OH-DPAT was directly correlated with 5-HT1A 
receptor expression in the NTS (P < 0.05).  Together, these data indicate that the 
pressor and sympathoexcitatory effects of 8-OH-DPAT administration observed 
in hypovolemic rats are due, at least in part, to activation of 5-HT1A receptors in 
the caudal NTS.   
 
Introduction 
 Previous studies from our laboratory have identified a role for 5-HT1A 
receptor agonists to facilitate compensation from blood loss.  As detailed in 
Chapter 2, the administration of 5-HT1A receptor agonists, including the full 
agonist, 8-OH-DPAT, produces a hemodynamically favorable outcome when 
administered to rats during hypotensive hemorrhage.  Moreover, the 
sympathoexcitatory and pressor effects of 8-OH-DPAT are reversed by 
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administration of 5-HT1A receptor antagonist, WAY-100635 (Scrogin, 2003; 
Scrogin et al., 2000).   
Subsequent studies utilizing a more severe hemorrhagic shock model 
(~50% estimated blood volume) showed that 8-OH-DPAT increased venous tone 
(as measured by mean circulatory filling pressure [MCFP]) and venous return, 
and reversed lactic acidosis in unanesthetized rats (Tiniakov et al., 2007; 
Tiniakov and Scrogin, 2006).  Increases in BP following 8-OH-DPAT 
administration were due almost exclusively to an increase in CO, with virtually no 
effect on TPR.  From these studies we concluded that 8-OH-DPAT promotes 
sympathetic drive to preferentially augment venoconstriction and mobilize venous 
blood back to the heart, and thereby improve tissue perfusion.  Mobilization of 
venous blood stores during hemorrhage is primarily mediated by the vascular 
beds of the splanchnic region (Greenway and Lister, 1974; Reilly et al., 2001).   
Accordingly, the rise in MCFP mediated by 8-OH-DPAT is abolished by 
sympathetic denervation of the splanchnic vasculature, as is the protective effect 
of 8-OH-DPAT against lactic acidosis (Tiniakov et al., 2012).    
 Prior work also suggests that 8-OH-DPAT accelerates recovery from 
hemorrhage by an agonist action on 5-HT1A receptors.  In these studies, the 
selective 5-HT1A receptor antagonist, WAY-100635, given prior to hemorrhage, 
dose-dependently inhibited the ability of 8-OH-DPAT to slow the hypotensive and 
sympatholytic response to blood loss.  However, WAY-100635 and 8-OH-DPAT 
have both been shown to possess affinity for other receptor types including 
AR2A receptors (Bonaventure et al., 2004; Sprouse et al., 2004).  The AR2A 
116 
 
 
 
receptors located in the caudal NTS have been implicated in sympathetic and 
ventilatory responses to chemoreflex activation by chemical hypoxia (Hayward, 
2001).  A more rostral AR2A receptor population located in the RVLM is also 
known to inhibit sympathetic activity by suppression of bulbospinal barosensitive 
neurons (Allen and Guyenet, 1993; Hayar and Guyenet, 1999).  8-OH-DPAT also 
has significant agonist activity on 5-HT7 receptors which are also expressed in 
the NTS (Gustafson et al., 1996; Sprouse et al., 2004; To et al., 1995).   
Therefore, it is conceivable that 8-OH-DPAT mediates its actions during 
hemorrhage through either an agonist or antagonist effect on 5-HT7 or AR2A 
receptors. 
 It is not clear where in the brainstem 8-OH-DPAT mediates its 
sympathoexcitatory effects in hemorrhaged animals.  Our prior work showed that 
8-OH-DPAT produced the most robust compensatory effects when injected into 
the cisterna magna, just above the floor of the 4th ventricle where the dorsal 
surface of the caudal NTS is located (Scrogin, 2003).  Evidence that the caudal 
NTS receives sinoaortic afferent input and that severing these same afferents 
attenuates the sympathetic and BP effects of 8-OH-DPAT led us to speculate 
that 8-OH-DPAT might act within the NTS to mediate its beneficial effects in 
hypovolemic animals.  Moreover, our prior work suggests that endogenous 
serotonin, released during hemorrhage, also contributes to sympathetic 
compensation following hemorrhage in a manner parallel to that of 8-OH-DPAT 
(Kung et al., 2010).  Our evidence that serotonin nerve terminal lesion in the NTS 
had the opposite effect of 8-OH-DPAT (i.e., delayed sympathetic recovery) led us 
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to further speculate that both endogenous serotonin and 8-OH-DPAT act on the 
same receptor population to mediate their effects (Kung and Scrogin, 2011).   
Therefore, we proposed that 8-OH-DPAT acts on 5-HT1A receptors in the caudal 
NTS to mediate its pressor and sympathoexcitatory effects during hypotensive 
hemorrhage.    
In unpublished studies, we noted that 8-OH-DPAT did not affect BP in 
hemorrhaged rats under any anesthesia so far tested including: urethane, -
chloralose, isoflurane, sodium pentobarbital, ketamine, chloral hydrate or 
thiobarbital.  The mechanisms behind the insensitivity to 8-OH-DPAT in 
anesthetized rats is unclear.  Nevertheless this anesthetic effect has complicated 
efforts to identify the specific brain region where 8-OH-DPAT mediates its action, 
particularly since the caudal hindbrain is difficult to access by chronic 
cannulation.  This complication, together with the evidence that 8-OH-DPAT has 
affinity for several different receptor subtypes led us to utilize highly specific 
shRNA knockdown technology as an approach to determine the location and 
receptor population on which 8-OH-DPAT acts to mediate its effects.  Here, we 
utilized AAV delivery of the 5-HT1A shRNA to selectively and discretely reduce 5-
HT1A receptor expression in the caudal NTS in order to determine whether 8-OH-
DPAT acts on the 5-HT1A receptors to mediate its pressor and sympathetic 
effects in unanesthetized hemorrhaged rats.    
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Methods 
Animals 
Experiments were performed on 27 Male Sprague-Dawley rats (275 to 
300 g; Harlan, Indianapolis, IN) which were acclimated to the institutional animal 
facility under standard conditions (22°C ambient temperature, 12:12 hour light 
cycle) with food and water available ad libitum for at least 1 week prior to 
surgery.  All experimental protocols were approved by the Institutional Animal 
Care and Use Committee and conducted in compliance with the Principles of 
Laboratory Animal Care, as adopted and promulgated by the United States 
National Institutes of Health. 
Surgical procedures 
AAV injections 
Prior to surgery, AAV vectors were diluted in viral storage buffer [400nM 
NaCl, 20 mM Tris base, (1x1012 vg/ml)] and dialyzed in 0.9% saline (Slide-a-
Lyzer, ThermoScientific) as described in Chapter 3.  Rats were anesthetized with 
ketamine/xylazine (85/13mg/kg, im) and placed in a stereotaxic apparatus with 
the nose bar positioned 11 mm below a flat skull plane then AAV vectors were 
injected as described previously in Chapter 3.  Animals were then allowed to 
recover for four weeks prior to hemorrhage experiments. 
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Vascular catheter and renal sympathetic recording electrode implantation 
The day before hemorrhage experiments, rats were anesthetized with 
isoflurane (5% for induction and 1.5-2.5% for maintenance) in 100% O2 (1L min-1) 
and instrumented with catheters and a renal sympathetic recording electrode as 
described in Chapter 3.  The electrode lead wires were tunneled under the skin 
to exit at the nape of the neck.  Rats were given ampicillin (150 mg/kg sc) 
antibiotic and ketoprofen (5 mg/kg sc) for analgesia and allowed to recover 
overnight.  Experiments were conducted the day after surgery.    
Experimental Protocols 
Hypotensive hemorrhage  
All rats were subjected to hypotensive hemorrhage conducted as 
described previously (Kung and Scrogin, 2011) and in detail in Chapter 3 with 
modifications described below.  Briefly, arterial lines (PE-50 tubing fused with 
PE-10) were connected to a withdrawal pump and an arterial pressure 
transducer through an overhead swivel system while the unrestrained rats rested 
in their home cage.  The recording electrode and venous line were connected to 
appropriate lead wires and tubing through the same overhead swivel system.   
Rats were habituated for at least one hour, after which blood withdrawal 
commenced at a rate of 3.2 mL/min/kg for 6 minutes, and then 0.52 mL/min/kg 
for an additional 4 minutes, to provide a total withdrawal of 21% of estimated 
blood volume over 10 minutes.  Precisely 7 minutes after the start of 
hemorrhage, 8-OH-DPAT was administered (30 nMoles/kg, iv) followed by a 150 
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µL bolus of isotonic saline.  Data acquisition began 20 minutes prior to the start 
of blood withdrawal and continued throughout the course of hemorrhage and for 
an additional 50 minute recovery period following termination of blood 
withdrawal.  In a subset of rats, femoral venous blood samples (150 µL) were 
taken 20 minutes prior to hemorrhage, as well as 10 and 60 minutes after the 
start of blood withdrawal to measure hematocrit, venous blood gases and acid-
base status with an i-STAT 1 Analyzer (i-STAT, East Windsor, NJ).   Plasma 
protein concentrations were determined by a handheld clinical refractometer 
(ATAGO U.S.A.  Inc.).  At the end of the experiment, rats were given 
hexamethonium chloride (30 mg/kg iv) to enable determination of background 
noise in the renal sympathetic recording electrode.  The majority of animals were 
quickly anesthetized with sodium pentobarbital (100 mg/kg, iv), and decapitated.   
Their brains were quickly extracted and flash frozen in cold isopentane and 
stored at -80°C for qPCR assessment of receptor gene expression.  A small 
subset of animals were anesthetized with sodium pentobarbital (100 mg/kg iv) 
then quickly perfused transcardially with 90 ml of sodium nitrate (0.1M) in 6.7 mM 
phosphate buffer followed by 90 ml 4% paraformaldehyde in 0.1 M phosphate 
buffer (PB).  Brains were then removed and post-fixed for 1 hour.  The brainstem 
was blocked and post-fixed overnight.  The following day, brains were transferred 
to 30% sucrose solution and stored at 4°C until sectioning.  Brains were 
sectioned on a freezing microtome in 40 µm sections and collected serially into 6 
wells filled with cryoprotectant (30% sucrose and 30% ethylene glycol in 0.1 M 
PB) and stored at -20° prior to histological assessment of the injection sites. 
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Spontaneous baroreflex sensitivity 
Five minute segments of baseline BP and HR data were recorded prior to 
hemorrhage and analyzed with Nevrokard SA-BRS software version 3.2.4 to 
determine spontaneous baroreflex gain using the sequence method as described 
in Chapter 3. 
Data acquisition  
Arterial pressure, HR, and renal sympathetic nerve activity (RSNA) were 
recorded on a Macintosh G4 Powerbook with PowerLab data acquisition 
software (Chart version 5.2.1; ADinstruments, Colorado Springs, CO) and 
analyzed as described in Chapter 3.    
Tissue Microdissection  
Brains were transferred to a Leica CM 3050 S Cryostat (-15 to -17°C).  
Five hundred µm thick sections were cut and 0.75 and 1 mm diameter 
micropunches were taken from areas of interest (listed below) localized 
according to the stereotaxic rat brain atlas of Paxinos and Watson as described 
in Chapter 3 (Watson, 1982).  The tissue was homogenized immediately in 1.0 
mL TRIzol® Reagent (Invitrogen) using a glass mortar and pestle on ice.  
Samples were transferred to microcentrifuge tubes for RNA extraction.    
Tissue homogenization and immunoblotting  
Total protein was extracted from a subset of micropunch samples using a 
homogenizing buffer that consisted of 50 mM Tris buffer (pH 7.6) with sodium 
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chloride (0.01 M) and the addition of a proteinase inhibitor cocktail (Roche).   
Protein concentration from the micropunch samples was determined by BCA 
assay (Pierce) as described in Chapter 3.  Immunoblotting protocols were also 
performed in the same manner as described in Chapter 3.  In addition, hrGFP 
protein expression was also determined in micropunch samples by incubating the 
membranes overnight with a mouse anti-hrGFP antibody (1:500, Assay Designs) 
in 1% nonfat dry milk at 4˚C.  Membranes were then incubated with HRP-
conjugated anti-mouse secondary antibody (1:2000, Pierce) for 1 hour at room 
temperature.  The membrane was washed a final time with TBST (3 times for 10 
minutes) then protein bands were developed with Super-Signal West Pico 
substrate (Themo) and exposed on autoradiographic film.  The band densities of 
5-HT1A receptor and hrGFP were quantified with Image J (NIH, USA), and 
normalized to actin.   
Tissue RNA Isolation and cDNA synthesis 
Total RNA was extracted, genomic DNA removed, and then synthesized 
into cDNA according to protocols described in Chapter 3. 
Quantitative Real-Time PCR  
Messenger RNA levels of the 5-HT1A receptor were determined from 
tissue obtained from the commissural NTS, mNTS, RO, hypoglossal nucleus, 
and DR as described in Chapter 3.  The 5-HT7 receptor and αAR2A receptors 
were also assessed in mNTS and commissural NTS to rule out off target, or 
compensatory effects of shRNA treatment.  Real-time qPCR was performed on 
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amplified cDNA using the CFX96 TouchTM Real-Time PCR Detection System 
(Bio-Rad).  The following general PCR protocol was used with various 
annealing/extension temperatures: 95°C for 30 sec, 40 cycles of 95°C for 5 sec 
and 56-63°C for 30 sec.  Melt curves from 65°C to 95°C were included to confirm 
that only a single product was formed for each primer pair.  Samples were 
prepared and analyzed as described in Chapter 3.  Primer sequences used for 
amplification and annealing temperatures for each gene are listed in Table 7.   
Results are presented as relative mRNA expression normalized to relative 
GAPDH mRNA. 
Statistical Analysis 
 Two-way ANOVA with repeated measures were used to determine the 
effects of viral injection on cardiovascular and sympathetic measures as well as 
and on blood gas parameters over time.  Holm-Šidák post-hoc tests were used to 
determine group differences every minute for the first 10 minutes, then every 5 
minutes until the end of the recovery period.  P values of < 0.05 were considered 
significant.  PCR data from rats treated with the 1ARshRNA-encoding virus were 
normalized to the group average of rats injected with the ScramshRNA that were 
in the same qPCR cohort.  Typically, two animals of each shRNA group were run 
in the same cohort.  Significance was determined by unpaired Student’s t-tests.   
When group data failed the Shipiro-Wilk normality test, the Mann-Whitney Rank 
Sum Test was used instead.  All qPCR results are expressed as the group mean 
± SEM.    
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Table 7.   PCR conditions for 8-OH-DPAT-treated rats 
Gene 
Symbol 
T 
(°C) 
Primer 
Efficiency 
(%) 
Forward Primer (5’ 3’) 
Reverse Primer (5’ 3’) 
Size 
(bp) 
GAPDH 56/61 99/96 
GAC ATG CCG CCT GGA GAA AC 
94 
AGC CCA GGA TGC CCT TTA GT 
5-HT1A 56 89 
AAG AAG AGC CTG AAC GGA 
171 
CAG AGG AAG GTG CTC TTT GG 
5-HT7 61 100 
GTG GAT CTT CGG CCA CTT CT 
108 CCA AGG TAC CTG TCG ATG 
CTG 
ADR2A 63 98 
CGG CAA TAG CAG CTG GAA CG 
129 
TTG CCA AAC ACG GTG AAC AG 
     
Primers for qPCR analysis.  Forward and reverse primers are shown for GAPDH, 
5-HT1A, 5-HT2A receptor (5-HT2A), 5-HT7 receptor (5-HT7) and α-adrenergic2A 
receptor (ARD2A).  Annealing temperature (T), primer efficiency, and product 
length are also shown 
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Results 
 Prior to the start of hemorrhage experiments, there was no significant 
difference in body weights between ScramshRNA and 1ARshRNA injected rats 
(Table 8).  Similarly, hematocrit and plasma protein values were not significantly 
different between groups.  Nor did indices of spontaneous baroreflex sensitivity 
differ between groups (Table 9).  Both groups displayed the typical multiphasic 
response to blood loss (Figure 16).  Specifically, BP was maintained with the 
onset of blood withdrawal while sympathetic drive and HR increased.  After 9-12 
ml/kg of estimated blood volume had been withdrawn, a syncopal-like phase 
ensued, characterized by a dramatic decline in BP, HR, and RSNA.  Seven 
minutes after the initiation of blood withdrawal, systemic administration of 8-OH-
DPAT (30 nM/kg, iv) produced a pressor effect in both treatment groups, but the 
effect was more pronounced in the ScramshRNA-treated rats compared to rats 
treated with the 1ARshRNA-encoding virus (P <0.01).  Specifically, the BP 
response to 8-OH-DPAT was slower the first 3 minutes after injection in 
1ARshRNA-treated rats compared to ScramshRNA animals.  However, BP in 
both groups eventually plateaued to a level that was no longer different.  8-OH-
DPAT raised HR in both groups as well.  While, the response was attenuated in 
rats treated with 1ARshRNA, the difference was not significant (P = 0.09).  Renal 
sympathetic nerve activity rose dramatically after 8-OH-DPAT in rats treated with 
the ScramshRNA.  Though the response tended to be less robust in rats treated  
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Table 8.  Body weight and blood volume indices for 8-OH-DPAT-treated rats 
  N 
Hemorrhage 
BW (g) 
Hematocrit 
(%) 
Plasma 
Protein (g/dL) 
SCRshRNA (3-12)    
0 min  
383  ± 9 
45 ± 1 6.0 ± 0.1 
10 min   35 ± 2**  4.8 ± 0.1** 
60 min   34 ± 1**  4.8 ± 0.1** 
1ARshRNA (4-13)    
0 min  
387  ± 7 
43 ± 1 6.1 ± 0.1 
10 min    34 ± 1**  4.7 ± 0.1** 
60 min    33± 1**  4.9 ± 0.1** 
 
Body weight (BW), hematocrit, and plasma protein levels before (0 min) after 
hemorrhage termination and 8-OH-DPAT injection (10 min) and 50 min after 
termination of hemorrhage (60 min) in rats treated with the scrambled shRNA 
encoding virus (ScramshRNA) or the 1ARshRNA-encoding virus.  The number of 
ScramshRNA and 1ARshRNA per group are 12 and 13 respectively for BW 
measurements and 3 and 4 respectively for hematocrit and protein samples.  
Values are group means ± SEM.  A 2-way ANOVA with repeated measures was 
used to examine the factors of Treatment and Time over the course of 
hemorrhage on hematocrit and protein plasma concentrations.  No interaction 
was found, but a main effect of Time in both groups was followed up by Holm-
Sidak post-hoc analysis.  Both plasma protein concentrations [F (1,6) = 108, P < 
0.001] and hematocrit levels [F (1,6) = 156, P <0.001] fell by 10 minutes after the 
start of hemorrhage and both remained below baseline at the end of the recovery 
period, ** P < 0.01 vs 0 minutes within group.   
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Table 9.  Spontaneous baroreflex indices in 8-OH-DPAT-treated rats 
 
Spontaneous baroreflex sensitivity (SBS) determined from baseline BP and HR recordings in rats treated with virus 
encoding the 1ARshRNA or ScramshRNAs.  Spectral analyses were performed in the low frequency (LF) and high 
frequency (HF) domains.  SDNN, standard deviation of normal beats; RRI, R-R interval (detected as peak to peak BP); 
nu, normalized units.   Number of animals is shown in parentheses.  Systolic (SBP), mean (MBP), and diastolic (DBP) 
blood pressure.  Data are group means ± SEM.  Student’s t-test were used to compare group means for ScramshRNA 
and 1ARshRNA treated groups.  No significant differences were identified. 
 
 
 
  
Up 
Sequences 
(ms/mmHg) 
Down 
Sequences 
(ms/mmHg) 
All 
Sequences 
(ms/mmHg) 
Alpha        
(LF) 
Alpha        
(HF) 
LF Power 
(mmHg2) 
BP SDNN 
LF RRI    
(nu) 
HF RRI   
(nu) 
LF/HF  
ScramshRNA 
(7) 
          
SBP 1.56  ± 0.18 1.44  ± 0.18 1.52  ± 0.17 0.48  ± 0.07 1.83  ± 0.36 21.08 ± 5.36 4.28 ± 0.43    
MBP 1.74  ± 0.17 1.69  ± 0.18 1.72  ± 0.17 0.50  ± 0.07 2.31  ± 0.40 22.16 ± 5.84 3.63 ± 0.18 17.89 ± 2.95 46.61 ± 7.31 0.47 ± 0.11 
DBP 1.81 ± 0.22 1.70  ± 0.19 1.75  ± 0.21 0.51  ± 0.07 2.08  ± 0.31 22.53 ± 5.90 3.43 ± 0.10    
1ARshRNA 
(9) 
          
SBP 1.89  ± 0.19 1.73  ± 0.27 1.87 ± 0.23 0.54  ± 0.09 2.21  ± 0.37 22.04 ± 6.90 3.76 ± 0.29    
MBP 2.23  ± 0.19 2.31  ± 0.31 2.28  ± 0.26 0.56  ± 0.09 3.12  ± 0.30 22.56 ± 7.43 3.49 ± 0.28 16.65 ± 3.45 46.82 ± 7.60 0.44 ± 0.10 
DBP 2.02  ± 0.14 1.88  ± 0.13 1.99  ± 0.11 0.56  ± 0.09 2.73  ± 0.21 22.54 ± 7.46 3.46 ± 0.28       
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Figure 16.  Effect of ScramshRNA and 1ARshRNA expression in the NTS on 
cardiovascular responses to 8-OH-DPAT in hemorrhaged rats.  Mean arterial 
pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA) 
during hemorrhage (shaded in gray), and subsequent recovery following 8-OH-
DPAT administration (indicated by arrow) of ScramshRNA (black circles) and 
1ARshRNA (open circles) injected rats.  Values are group means ± SEM.  
Number of subjects for ScramshRNA were 5 for RSNA and 11 for BP and HR 
recordings.  The 1ARshRNA subject number was 6 for RNSA and 13 for BP and 
HR measurements.  Data were analyzed by 2-way ANOVA with repeated 
measures using ShRNA treatment and Time as factors.  A significant interaction 
between ShRNA treatment and Time on BP during the first 10 minutes of 
hemorrhage was revealed [F (1, 207), = 2.44, P < 0.01].  Post-hoc analysis with 
Holm-Šidák performed at each time point showed a lower BP in 1ARshRNA 
treated rats immediately following 8-OH-DPAT administration.   
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with the 1ARshRNA-encoding virus, the group difference was not significant at 
any time point when all animals were included in the analysis (P = 0.27).    
In the small subset of animals tested (n = 6), there was no effect of shRNA 
treatment on acid-base balance or lactic acidosis with hemorrhage (Table 10).   
However, a 2-way ANOVA with repeated measures using Treatment and Time 
as factors revealed a significant interaction on PvO2.  Post-hoc analysis revealed 
that 1ARshRNA-treated rats had significantly decreased PvO2 immediately after 
8-OH-DPAT administration (10 min time point).   
In most subjects, viral transduction was considered successful as 
determined by the presence of hrGFP fluorescence in neurons of the caudal NTS 
when tissue was saved for histological analysis, or by evidence of hrGFP mRNA 
expression in micropunch samples.  Since, hrGFP expression was driven by a 
different promoter than the shRNA expression, hrGFP expression was not used 
for normalization of shRNA expression.  Instead, it was used as a qualitative 
measure to determine success or failure of viral transduction.  In a subset of 
animals in which we collected brains for histological examination, we observed 
rare occasions of off target hrGFP expression in which the center of the injection 
site was not located within the NTS, but instead, was identified more ventrally 
within the hypoglossal nucleus (Figure 17A vs. B).  On rare occasions we noted a 
complete lack of hrGFP expression in neurons (Figure 17C).  Instead, significant 
gliosis with some hrGFP expression limited almost exclusively to glia was 
observed.   Also, in one 1ARshRNA-treated rat, we failed to observe any hrGFP 
expression in any tissue samples.  In some animals, brain tissue was used for  
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Table 10.  Venous blood gas and acid-base status for 8-OH-DPAT-treated rats 
 
 
 
 
 
 
Effects of hemorrhage and 8-OH-DPAT administration on venous blood gas variables and acid-base status for rats 
treated with virus encoding the scrambled shRNA (ScramshRNA) or the 1ARshRNA.  Values are group means ± SEM at 
baseline (0 minutes), 10 and 60 minutes after the start of hemorrhage.  A 2-way ANOVA with repeated measures was 
utilized to examine the factors of Treatment and Time on blood gas variables and acid-base status.  A significant 
interaction was found between Treatment and Time on pvO2 [F (1,2) = 4.03, P < 0.05].  Post-hoc analysis by Holm-Šidák  
revealed a significantly reduction in pvO2 among 1ARshRNA injected rats compared to rats treated with the ScramshRNA 
10 minutes after the start of hemorrhage, but not at baseline or the end of the recovery period (60 minutes), * P < 0.05 vs 
ScramshRNA.  There were no other significant interactions, but a main effect of Time was found for all parameters due to 
reductions in all variables with hemorrhage and/or subsequent recovery by 60 minutes.  †P < 0.05 vs 0 minutes within 
group, ‡P < 0.01 vs 0 minutes within group, §P < 0.05 vs 10 minutes within group, and #P < 0.01 vs 10 minutes within 
group.    
 N pH pvCO2      
(mmHg) 
pvO2        
(mmHg) 
BE    
(mmol/L) 
Lactate 
(mmol/L) 
ScramshRNA (3)      
0 min  7.50  ± 0.01 43.47 ± 0.99 36.67 ± 2.19 11.33 ± 1.86 0.71 ± 0.14 
10 min  7.48  ± 0.02 41.17 ± 1.23 35.33 ± 0.88    8.67 ± 2.19‡ 1.86 ± 0.41‡ 
60 min   7.47  ± 0.02†   46.87 ± 1.24†,# 32.33 ± 1.67    9.00 ± 0.58†   1.05 ± 0.18†,§ 
1ARshRNA (5)      
0 min  7.52  ± 0.01 43.16 ± 0.46 32.60 ± 1.83 11.8 ± 0.74 0.56 ± 0.05 
10 min  7.48  ± 0.01 40.88 ± 1.95 30.20 ± 1.63*  7.00 ± 0.89‡   2.63 ± 0.41‡ 
60 min    7.47  ± 0.01†   46.84± 1.53†,#   33.80± 0.74  10.00± 1.30†    1.62 ± 0.12†,§ 
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Figure 17.  Coronal rat brain sections demonstrating variations in hrGFP 
expression in AAV-treated rats.  A) Successful injection centered in the NTS, 
B) off target injection centered in the hypoglossal nucleus.  C) Absence of 
neuronal expression of hrGFP expression with significant gliosis and glial hrGFP 
expression (magnified inset). 
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Western blot analysis of 5-HT1A receptor expression.  However, the lack of 
specificity of the 5-HT1A antibody in tissue prevented us from making 
determinations of 5-HT1A receptor protein levels.  However, hrGFP expression 
could be confirmed in these samples by Western blot.  In some cases there was 
insufficient tissue for gene expression studies after failed attempts at Western 
blot determination of 5-HT1A receptor protein.  Therefore, confirmation of the 
degree of knockdown was not possible in some regions of a subset of animals.     
Among those animals for which gene expression data were obtained, 5-
HT1A receptor mRNA levels were decreased in 1ARshRNA-treated rats by ~50% 
in the commissural NTS (Figure 18).  Transduction in the mNTS was more 
variable and achieved only a modest (~20%) reduction in 5-HT1A receptor gene 
expression.  Average receptor expression in the hypoglossal nucleus was also 
reduced by approximately 20% in 1ARshRNA-treated rats, but overall the 
expression was not different from ScramshRNA-treated rats (Figure 18C).   
There was no effect of treatment with the 1ARshRNA-encoding virus on 5-HT1A 
receptor mRNA levels in the RO or DR.    
Latency to recover 75% of baseline BP was inversely correlated with 5-
HT1A receptor expression in both the commissural NTS and mNTS injection sites 
(Figure 18A and B; Spearman coefficient = - 0.81 and - 0.56, r2 = - 0.66 and - 
0.31, P < 0.01 and P < 0.05 respectively).  Despite the tendency for reduced 5-
HT1A receptor expression in the hypoglossal nucleus of 1ARshRNA-injected rats, 
relative 5-HT1A receptor expression in the hypoglossal nucleus did not correlate 
with the time to recover 75% of baseline BP (Figure 18D; Spearman coefficient    
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Figure 18.  Relationship of 5-HT1A receptor mRNA levels and latency to 
recover 75% of baseline blood pressure after hypotensive hemorrhage.  
Relative 5-HT1A receptor mRNA levels correlations with time to recover 75% of 
baseline blood pressure.  A) Spearman correlation of 5-HT1A receptor mRNA 
levels in commissural (A) and mNTS (B) and time to recover 75% of baseline 
blood pressure following 8-OH-DPAT injection.  C) Relative 5-HT1A receptor 
expression in the cNTS, mNTS, hypoglossal nucleus, RO, and DR of 
ScramshRNA and 1ARshRNA- injected rats.  D) Correlation between relative 5-
HT1A receptor expression in hypoglossal nucleus and time to recover 75% of 
baseline BP.  Values are group means ± SEM.  An unpaired Student’s t-test 
revealed a significant decrease in 5-HT1A receptor expression in the cNTS of 
1ARshRNA injected rats [df = 12, t = 2.52, P < 0.05] but not in the mNTS 
injection sites (df = 15, t = 1.50, P = 0.15), hypoglossal nucleus (df = 13, t = 1.94, 
P = 0.07), RO (df = 11, t = - 0.23, P = 0.82) or DR (df = 12, t = - 0.41, P = 0.69).   
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-0.31, r2 = -0.10, P = 0.317).  Though fewer samples were available for rats that 
had adequate renal sympathetic recordings, there was a clear direct correlation 
between the 8-OH-DPAT-induced rise in RSNA (one minute after injection) and 
5-HT1A receptor expression in the mNTS.  Likewise, there was a tendency for the 
sympathoexcitatory effect of 8-OH-DPAT administration to correlate with 5-HT1A 
receptor expression in the commissural NTS (Figure 19; Pearson correlation 
coefficient = 0.728, r2 = 0.57, P < 0.05 and 0.74, r2 = 0.55, P = 0.057).  Neither 
expression of 5-HT7 receptors nor AR2A was affected by 1ARshRNA treatment 
(Figure 20). 
Given the apparent lack of viral transduction of the NTS in a subset of 
animals, cardiovascular parameters were reanalyzed after exclusion of two 
1ARshRNA-treated animals that showed no evidence of hrGFP within the NTS.    
Among animals that showed significant infection within either the commissural or 
mNTS, there still was a clear deficit in 8-OH-DPAT-induced pressor responses (P 
< 0.01).  When the two 1ARshRNA-injected rats that did not demonstrate viral 
infection within the NTS were excluded, a clear group difference emerged in the 
sympathoexcitatory effect of 8-OH-DPAT administration (Figure 21; P < 0.05). 
 
Discussion  
 Transduction with a 1ARshRNA-encoding AAV produced a selective 20-
50% knockdown of 5-HT1A receptors in the commissural and mNTS and impaired 
the sympathoexcitatory and pressor effect of 8-OH-DPAT in unanesthetized rats 
subjected to hypotensive hemorrhage.  Additionally, the speed at which 8-OH- 
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Figure 19.  Relative 5-HT7 and αAR2A expression in commissural NTS and 
mNTS of rats injected with ScramshRNA or 1ARshRNA.  Values are group 
means ± SEM.  Unpaired Student’s t-test revealed no significant effect of shRNA 
treatment on 5-HT7 and αAR2A receptor mRNA levels.    
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Figure 20.  Relationship of 5-HT1A receptor mRNA levels in the commissural 
and mNTS to RSNA one minute after 8-OH-DPAT administration.  A Pearson 
correlation of 5-HT1A receptor mRNA levels in the commissural (left) and mNTS 
(right) and RSNA 1 minute after 8-OH-DPAT administration. 
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Figure 21.  Effect of ScramshRNA and 1ARshRNA on responses to 
hemorrhage after exclusion of unsuccessfully transduced rats.  Mean 
arterial pressure (MAP), heart rate (HR), and renal sympathetic nerve activity 
(RSNA) during hemorrhage (shaded in gray), and subsequent recovery following 
8-OH-DPAT administration (indicated by arrow) of ScramshRNA and 
1ARshRNA- injected rats when data from 2 rats that showed no sign of viral 
infection in the NTS were excluded.  Values are group means ± SEM.  Number of 
subjects for ScramshRNA were 5 for RSNA and 11 for BP and HR recordings.  
The 1ARshRNA subject number were 4 for RNSA and 11 for BP and HR 
measurements.  Data were analyzed by 2-way ANOVA with repeated measures 
using Time and ShRNA treatment as factors.  Significant interactions were 
followed by Holm-Šidák post-hoc analysis.  A 2-way ANOVA revealed a 
significant interaction between ShRNA treatment and Time due to a reduction in 
the initial pressor response to 8-OHDPAT in 1ARshRNA-injected rats [F (1,200) 
= 2.88, P < 0.01].  Similarly, a significant interaction between ShRNA treatment 
and Time was also seen on RSNA [F (1, 70) = 3.00, P < 0.05] due to the lack of a 
sympathoexcitatory effect of 8-OH-DPAT in 1ARshRNA-treated rats.  There were 
main effects of ShRNA treatment [F (1,20) = 4.60, P < 0.05) and Time [F (10,20) 
= 39.24, P < 0.01] on HR.  The effect of treatment was due to lower HR in 
1ARshRNA-treated rats, but group differences were not significant at any one 
time point.     
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DPAT promoted BP compensation was inversely correlated with 5-HT1A receptor 
mRNA levels in the NTS, particularly in the commissural NTS.  Moreover, the 
sympathoexcitatory effect of 8-OH-DPAT administration was significantly 
correlated with the expression of 5-HT1A receptors in the NTS.  Thus, the major 
findings of this study are that the sympathoexcitatory and pressor effects of 8-
OH-DPAT are, at least in part, mediated by 5-HT1A receptors expressed in the 
caudal NTS. 
These findings extend our previous work by demonstrating that at least part 
of the effect of 8-OH-DPAT is due to a specific action of the drug on 5-HT1A 
receptors, most likely within the commissural NTS.  In prior work we noted that 
the pressor effect of 8-OH-DPAT was prevented by prior administration of the α1 
adrenergic receptor (αAR1) antagonist, prazosin (25μg/kg, iv) and the ganglionic 
blocker, hexamethonium chloride (30mg/kg, iv).  Hexamethonium alone only 
partially blocked the 8-OH-DPAT-mediated rise in BP (Tiniakov and Scrogin, 
2006).  Together, these findings indicate that 8-OH-DPAT has dual effects when 
administered to hypovolemic rats.  Specifically, 8-OH-DPAT has a direct 
vasoconstrictor effect on the peripheral vasculature mediated by αAR1 receptors 
as well as a central sympathoexcitatory effect.  Our findings that knockdown of 5-
HT1A receptors in the NTS partially blocked the pressor response but completely 
blocked the immediate sympathetic response are consistent with a direct effect of 
8-OH-DPAT on the vasculature.  Indeed, this direct pressor effect might be 
expected to further inhibit sympathetic drive in the absence of a 5-HT1A-mediated 
sympathoexciatory effect due to baroreceptor activation. 
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  Prior efforts to identify the specific receptor population on which 8-OH-
DPAT acts to mediate its ability to accelerate recovery from hypotensive 
hemorrhage have been limited by the lack of highly selective 5-HT1A agonists 
and antagonists.  The most selective of the 5-HT1A antagonists, WAY-100635, 
has approximately 300 nM affinity for αAR2A receptors (Martin et al., 1999).  
Moreover, αAR2A receptors are also located in the NTS, and prior work suggests 
that 8-OH-DPAT has affinity for these receptors as well (Bonaventure et al., 
2004; Kubo et al., 1990; Kubo et al., 1987).  More recent data also suggests that 
WAY-100635 has significant affinity for dopamine receptors which are also 
thought to mediate BP responses within the NTS (Chemel et al., 2006; Granata, 
1982; Hyde et al., 1996; Kline et al., 2002).  Thus, our prior work in which WAY-
100635 was found to block the effects of 8-OH-DPAT did not completely exclude 
the possibility that 8-OH-DPAT acted on these alternative receptor populations to 
mediate its effects.    
Another difficulty in identifying this receptor population lies in the inability to 
observe an effect of 8-OH-DPAT during hemorrhage in the anesthetized animal.   
Thus, a pharmacological approach for identifying the precise location would 
involve insertion of a chronic guide cannula and subsequent injection of drug 
during hypotensive hemorrhage in unanesthetized animals.  The NTS is located 
on the dorsal surface of the brainstem just above the cervical vertebrae (Berger, 
1979; Ciriello, 1983; Torvik, 1956).  Thus, the precise location of a guide cannula 
would require placement in region that is subject to significant movement during 
flexion of the neck and increase the potential for lesion of the brainstem.   
140 
 
 
 
Moreover, relatively high concentrations of antagonist are typically used for 
localized in vivo brain injection in order to ensure sufficient receptor occupancy 
by drug.  However, several alternative receptors for which 8-OH-DPAT has 
affinity are located within the NTS, making pharmacological methods 
problematic.    
The use of the shRNA AAV delivery system in the current study solves both 
problems by ensuring that the effects of 8-OH-DPAT are mediated specifically by 
the 5-HT1A receptor.  Moreover, this system induces chronic down regulation of 
receptors which enabled us to examine responses to 8-OH-DPAT in 
unanesthetized animals.  Nevertheless, the limitation of this approach is the 
possibility that changes in gene expression of the target gene may interfere with 
the expression of other genes that may alter the cardiovascular effects during 
hemorrhage.  While we cannot rule out the possibility that non-specific effects on 
other proteins contributed to our results, we can rule out off-target effects of other 
likely candidates.  We chose to examine the 5-HT7 and αAR2A receptors.  8-OH-
DPAT has very high affinity for the 5-HT7 receptor, and expression of the 5-HT7 
receptor has been identified in the dorsal midline brainstem (Bonaventure et al., 
2004).  Furthermore, the 5-HT7 receptors expressed in the brainstem have been 
shown to augment cardiac vagal activity (Kellett et al., 2005).  However, a role for 
5-HT7 receptors to modulate cardiovascular responses to hemorrhage have not 
been investigated.  Our data illustrates that reduced 5-HT1A receptor mRNA 
levels did not affect 5-HT7 receptor expression in the caudal NTS, suggesting 
that the reduced sympathoexcitatory and pressor effects of 8-OH-DPAT during 
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recovery from blood loss are not due to off-target effects of 1ARshRNA on 5-HT7 
receptors.  Likewise, we investigated the effect on αAR2A receptors since 
antagonists of these receptors have significant sympathoexcitatory effects when 
injected in the RVLM, and are known to facilitate chemoreflex responses in the 
NTS (Allen and Guyenet, 1993; Hayar and Guyenet, 1999; Hayward, 2001).  But 
again, our studies suggest that alterations in expression of these receptors are 
likely not responsible for the attenuated pressor and sympathoexcitatory effects 
of 8-OH-DPAT seen in 1ARshRNA-injected rats. 
Our prior studies also showed that 8-OH-DPAT improved acid-base balance 
and reduced lactic acidosis in rats subjected to hypovolemic shock in which 
approximately 50% of blood volume was withdrawn (Tiniakov et al., 2007; 
Tiniakov et al., 2012; Tiniakov and Scrogin, 2009).  However, we did not observe 
an effect of 5-HT1A receptor knockdown on the ability of 8-OH-DPAT to reduce 
lactic acidosis with the milder, 21% blood volume withdrawal used to induce 
hypotensive hemorrhage in this study.  However, 10 minutes after the start of 
hemorrhage, we did note a qualitatively smaller rise in lactate in both groups 
given 8-OH-DPAT (3 minutes before blood sampling) than observed in animals 
subjected to the same blood withdrawal, but not given drug, i.e., experiments in 
Chapter 3.  Thus, it is possible that 8-OH-DPAT was able to facilitate improved 
peripheral perfusion within the short time frame between drug injection and blood 
sampling.  Nevertheless, the lack of difference in lactic acid between treatment 
groups observed in this study suggests that 5-HT1A receptors in the caudal NTS 
do not mediate this early beneficial effect of 8-OH-DPAT on acid-base status.  It 
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should be noted that blood gases were only obtained in a small subset of 
animals.  Unfortunately, many of the brain tissue samples obtained from animals 
for which we had blood gas data were used for Western blot, and thus there was 
no data confirming knockdown of gene expression in these animals.  Therefore, it 
is not possible to determine if the lack of effect of 1ARshRNA treatment on lactic 
acidosis was due to lack of 5-HT1A receptor knockdown. 
As described above, there are 2 distinct mechanisms behind the pressor 
effect of 8-OH-DPAT (Tiniakov and Scrogin, 2006):  direct vasoconstriction 
through peripheral αAR1 receptor activation and increased sympathetic mediated 
venoconstriction.  It is not clear whether the direct vascular effects of 8-OH-DPAT 
contribute to increased venous tone and increased perfusion, but this seems 
quite likely given the dependence of venoconstriction on sympathetic drive (Reilly 
et al., 2001; Toung et al., 2000).  Both αAR1 and αAR2A receptors are expressed 
in the venous vasculature and give rise to increased venous tone when 
sympathetic drive is elevated (D'Oyley and Pang, 1990; Ito and Hirakawa, 1984; 
Pang and Tabrizchi, 1986).  Thus, direct vasoconstrictor effects of 8-OH-DPAT 
on the venous vasculature may contribute to improved venous return, particularly 
when drug is administered early after hypotensive hemorrhage when sympathetic 
tone is low and venous pooling of blood is high (Guyton et al., 1954).  Early 
mobilization of venous blood through these vascular effects of 8-OH-DPAT may 
have masked the beneficial effect of sympathetic-mediated vasoconstriction on 
lactic acidosis. 
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These studies further indicate that the central pressor effects of 8-OH-DPAT 
are mediated by activation of 5-HT1A receptors in the commissural NTS.  This 
conclusion is based on evidence in the present study that the pressor effect of 8-
OH-DPAT was robustly correlated to 5-HT1A receptor expression in the 
commissural NTS, and less so to receptor expression in the mNTS.  Recent 
findings indicate that the 5-HT1A receptor is co-localized with GAD67 in cells of 
the rat commissural NTS (Ostrowski et al., 2014).  Typically, 5-HT1A receptor 
activation leads to neuronal cell hyperpolarization due to inhibition of Ca2+ 
conductance and/or increases in K+ conductance (Albert et al., 1996; Jeong et 
al., 2001).  Thus, hyperpolarization of GABAergic cells of the commissural NTS 
by 8-OH-DPAT may contribute to disinhibition of excitatory functions of the region 
including direct excitation of pre-motor sympathetic neurons of the RVLM.    
In prior studies, others have noted that 8-OH-DPAT typically produces 
significant and rapid sympathoinhibition in unanesthetized euvolemic rats (Bago 
et al., 1999; Kubo et al., 1995; Nosjean and Guyenet, 1991; Wang and Lovick, 
1992).  We have also demonstrated that the sympathoexcitatory effect of 8-OH-
DPAT in hypovolemic animals is dependent upon sinoarotic innervation of the 
NTS (Osei-Owusu and Scrogin, 2006).  Thus, it is possible that the 
sympathoexcitatory effects of 8-OH-DPAT require activation of sinoarotic 
afferents during hemorrhage that, in turn, contributes to activation of GABAergic 
neurons in the commissural NTS.  In fact, peripheral chemoreceptor afferent 
activation during prolonged hypoxia has been found to increase extracellular 
levels of GABA in the commissural NTS, and elevation of GABA with sustained 
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hypoxia is dependent on integrity of the carotid sinus nerve (Tabata et al., 2001).   
It remains to be determined if 8-OH-DPAT acts to increase sympathoexcitation 
by inhibiting GABA neurotransmission in the commissural NTS.  Recent work 
suggests that 8-OH-DPAT inhibits both GABAergic and glutamatergic 
neurotransmission in the commissural NTS in the rat brain slice (Ostrowski et al., 
2014).  In these studies, the predominant effect was a decrease in glutamatergic 
responses under basal conditions.  Our findings are consistent with the possibility 
that prolonged excitatory neurotransmission in the NTS during hemorrhage 
contributes to increased GABA cell activation, and that 8-OH-DPAT acts to 
reverse this effect.  Thus, differences in response to 8-OH-DPAT in the presence 
and absence of sinoaortic nerve activation may be due to changes in the 
prevailing level of GABAergic tone present in the NTS.  Prolonged hypoxia 
increases GABA release in the commissural NTS, and the ability of 8-OH-DPAT 
to increase blood pressure was more strongly correlated with receptor 
expression in the commissural NTS where chemoreceptor afferents terminate in 
the highest density.  Moreover, we did not observe any effect of 5-HT1A receptor 
knockdown on spontaneous arterial baroreflex sensitivity.  Together these 
findings suggest that 5-HT1A receptors in the commissural NTS may disinhibit 
sympathetic drive during prolonged activation of peripheral chemoreceptors.    
In summary, our work indicates that 8-OH-DPAT acts through 5-HT1A 
receptors in the commissural NTS to produce sympathoexcitation and increased 
BP in the unanesthetized rat subjected to hypotensive hemorrhage.  These 
findings suggest that 5-HT1A receptor agonists that penetrate the blood brain 
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barrier may be useful in the treatment of hypotensive hemorrhage or 
hemorrhagic shock. 
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CHAPTER V 
5-HT1A RECEPTORS IN THE CAUDAL NUCLEUS TRACTUS SOLITARIUS 
MEDIATE THE INDICES OF AROUSAL TO HYPOXIC HYPERCAPNIA 
 
Abstract 
Prior studies in our laboratory and within this dissertation have identified a 
role for 5-HT1A receptors of the caudal NTS in the sympathoexcitatory response 
observed during recovery from hemorrhage.  However, the role of serotonin and 
5-HT1A receptors in chemoreflex responses, such as those elicited during 
hemorrhage, remain to be fully elucidated.  In the current study, we tested the 
hypothesis that hypercapnia, sufficient to acidify arterial blood to the same extent 
seen in hemorrhage, would activate serotonin neurons of the caudal raphe and, 
in turn, augment peripheral chemoreflex responses to hypoxia through activation 
of 5-HT1A receptors in the NTS.    
In contrast to our hypothesis, hypercapnia (in the presence of hyperoxia) 
sufficient to lower arterial blood pH to levels observed in hemorrhagic shock (i.e., 
decrease ~0.07 pH units) did not increase c-Fos expression in serotonin neurons 
of the caudal raphe.  Instead, only hypoxic hypercapnia increased c-Fos 
expression in serotonin immunoreactive neurons in the RM and RO.  Exposure to 
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hyperoxic hypercapnia or hypoxic hypercapnia increased c-Fos expression in the 
commissural NTS to the same extent (P<0.01).  Treatment with the 1ARshRNA-
encoding virus did not affect overall ventilatory rate, tidal volume, or cumulative 
minute ventilation during hypoxic normocapnia, hyperoxic hypercapnia or hypoxic 
hypercapnia.  However, rats treated with the ScramshRNA-encoding virus 
exhibited intermittent bouts of high frequency ventilation during hypoxic 
hypercapnia that was suppressed in rats treated with the 1ARshRNA-encoding 
virus.  Accordingly, ventilatory rate determined over the entire course of the 45 
min exposure to hypoxic hypercapnia, but not that determined during hypoxia or 
hypercapnia alone, was attenuated by 5-HT1A knockdown (1,121 ± 99 vs 599 ± 
38 bpm over 45 min, P<0.01).  Group differences in intermittent high frequency 
ventilation were due to decreased percent of time spent sniffing in rats treated 
with the 1AshRNA-encoding virus compared to ScramshRNA-injected rats (4.9 ± 
1.1 vs 11.2 ± 2.4 % time,  P < 0.05).  Together, these data support the 
hypothesis that the combination of hypoxia and hypercapnia stimulates serotonin 
neurons in the caudal raphe to release serotonin in the NTS, which in turn 
stimulates arousal by activation of 5-HT1A receptors.    
  
Introduction 
Studies performed in our laboratory indicate that serotonin cells of the 
caudal raphe and serotonin nerve terminals in the dorsomedial medulla that 
include the caudal NTS are necessary for normal ventilatory and sympathetic 
responses following compensation from blood loss.  Our work further indicates 
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that serotonin release improves peripheral tissue perfusion following hypotensive 
hemorrhage.  Serotonin cells of the caudal raphe are also necessary for normal 
ventilatory responses to hypercapnia in unanesthetized rats (Kung et al., 2010).   
Together, these findings led us to hypothesize that serotonin cells of the caudal 
raphe are activated by the acidosis that develops during hemorrhage.  The 
resulting release of serotonin in the NTS is further hypothesized to facilitate 
peripheral chemoreflex responses and thereby improve ventilation and 
sympathetic activity following blood loss.  Our findings that the 5-HT1A agonist 8-
OH-DPAT acts in a manner that mimics the beneficial effects of serotonin during 
hemorrhage led us to further speculate that serotonin acts in the NTS to facilitate 
peripheral chemoreflex activation by stimulating 5-HT1A receptors. 
Controversial evidence from other laboratories has suggested a role for 
serotonin neurons in the caudal raphe as central chemoreceptors.  Serotonin 
neurons located along the major blood vessels that perfuse the brainstem are 
ideally situated to directly assess the acid-base status of blood entering cerebral 
circulation (Bradley et al., 2002).  Moreover, primary cultures of caudal raphe 
serotonin neurons were found to be directly sensitive to changes in CO2 and pH 
(Wang et al., 1998; Wang and Richerson, 1999; Wang et al., 2001).  Given our 
previous evidence that destruction of the same serotonin neurons resulted in 
impaired chemosensitivity to respiratory acidosis, we began to question whether 
serotonin neurons of the caudal raphe may be activated in response to the 
metabolic acidosis that develops during hemorrhage.   
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Several serotonin receptor subtypes are expressed in the caudal NTS and 
several of these have been implicated in the regulation of ventilatory responses 
to various stimuli.  A recent study by Zhuang et al., showed that 8-OH-DPAT, 
reversed fentanyl-induced apnea in urethane anesthetized rats.  This response 
was completely abolished by microinjection of 5HT1A receptor antagonist, WAY-
100635 directly into the caudal NTS prior to 8-OH-DPAT administration, or by 
destruction of the vagal projections to the NTS.  Together, these findings suggest 
that 5-HT1A receptors of the caudal NTS facilitate ventilation when an organism is 
challenged by central hypoxic hypoventilation (Zhuang et al., 2012).   
During prolonged hypoxic exposure, attenuated ventilatory drive termed 
hypoxic ventilatory decline is associated with accumulation of GABA in the 
caudal NTS (Tabata et al., 2001).  Activation of 5-HT1A receptors typically 
induces neuronal hyperpolarization (Fargin et al., 1989) .  Thus, we speculated 
that serotonin may activate 5-HT1A receptors in the NTS during hemorrhage and 
thereby facilitate peripheral chemoreflex responses that would reverse hypoxic 
ventilatory decline.  The accumulation of GABA that mediates hypoxic ventilatory 
decline is dependent on the integrity of the sinoaortic nerves.  The 
sympathoexcitatory effect of 8-OH-DPAT is also dependent on integrity of 
sinoaortic nerves (Osei-Owusu and Scrogin, 2006).  Therefore, we hypothesized 
that the acidosis that develops during hemorrhage would promote activation of 
serotonin neurons in the caudal raphe.  We further speculated that the resulting 
release of serotonin in the NTS would facilitate peripheral chemoreflex response 
to hypoxia by activating 5-HT1A receptors.  Therefore, in this study, we tested 
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whether serotonin neurons of the caudal raphe are activated by acidosis 
(hypercapnia) and whether this condition further improves peripheral chemoreflex 
responses to hypoxia.  We also tested the hypothesis that knockdown of 5-HT1A 
receptors in the NTS would attenuate peripheral chemoreflex responses to 
hypoxia under acidic conditions in unanesthetized rats.      
 
Methods 
Animals 
Male Sprague-Dawley rats (275 to 300 g; Harlan, Indianapolis, IN) were 
acclimated to the institutional animal facility under standard conditions (22°C 
ambient temperature, 12:12-h light-dark cycle) with food and water available ad 
libitum for at least 1 week prior to surgery.  All experimental protocols were 
approved by the Institutional Animal Care and Use Committee and conducted in 
compliance with the Principles of Laboratory Animal Care, as adopted and 
promulgated by the United States National Institutes of Health. 
Surgical procedures 
Femoral catheter implantation 
In a subset of rats, blood sampling was performed during gas exposure in 
order to determine the extent of blood gas and acid-base balance changes 
elicited by the chemoreflex stimuli.  Rats (n = 5) were anesthetized with 
isoflurane (5% for induction and 1.5-2.5% for maintenance) in 100% O2 (1L/ min) 
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and instrumented with a femoral arterial catheter (PE-50 fused with PE-10 
tubing) to enable blood sampling.  The arterial catheter was externalized at the 
nape of the neck and secured with 3-0 silk suture.  Following catheter 
implantation, a Vascular Access Harness™ (Instech Laboratories, Inc., USA) 
was attached and secured to the catheter to allow blood sampling.  Rats were 
given ampicillin (150 mg/kg sc) and buprenorphine (0.05 mg/kg sc) and allowed 
to recover in their home cage.  Forty-eight hours after surgery, the catheters 
were flushed daily with dexamethasone (0.1 mg/mL) in heparinized saline (75 U) 
to maintain patency (Yang et al., 2005).   
AAV injections 
Prior to surgery, AAV vectors were diluted in viral storage buffer [400nM 
NaCl, 20 mM Tris base, (1x1012 vg/ml)] and dialyzed in 0.9% saline (Slide – a – 
Lyzer, ThermoScientific) as described in Chapter 3.  Rats (n = 28) were 
anesthetized with ketamine/xylazine (85/13mg/kg, im) and placed in a stereotaxic 
apparatus with the nose bar positioned 11 mm below a flat skull plane then AAV 
vectors were injected as described previously in Chapter 3 and utilizing the same 
injection parameters.  Animals were then allowed to recover for four weeks prior 
to chemoreflex protocol 3. 
Experimental Protocols 
1. Unrestrained whole body plethysmography to determine caudal raphe 
serotonin cell activation (c-Fos expression) in response to hypoxic 
normocapnia, hyperoxic hypercapnia or hypoxic hypercapnia. 
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Naïve rats (n = 32) were habituated to a whole body plethysmograph 
(Buxco Research Systems) for 10 days prior to study.  During habituation, rats 
were handled and placed in the chamber which was situated in a visually–
isolated, low–ambient noise room while continuously flushed with 21% O2 
balanced with N2 at a rate of 2 L/min.  Gas flow was regulated by a custom-made 
mass flow controller for O2, N2, and CO2 (Buxco Research Systems).  
Temperature within the chamber was stable across experimental groups (± 0.5° 
C), but varied from 23-25° C between cohorts.  Ventilatory variables were 
captured and analyzed by iox2 software (EMKA Technologies).  On the day of 
the experiment, rats were placed in the chamber and allowed to acclimate for at 
least 1 hour.  Baseline ventilation variables were then recorded for 60 minutes 
prior to gas change.  After baseline recordings, rats were randomly assigned to 
receive a 60 minute exposure to one of three conditions: hypoxic normocapnia 
(10%O2/0.04% CO2), hyperoxic hypercapnia (95%O2 /5%CO2), or hypoxic 
hypercapnia (10%O2/5%CO2).  Changes in gas concentration required 5-10 
minutes.   Once the new gas concentration had stabilized, the condition was 
sustained for 60 minutes during which ventilatory variables were assessed.  After 
60 minutes, the gas mixture was switched back to normoxic conditions and the 
animal recovered in the chamber for an additional 30 minutes to allow maximal c-
Fos protein expression to develop.  Immediately after the end of the experiment, 
rats were deeply anesthetized with sodium pentobarbital (100mg/kg, ip).  Once 
anesthetized the rat was given an injection of heparinized saline (100 U/0.1 ml) 
into the apex of the left cardiac ventricle.  The rat was then perfused 
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transcardially with 250 mL (25 mL/min) sodium nitrate (0.1M) in 6.7 mM 
phosphate buffer followed by 360 mL (18 mL/min) 4% paraformaldehyde in 0.05 
M potassium phosphate buffer (KPB), pH 6.8.  Subsequently, brains were 
removed and post-fixed with the same solution for one hour, then blocked in the 
same solution overnight at 4°C.  The following day, brains were transferred to 
30% sucrose and stored until sectioning could be performed.   Brains were 
sectioned on a freezing microtome in 40 µm sections and collected serially into 6 
wells filled with cryoprotectant (30% sucrose and 30% ethylene glycol in 0.1 M 
phosphate buffer) and stored at -20° until immunohistochemical analysis was 
performed. 
2.  Unrestrained whole body plethysmography for analysis of gas effects 
on acid-base balance and blood gases. 
Two days after catheter implantation, rats were habituated for 4 days to a 
whole body plethysmograph (Buxco Research Systems) as described above in 
protocol 1, except that their catheters were connected to a tether that consisted 
of a spring covered catheter connected to a fluid swivel (Instech Laboratories) 
placed in the top of the chamber.  On the day of the experiment, rats were 
acclimated to the chamber and attachment to the tether, after which, baseline 
ventilatory variables were recorded for 60 minutes during exposure to normoxic 
conditions.  An arterial blood sample was then withdrawn through the fluid swivel.  
Two times the dead space of the catheter and tether system was withdrawn, after 
which a 150 l sample was obtained.  The fluid was returned to the animal and 
the catheter was flushed with isotonic saline.  Rats were then randomly assigned 
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to receive exposure to one of the following three conditions: hypoxic 
normocapnia (10%O2/0.04% CO2), hyperoxic hypercapnia (95%O2 /5%CO2), or 
hypoxic hypercapnia (10%O2/5%CO2).  The condition was sustained for 60 
minutes during which ventilatory data were measured.  At the end of the 60 
minute gas exposure, a second arterial blood sample was obtained in the same 
manner as the first.  Arterial blood samples were analyzed with an i-STAT 1 
analyzer (i-STAT, East Windsor, NJ).  At the end of each experiment, rats were 
returned to their home cage and allowed to recover for 40 hours.  The procedure 
was then repeated until blood was sampled under each condition for each rat.   
The order of the gas conditions was randomized across rats.  After the last 
experiment, rats were euthanized by an overdose of sodium pentobarbital (100 
mg/kg, ip) and subsequent thoracotomy.   
3.  Assessment of 5-HT1A receptor knockdown in the caudal NTS on 
chemoreflex responses.   
Four weeks following viral injections, the ventilatory function of rats was 
assessed in the whole body plethysmograph (Buxco Research Systems) as 
described above with slight modifications.  Each animal was subjected to 5 
acclimation sessions of escalating duration (15, 25, 35, 45, and 60 minutes) over 
5 days prior to experiments.  Each rat was exposed to the 3 gas conditions 
described above in protocol 2 on separate days, with a day of rest between each 
of the 3 experiments.  For each experiment, rats were acclimated to the chamber 
and baseline ventilation variables were recorded for at least 30 minutes prior to 
gas change.  The gas concentration was then changed over the next 5-10 
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minutes to one of the three conditions.  Once the gas transition was complete, 
ventilatory data were recorded for 45 minutes.  The gas was then switched back 
to normoxia and animals were removed and allowed to rest in their home cage 
for approximately 40 hours prior to the next experiment.     
Tissue homogenization  
Total RNA was extracted from a subset of micropunch samples using a 
homogenizing buffer that consisted of 50 mM Tris buffer (pH 7.6) with sodium 
chloride (0.01M) and the addition of a proteinase inhibitor cocktail (Roche).   
Protein concentration from the micropunch samples was determined by BCA 
assay (Pierce) as described in Chapter 3.  Immunoblotting protocols were also 
performed in the same manner as described in Chapter 3.   
Tissue RNA Isolation and cDNA synthesis 
Total RNA was extracted, genomic DNA removed, and then synthesized 
into cDNA according to protocols described in Chapter 3. 
Quantitative Real-Time PCR  
Messenger RNA levels of the 5-HT1A receptor were determined from 
tissue obtained from the commissural NTS, mNTS, RO, hypoglossal nucleus, 
and DR as described in Chapter 3.  The 5-HT2A receptor was also assessed in 
mNTS and commissural NTS to rule out off target, or compensatory effects of 
shRNA treatment.  Real-time qPCR was performed on amplified cDNA using the 
CFX96 TouchTM Real-Time PCR Detection System (Bio-Rad).  The following 
general PCR protocol was used with various annealing/extension temperatures: 
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95°C for 30 sec, 40 cycles of 95°C for 5 sec and 56-63°C for 30 sec.  Melt curves 
from 65°C to 95°C were included to confirm that only a single product was 
formed for each primer pair.  Samples were prepared and analyzed as described 
in Chapter 3.  Primer sequences used for amplification and annealing 
temperatures for each gene are listed in Table 11.  Results are presented as 
relative mRNA expression normalized to relative GAPDH mRNA.   
Immunohistochemistry 
For c-Fos and serotonin (5-HT) immunolabel, one of every six 40-µM sections 
through the brainstem was washed 6 times for 10 minutes in 0.05 M potassium 
phosphate buffered saline (KBPS), incubated in 0.1% H2O2 for 15 minutes, 
washed 5 times for 5 minutes, then incubated for 48 hours at 4°C with rabbit anti-
c-Fos primary antibody (1:10,000 dilution; PC#38 from EMD Sciences) in 0.4% 
Triton X-100 KPBS (KPBST).  Sections were then washed 10 times for 6 minutes 
and incubated in biotinylated goat anti-rabbit IgG (1:1,000 dilution in KPBST; 
Vector Laboratories) for 1 hour at room temperature, washed 5 times for 10 
minutes, then incubated for 1 hour in Avidin DH solution combined with 
biotinylated horse-radish peroxidase (5 l each/ml prepared 30 minutes prior to 
use, Vectastain Elite ABC Kit Standard, Vector Laboratories) in KPBST.  
Sections were then rinsed 3 times for 5 minutes with KPBS and then washed 3 
times for 5 minutes in 0.175M sodium acetate, pH 7.0.  During washes nickel 
sulfate-intensified 3,3’-diaminobenzadine tetrahydrochloride (NiDAB) chromagen 
solution was prepared as follows: 250 mg nickel (II) sulfate hexahydrate, 2 mg 
DAB, 20mg D-glucose, 1.5μL glucose oxidase (Sigma) in 10 mL 0.175M sodium  
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Table 11.   Primers for qPCR analysis of chemoreflex challenged AAV rats. 
Gene 
Symbol 
T 
(°C) 
Primer 
Efficiency 
(%) 
Forward Primer (5’ 3’) 
Reverse Primer (5’ 3’) 
Size 
(bp) 
GAPDH 56/61 99/96 
GAC ATG CCG CCT GGA GAA AC 
94 
AGC CCA GGA TGC CCT TTA GT 
5-HT1A 56 89 
AAG AAG AGC CTG AAC GGA 
171 
CAG AGG AAG GTG CTC TTT GG 
5-HT2A 56 102 
TCA TCA TGG CAG TGT CCC TA 
172 
ATC CAG ATC GCA CAG AGC TT 
     
Forward and reverse primers are shown for GAPDH, 5-HT1A (5-HT1A), and 5-
HT2A receptor (5-HT2A).  Annealing temperature (T), primer efficiency, and 
product length are also shown. 
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acetate buffer.  Sections were incubated in NiDAB to produce a black nuclear 
label over the course of 7 minutes.  The reaction was stopped by washing 
sections 3 times for 5 minutes in 0.175 M sodium.  Afterwards, sections were 
washed 4 times for 15 minutes, and incubated with rabbit anti-serotonin primary 
antibody (1:400,000 dilution in KPBST; Immunostar) for 48 hrs at 4°C.  Sections 
were then subjected to the same secondary and tertiary antibodies as described 
above, but this time immunoreactivity was exposed with DAB in the absence of 
nickel (5 minutes) to produce a brown cytoplasmic label.  Omission of either 
primary antibody completely abolished cellular label.  After the final set of 
washes, sections were mounted onto gelatin-coated slides and allowed to dry 
overnight.  The next day sections were dehydrated and cleared by immersion in 
the following solutions: distilled water, 50% ethanol (5 minutes), 75% ethanol (5 
minutes), 95% ethanol (5 minutes), 100% ethanol (10 minutes), fresh 100% 
ethanol (10 minutes), xylene (10 minutes), fresh xylene (10 minutes).  Slides 
were then immediately coverslipped with Permount mounting media (Fisher 
Scientific).   
Histology 
Cells that showed immunolabel for both c-Fos and serotonin were counted 
in one out of every six 40 m sections (240 μM apart) throughout the anatomical 
extent of each serotonin-rich caudal raphe nuclei as described previously (Kung 
et al., 2010).  Specifically, we examined double-labeled of neurons in the RP, RM 
and its lateral extensions around the pyramids (referred to as the parapyramidal 
region), RO, cells in the subependymal layer on the ventrolateral border of the 
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pyramids (referred to as the subependymal region), and the RP (Steinbusch, 
1981).  The percent of serotonin-labeled neurons that showed c-Fos 
immunoreactivity were summed for the entire raphe region (Table 12).  Rostro-
caudal profiles of double-labelled cells were determined for each nuclei.  For 
these determinations, the total number of double-labeled cells were combined 
from three sections (720 μm) and compared for each gas condition.  Cell counts 
were pooled in this way to reduce the impact of small variations in the anatomical 
location of serial sections between animals.   
Cells showing c-Fos immunoreactivity were also counted in one of every 
six sections (240 μM apart) throughout the commissural and medial NTS (-15.00 
mm to -13.8 mm from Bregma).   
Statistical Analysis 
Effect of Gas Treatment on blood gases and acid-base balance was 
determined by 2-way repeated measures ANOVA with Newman-Kuels post hoc  
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Table 12.   The percentage of serotonin-immunoreactive neurons that also express c-Fos immunoreactivity 
during chemoreflex challenges 
 
 Normoxia (8) 
Hypoxic  
Normocapnia (6) 
Hyperoxic 
Hypercapnia (6) 
Hypoxic 
Hypercapnia (7) 
Raphe Pallidus 12.9 ± 2.3 21.3 ± 3.8 22.0 ± 8.0 22.8 ± 4.5 
Raphe Obscurus 1.3 ± 0.3 2.9 ± 0.6 2.6 ± 0.6 4.7 ± 0.7**,†,‡ 
Subependymal region 4.0 ± 0.9 8.8 ± 2.0 7.0 ± 2.8 5.9 ± 1.0 
Parapyramidal region 2.5 ± 0.6 5.0 ± 0.7 4.3 ± 2.0 7.2 ± 2.0 
Raphe Magnus 2.5 ± 0.8 5.7 ± 0.9 4.5 ± 0.5 6.8 ± 0.6* 
 
Values are group means ± SEM in 40 μm sections obtained every 240 μm throughout the anatomical extent of the 
indicated nucleus.  A one-way ANOVA with Gas treatment as a factor revealed an effect of Gas treatment on activation of 
serotonin neurons within the RO [F(3) = 6.79, P < 0.01].  Post-hoc analysis with Newman-Keuls’ method determined that 
hypoxic hypercapnia increased the percent of serotonin neurons that were activated during the gas exposure compared to 
all other treatment groups.  A Kruskal-Wallis one-way ANOVA on Ranks also revealed an effect of Gas treatment on 
activation of serotonin neurons within the RM [H(3) = 13.06, P < 0.01].  Post-hoc analysis by Dunn’s method determined 
that the difference of treatment was due to the fact that hypoxic hypercapnia increased the percent of serotonin neurons 
that expressed c-Fos compared to normoxia,*P < 0.05 vs Normoxia, **P < 0.01 vs Normoxia, †P < 0.05 vs Hyperoxic 
hypercapnia, ‡P < 0.05 vs Hypoxic Normocapnia.  The raphe pallidus, subependymal region, and parapyramidal region 
did not show significant changes in double-label following gas treatments, P = 0.384, P = 0.257, and P = 0.101 
respectively.   
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tests.  Effect of Gas Treatment on total number of cells expressing c-Fos was 
determined for each raphe region by one-way ANOVA or a Kruskal-Wallis one-
way ANOVA on Ranks.  Effect of Gas Treatment and Distance from Bregma for 
RO and RM were analyzed by 2-way ANOVA with repeated measures.  
Newman-Keuls post-hoc tests were used to compare effects of gas exposure at 
each location.  Effect of Viral injection over Time on ventilatory variables was 
assessed independently for each gas treatment by 2-Way ANOVA.  Effect of 
Viral injection on cumulative minute volume and area under the curve of 
ventilatory rate for the entire 45 minute exposure was assessed by 2-way 
repeated measures ANOVA with Bonferroni correction for the 3 gas exposures.   
PCR data from rats treated with the 1ARshRNA-encoding virus were normalized 
to the group average of rats injected with the ScramshRNA that were in the same 
qPCR cohort.  Typically, two animals of each shRNA group were run in the same 
cohort.  Significance was determined by unpaired Student’s t-tests.   When group 
data failed the Shipiro-Wilk normality test, the Mann-Whitney Rank Sum Test 
was used instead.  All qPCR results are expressed as the group mean ± SEM.    
 
Results 
Chemoreflex- elicited c-Fos expression in caudal raphe serotonin neurons  
As expected, exposure to hypoxic normocapnic gas reduced PaCO2 and 
PaO2, caused respiratory alkalosis and increased lactate accumulation.  
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Hyperoxic hypercapnia increased PaCO2 and PaO2, caused a primary respiratory 
acidosis and reduced lactate levels.  The addition of hypercapnic gas to hypoxia 
normalized PaCO2 and PaO2 and respiratory alkalosis and also lowered lactate 
accumulation (Table 13). 
More serotonin neurons of the RM showed c-Fos expression over the 
entire nucleus following hypoxic hypercapnic gas exposure compared to 
normoxia, hypoxic normocapnia, and hyperoxic hypercapnia (Table 12, P < 0.01, 
P < 0.05, and P < 0.05, respectively), but not in any one specific region of the RM 
(Figure 22).  Similarly, only hypoxic hypercapnia increased c-Fos expression in 
the RO compared to normoxia and hyperoxic hypercapnia (Figure 23, P < 0.01 
and P < 0.05 respectively), but not in any particular region of the RO.  No other 
caudal raphe region showed elevated c-Fos expression in serotonin neurons.    
Expression of c-Fos was increased in the middle and rostral portions of 
the commissural NTS, as well as the caudal portions of the medial NTS by 
hypoxia alone and hypoxic hypercapnia, and the response was similar between 
gas treatments (Table 14 and Figure 24, P < 0.01).  Hyperoxic hypercapnia only 
increased c-Fos expression in the caudal portions of the medial NTS.    
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Table 13.   Arterial blood gases and acid-base status determined before and after a 60-minute exposure to 
chemoreflex challenges 
 
 n pH 
paCO2      
(mmHg) 
paO2        
(mmHg) 
BE       
(mmol/L) 
Lactate 
(mmol/L) 
Hypoxia 
Normocapnia 
5     
 
0 min  7.46 ± 0.01 43.  86 ± 0.65 84.40 ± 1.03 7.00 ± 0.63 0.84 ± 0.17 
60 min  7.58 ± 0.01## 29.76 ± 1.01##  37.80 ± 0.66## 6.00 ± 0.89 1.21 ± 0.11## 
Hyperoxic 
Hypercapnia 
5     
 
0 min  7.45 ± 0.01 45.74 ± 0.  60 88.60 ± 1.40 7.4 ± 0.68 0.97 ± 0.08 
60 min  7.38 ± 0.01**,## 60.18 ± 2.12**,##  437.20 ± 21.73**,## 10.00 ± 0.71 0.42 ± 0.03**,## 
Hypoxic 
Hypercapnia 
5     
 
0 min  7.45 ± 0.01 43.78± 0.  72 89.80 ± 3.46 6.2 ± 0.66 1.03 ± 0.12 
60 min   7.40 ± 0.01**,†,## 49.00 ± 0.90**,‡,## 54.00 ± 1.10‡,# 7.4 ± 1.12 0.62 ± 0.07*,## 
       
Values are group means ± SEM.  Significant interactions were followed up by Newman-Keuls’ post-hoc analysis.  *P < 
0.05, **P<0.01 vs hypoxia normocapnia, †P < 0.05, ‡P<0.01 vs hyperoxic hypercapnia, #P < 0.05, ##P<0.01 vs baseline (0 
minutes) within group. 
 
Two-way ANOVA with repeated measures revealed an interaction between Gas treatment and Time on arterial blood pH 
[F (4,8) = 171.07, P < 0.01].  Post-hoc analysis showed that hypoxic normocapnia increased pH while both hyperoxic 
hypercapnia and hypoxic hypercapnia reduced pH.   
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Two-way ANOVA with repeated measures revealed a significant interaction between Gas treatment and Time on paCO2 
values [F (4,8) = 273.59, P < 0.01].  Post-hoc analysis showed that hypoxic normocapnia reduced paCO2 while both 
hyperoxic hypercapnia and hypoxic hypercapnia increased paCO2.   
 
Two-way ANOVA with repeated measures revealed an interaction between Gas treatment and Time on paO2 values [F 
(4,8) = 303.96, P < 0.01].  Post-hoc analysis showed that hypoxic normocapnia reduced paO2 while paO2 was reduced to a 
similar degree when hypercapnia was combined with hypoxia.  Conversely, hyperoxic hypercapnia dramatically increased 
paO2 following treatment.   
 
Two-way ANOVA with repeated measures revealed an interaction between Gas treatment and Time on lactate levels [F 
(4,8) = 96.56, P < 0.01].  Post-hoc analysis showed that hypoxic normocapnia augmented lactate accumulation, whereas 
hyperoxic hypercapnia and hypoxic hypercapnia both reduced lactate levels. 
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Figure 22.   Effect of gas challenges on c-Fos expression in serotonin 
neurons of the raphe magnus.  A) Representative 5-HT and c-Fos 
immunoloabel in raphe magnus (RM) of rats subjected to normoxia (left) and 
hypoxic hypercapnia (right).  B) number of serotonin neurons within the RM that 
were also expressed c-Fos in rats exposed to normoxia, hypoxic normocapnia, 
hyperoxic hypercapnia, hypoxic hypercapnia.  Total number of serotonin neurons 
are shown at each location for comparison.  Data were combined for 3 sections 
(720μm) at each point along the rostro-caudal extent of the nucleus and are 
expressed as groups means ± SEM.  A 2-way ANOVA with repeated measures 
with Gas treatment and Distance from Bregma as factors revealed only a main 
effect of Distance from Bregma in the RM [F (3) = 14.65, P < 0.01].   
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Figure 23.   Effect of gas challenges on c-Fos expression in serotonin 
neurons of the raphe obscurus.  A) Representative coronal sections of 
brainstem showing typical c-Fos and serotonin double immuno-label (arrows)  in 
the Raphe Obscurus (RO) of rats exposed to normoxia (left) and hypoxic 
hypercapnia (right).  B) Number of serotonin-immunoreactive neurons that also 
showed c-Fos expression in brain sections from rats exposed to normoxia, 
hypoxic normocapnia, hyperoxic hypercapnia or hypoxic hypercapnia  and total 
number of serotonin positive neurons.  Data are group mean of cells identified in 
3 sections taken at 240 μm intervals across the rostro-caudal plane, and shown 
as a single value every 720 μms.  A 2-way ANOVA with repeated measures with 
Gas treatment and Distance from Bregma as factors revealed main effects of 
Gas treatment [F (3,23) = 5.93, P < 0.01] and Distance [F (3,23) = 13.31, P < 
0.01].  Post-hoc analysis using Newman-Keuls’ method showed that the main 
effects were due to increased c-Fos immunoreactivity in the RO of rats exposed 
to hypoxic hypercapnia vs normoxia (P<0.01) and hypercapnia (P<0.05).  
Although not significant, there was a strong tendency for hypoxic hypercapnia to 
increase c-Fos expression compared to hypoxic normocapnia (P = 0.055) 
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Figure 24.  Effect of gas challenges on c-Fos expression in the 
commissural and mNTS.  Typical c-Fos label in commissural NTS of rats 
subjected to normoxia (A) hypoxic normocapnia (B), hyperoxic hypercapnia (C) 
and hypoxic hypercapnia (D).  E) Numbers of c-Fos positive cells in the 
commissural and mNTS shown throughout rostral-caudal extent of the nucleus 
for each gas condition. Data a group means ± SEM.  A 2-way ANOVA with 
repeated measures using Gas treatment and Distance from Bregma as factors 
revealed a significant interaction between factors [F (3,183) = 4.98, P < 0.01].  
Post-hoc analysis with Newman-Keuls’ showed that both hypoxic normocapnia 
and hypoxic hypercapnia significantly increased c-Fos expression in the mid and 
rostral portions of the commissural NTS and all three conditions resulted in 
increased c-Fos expression in the mNTS compared to normoxia, *P < 0.05 and ** 
P < 0.01.  Both hypoxic normocapnia and hypoxic hypercapnia also showed 
significantly increased c-Fos expression compared to hyperoxic hypercapnia, #P 
< 0.05, $P < 0.01.
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Table 14.   Total number of cells that expressed c-Fos in the commissural and medial NTS during exposure to 
chemoreflex challenges.   
 
Total number of c-Fos positive cells in the commissural and medial NTS after exposure to normoxia, hypoxic 
normocapnia, hyperoxic hypercapnia and hypoxic hypercapnia.  Values are group means ± SEM.  A Kruskal-Wallis one-
way ANOVA on Ranks with Gas treatment as the factor revealed a main effect of Gas treatment on c-Fos expression 
within the commissural NTS [H (3) = 15.99, P < 0.01].  Post-hoc analysis using Dunn’s method showed that hypoxic 
hypercapnia and hypoxic normocapnia increased c-Fos expression in the commissural NTS.  A Kruskal-Wallis one-way 
ANOVA on Ranks also revealed a signficant effect of Gas treatment on activation of neurons within the mNTS [H (3) = 
16.36, P < 0.01].  Post-hoc analysis using Dunn’s method showed increased c-Fos expression during hypoxic 
normocapnia and hypoxic hypercapnia.  *P < 0.05.  Exposure to normoxia or hyperoxic hypercapnic gas did not produce 
significant changes in c-Fos expression in either the commissural or medial NTS.   
 
 
 
 
 
 
 Normoxia (8) 
Hypoxic  
Normocapnia (6) 
Hyperoxic 
Hypercapnia (6) 
Hypoxic 
Hypercapnia (7) 
Commissural NTS 79 ± 3 606 ± 32* 255 ± 14 590 ± 24* 
Medial NTS 131 ± 5 556 ± 27* 369 ± 20 649 ± 17* 
169 
 
 
 
 
 
5-HT1A receptor activation contributes to ventilatory compensation during 
hypoxic hypercapnia 
Body weight did not differ between groups injected with virus encoding the 
ScramshRNA and 1ARshRNA (353 ± 5 and 358 ± 5 g respectively).  Baseline 
ventilatory variables of ventilatory rate (VR), and minute ventilation (MV) did not 
differ between groups (Figure 25).  In both treatment groups, hypoxic  
normocapnic gas exposure elicited a dramatic increase in VR and MV which 
quickly declined over the first 5 minutes of exposure and then declined more 
slowly over the remainder of the recording period.  Hyperoxic hypercapnic gas 
exposure also produced an immediate and robust increase in VR and MV that 
declined over the first 10 minutes of exposure.  Ventilation stabilized after 10-15 
minutes and remained at this elevated level throughout the gas exposure period.  
There were no differences in ventilation between groups during either hypoxic 
normocapnia or hyperoxic hypercapnia alone.  During hypoxic hypercapnia, both 
groups had an initial increase in ventilation that diminished over the first 10 
minutes and stabilized, but there were obvious intermittent fluctuations in 
ventilatory rate in the ScramshRNA-treated group that were not observed in 
1ARshRNA-treated rats.  But there was no group difference in ventilatory 
variables at any time point during the recording period.   
 Examination of data from individual rats showed a clear increase in ventilatory 
rate fluctuations in control rats that was not apparent in rats treated with the 
1ARshRNA (Figure 26A).  To determine if the fluctuations were greater 
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Figure 25.  Ventilatory rate (VR) and minute volume (MV) in rats treated with AAV encoding the scrambled shRNA 
(ScramshRNA) or the 1ARshRNA.  Shown are values determined prior to gas change (-5-0 min) and during exposure to 
hypoxic normocapnia (left panel), hyperoxic hypercapnia (middle panel), and hypoxic hypercapnia (right panel).  Two-way 
ANOVA with repeated measures using ShRNA treatment and Time as factors revealed no significant effects or 
interactions.    
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Figure 26.   Ventilatory rate changes of individual rats over the course of 
exposure to hypoxic hypercapnia.  A) Individual ventilatory rate (VR) during 45 
minute exposure to hypoxic hypercapnia in all animals treated with the 
ScramshRNA-encoding virus (left) or the 1ARshRNA-encoding virus (right).  B) 
Area under the curve of VR during entire exposure period hypoxic hypercapnia in 
ScramshRNA- and 1ARshRNA-injected rats.  Data are group means ± SEM.  
Mann Whitney U Rank Sum test determined that 1ARshRNA-injected rats had 
lower overall variability in ventilatory rate during the course of hypoxic 
hypercapnia compared to ScramshRNA treated rats (U = 14, T = 105, P < 0.01).   
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To determine if intermittent fluctuations in ventilatory rate affected total 
ventilation, cumulative minute ventilation at the end of gas exposure was 
determined (Figure 27).  There was a strong trend for decreased ventilation over 
the course of gas exposure during hyperoxic hypercapnia in rats treated with the 
1ARshRNA-encoding virus.  But correction for repeated measures reduced 
significance below the acceptable alpha level.    
Inspection of the ventilatory wave form data revealed that 1ARshRNA-
treated rats spent less time sniffing than ScramshRNA rats during hypoxic 
hypercapnia (Figure 28A and B).  There was no difference in time spent sniffing 
between hypoxic normocapnia or hyperoxic hypercapnia alone.  In a small 
subset of rats, ventilation was recorded during normoxic conditions prior to gas 
change for at least 45 minutes.  Therefore, data from these animals were also 
analyzed for sniffing.  These data are shown for comparison but were not 
included in the analysis.  Qualitatively, animals showed little sniffing during 
normoxia and the percent time spent sniffing was similar between groups.      
Analysis of brain tissue showed a correlation between 5-HT1A mRNA 
levels in the commissural NTS and the area under the curve of ventilatory rate 
during exposure to hypoxic hypercapnia (R = 0.52, r2 = 0.27, P < 0.05) , but there 
was no correlation with the mNTS 5-HT1A receptor expression and (R = 0.05, r2 = 
0.01, P = 0.87; Figure 29A and B).  The 5-HT2A receptor gene expression in the 
caudal NTS was not affected by 1ARshRNA AAV injection (Figure 29C).  
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Figure 27.  Effect of ScramshRNA and 1ARshRNA expression in NTS on 
cumulative minute ventilation (MV) during gas challenges.  Cumulative 
minute ventilation (MV) over the 45 minute exposure to hypoxic normocapnia (left 
panel), hyperoxic hypercapnia (middle panel) and hypoxic hypercapnia (right 
panel) in ScramshRNA-treated and 1ARshRNA-treated rats.   Values are group 
means ± SEM.  Effects of AAV injection and gas exposure on cumulative MV at 
45 minutes of gas exposure (i.e., last value at 45 minutes) were assessed by 2-
way ANOVA with repeated measures of Gas treatment and ShRNA treatment as 
factors.   Though a strong trend for decreased cumulative MV was observed 
(P=0.048) in rats treated with the 1ARshRNA-encoding virus, Bonferroni 
correction for exposure to the 2 other gas treatments reduced the significance of 
the effect.   
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Figure 28.  Percent of time during each gas challenge spent sniffing.   
Normoxia is shown for comparison, but not included in the analysis.  Rats treated 
with the 1ARshRNA-encoding virus showed decreased sniffing during hypoxic 
hypercapnia compared to ScramshRNA-injected rats.  A) Time spent sniffing 
(determined as VR > 250 bpm) during normoxia, hypoxic normocapnia, hyperoxic 
hypercapnia, and hypoxic hypercapnia in ScramshRNA (blue) and 1ARshRNA 
(pink) injected rats.  Group n for normoxia is 4 and 5 for ScramshRNA and 
1ARshRNA-injected rats, and 15 and 13 for ScramshRNA and 1ARshRNA-
treated rats respectively in other conditions.  Bars show group means ±SEM.  
Data from individual animals are shown as dot plots over the appropriate bar.  
Mann-Whitney U Rank Sum test showed that ScramshRNA-treated rats spent 
more time sniffing during exposure to hypoxic-hypercapnic gas compared to 
1ARshRNA-injected rats [U = 44, T = 135,  P < 0.05].  The shRNA treatment 
during exposure to hypoxic gas alone [df = 26, t = -0.01, P = 0.996] or 
hypercapnia alone [U = 77, T = 168, P = 0.357] as determined by Student’s t-test 
and Mann-Whitney Rank Sum test respectively, failed to have any significant 
effects.  B) Individual recording of flow in a ScramshRNA-injected rat illustrating a 
short bout of sniffing.   
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Figure 29.  Relationship of 5-HT1A mRNA expression in commissural and 
medial NTS to area under the curve of ventilatory rate during exposure to 
hyperoxic hypercapnia.  Pearson’s correlation between the area under the 
curve of ventilatory rate over the full duration of exposure to hyperoxic 
hypercapnia and relative 5-HT1A receptor mRNA in the commissural NTS (cNTS) 
A) and mNTS B) showed significant correlation only in the commissural NTS.   C) 
Relative 5-HT2A receptor mRNA levels in the commissural and medial NTS of 
AAV injected rats.  Values are group means ± SEM.  Unpaired Student’s t-test 
revealed no significant effect of shRNA treatment on 5-HT2A receptor mRNA 
levels.   
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Discussion 
In the current study, hypoxic hypercapnia increased c-Fos expression in 
caudal serotonin neurons of the RO and RM.  However, both hypoxia and 
hypoxic hypercapnia induced c-Fos expression in the commissural and mNTS to 
the same extent.  Reduction in 5-HT1A receptor gene expression reduced 
intermittent bouts of sniffing behavior during hypoxic hypercapnia, but did not 
otherwise affect ventilation during normoxia, hypoxic normocapnia, hyperoxic 
hypercapnia or hypoxic hypercapnia.  These findings indicate that in the absence 
of central chemoreceptor activation, peripheral chemoreceptor activation is 
sufficient to activate serotonin neurons of caudal raphe regions known to 
innervate the commissural and mNTS.  Moreover, activation of the peripheral 
chemoreflex sensitizes serotonin cells of the caudal raphe to activation by 
hypercapnia.  Serotonin, released in the NTS during the combined activation of 
peripheral and central chemoreflexes, acts on 5-HT1A receptors to mediate 
arousal.      
 Our findings contradict our original hypothesis that hypercapnia per se is 
sufficient to activate serotonin cells of the caudal raphe.  This prediction was 
based on evidence provided by da Silva et al., who recently showed that lesion of 
RO neurons using a saponin toxin targeting cells that express serotonin reuptake 
proteins, reduced the ventilatory response to 7% CO2 in unanesthetized rats 
when oxygen levels were normal (da Silva et al., 2013).  We also found that 
selective lesion of serotonin neurons in the caudal raphe using 5, 7-
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dihydroxytryptamine attenuated the ventilatory and sympathetic responses to 
hyperoxic hypercapnia (Kung et al., 2010).  In these studies hyperoxic gas was 
used to suppress peripheral chemoreceptors and determine the effect of central 
chemoreceptor activation per se.  However, recent findings have shown that the 
sensitivity of the ventilatory response to hypercapnia is suppressed when 
peripheral chemoreflex responses are inhibited (Blain et al., 2010).  In our prior 
study, the effect of serotonin cell lesion on ventilatory response to hypercapnia 
was only apparent when CO2 levels were raised to 8%.  There was no difference 
in ventilatory response upon exposure to 5% CO2.  Thus, the inability of 5% 
hypercapnia to activate serotonin cells of the caudal raphe in the current study 
may have been due to reduced sensitivity of serotonin cells as a result of 
peripheral chemoreceptor suppression by hyperoxia.  Thus, when peripheral 
chemoreceptor activation is absent, serotonin cells of the caudal raphe may 
require a greater CO2 challenge to become activated.  Indeed, we found that 
when peripheral chemoreceptors were activated by hypoxia, c-Fos expression in 
serotonin cells was evident with 5% hypercapnia.    
 As expected, hypoxia also induced c-Fos expression primarily in the 
commissural NTS where the majority of peripheral chemoreceptor afferents 
terminate, as has been repeatedly shown by others (Gozal et al., 1999; Song et 
al., 2011; Teppema et al., 1997).  Hypoxic hypercapnia also produced the same 
degree of NTS cell activation.  Thus, despite greater activation of serotonin 
neurons in the caudal raphe during hypoxic hypercapnia, there was no additional 
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activation of NTS cells, contrary to our hypothesis.  However, it remains to be 
determined what percentage of cells activated by hypoxia are GABAergic or 
glutamatergic.  We originally hypothesized that serotonin facilitates peripheral 
chemoreflex responses by reversing the GABAergic cell activation that mediates 
hypoxic ventilatory decline.  Thus, it is possible that the same number of NTS 
cells are activated during hypoxia in the presence or absence of serotonin cell 
activation, but that a larger percent of activated cells are glutamatergic when 
serotonin cells have been activated by hypoxic hypercapnia.  This remains to be 
determined.       
 Studies in this dissertation implicate 5-HT1A receptors expressed in the 
NTS as the mediator of the sympathoexcitatory effects of endogenous serotonin 
and 8-OH-DPAT during the second wave of compensation that develops after 
syncope with blood loss.  This effect appears to be dependent upon sinoatrial 
nerve signaling.  During the syncopal phase of hemorrhage, loss of blood flow to 
the carotid bodies increases activation of chemoreceptor afferents.  Thus, we 
speculated that 8-OH-DPAT may act on 5-HT1A receptors in the NTS to facilitate 
chemoreflex responses to hypoxia.  However, our data did not support this 
conclusion.  Decreased 5-HT1A receptor mRNA expression did not influence 
either ventilatory frequency, tidal volume or cumulative minute volume at any 
time during a 45 min exposure to hypoxic hypercapnia, despite our evidence that 
this same stimulus was sufficient to activate serotonin neurons.  Instead, during 
hypoxic hypercapnia we did notice a difference in ventilatory pattern between 
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groups.  The ventilatory pattern of control rats was characterized by fluctuations 
in ventilatory frequency.  This was verified by statistical evidence of increased 
variability in ventilatory rate over the course of hyperoxic hypercapnic gas 
exposure.  Assessment of ventilatory wave forms showed an increased incidence 
of intermittent bouts of high frequency ventilation characteristic of sniffing 
behavior.  Indeed, during 5% hypercapnia, rats treated with the ScramshRNA-
encoding virus tended to investigate the chamber and sniff the perimeter in what 
looked like an effort to find the gas inlet.  In contrast, rats with successful 5-HT1A 
receptor knockdown did not show such investigative behaviors.  Sniffing during 
chemosensory stimuli has been associated with arousal (Carnevali et al., 2013).   
Thus, it appears that instead of mediating chemoreflex responses, serotonin may 
act on 5-HT1A receptors in the NTS to mediate arousal to chemosensory input.    
 It remains to be determined if such 5-HT1A receptor-dependent arousal 
facilitates sympathetic and ventilatory responses to hemorrhage.  Interestingly, a 
similar deficit in sniffing was reported during peripheral and central chemoreflex 
challenge in unanesthetized rats with lesion of the lateral parabrachial nucleus 
(Mizusawa et al., 1995).  It was reported that control animals were restless and 
rambled during the initial gas change while lesioned animals remained calm.   
Control animals eventually calmed down with prolonged hypoxia.  Thus, activity 
appeared to parallel changes in ventilation attributed to hypoxic ventilatory 
decline.  It was proposed that such behavioral responses to chemosensory input 
require transmission of chemosensory-related signals to higher cortical or 
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subcortical centers that project through the parabrachial nucleus.  Indeed, full 
ventilatory responses to hypercapnia requires intact supercollicular structures 
and is attenuated in sleep (Murphy et al., 1990).  Interestingly, similar lesions of 
the parabrachial nucleus have also been found to greatly attenuate the 
secondary compensatory phase of compensation during hemorrhage (Blair et al., 
2001; Blair and Mickelsen, 2006).  Thus, our data are consistent with the 
hypothesis that arousal during the combined activation of peripheral and central 
chemoreflex responses is dependent upon 5-HT1A receptors in the NTS.  It 
remains to be determined if the same arousal mechanism is responsible for 
sympathetic and ventilatory compensation following hypotensive hemorrhage.   
  
 
 
 
 
181 
 
CHAPTER VI 
GENERAL DISCUSSION 
The main findings from the studies conducted in this dissertation are 
highly novel in that they are the first to identify 5-HT1A receptors in the caudal 
NTS as a downstream target by which endogenous serotonin and exogenous 8-
OH-DPAT mediate sympathoexcitatory and pressor effects in recovery from 
hypotensive hemorrhage.  Furthermore, 8-OH-DPAT appears to augment the 
effects of endogenous serotonin release that occurs with blood loss.  Given our 
evidence that 5-HT1A receptors in the NTS, particularly the commissural NTS, are 
critical in reducing lactic acidosis in the unanesthetized rat subjected to 
hemorrhage, the data further indicate an important role for 5-HT1A receptor 
agonists in improving oxygenation of peripheral tissue following hypotensive 
hemorrhage.   
Based on prior work, we constructed a working hypothesis of how 
endogenous serotonin and 8-OH-DPAT mediate their ability to improve 
peripheral oxygenation following hypotensive hemorrhage (Figure 29).  Evidence 
from other laboratories identified serotonin neurons in the caudal raphe as 
putative central chemoreceptors that are intrinsically sensitive to changes in pH 
and CO2.  Although this remains a controversial topic, there is some consensus 
that serotonin neurons somehow facilitate the chemoreflex response to  
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Figure 30. Original working model.  During hypotensive hemorrhage, 
peripheral chemoreceptors in the carotid bodies are activated by reduced blood 
flow.  Activation of second-order chemosensitive neurons in the caudal NTS to 
stimulate sympathetic and ventilatory drive through downstream activation of the 
RVLM and PreBötC respectively.  During prolonged activation of the peripheral 
chemoreceptors, GABA interneurons become activated and reduce sympathetic 
and ventilatory drive.  As blood loss continues, metabolic acidosis develops, 
which activates serotonin neurons in the caudal raphe to release serotonin in the 
NTS.  In turn, activation of 5-HT1A receptors on GABAergic neurons disinhibits 
the peripheral chemoreflex, ultimately restoring sympathetic and ventilatory drive.   
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respiratory acidosis in unanesthetized animals (Bradley et al., 2002; Guyenet et 
al., 2010; Teran et al., 2014; Wang et al., 1998; Wang and Richerson, 1999; 
Wang et al., 2001).  Whether serotonin neurons themselves have intrinsic 
chemosensitivity in vivo remains to be determined.  Given their importance in 
mediating the response to acidosis, we predicted that serotonin neurons in the 
caudal raphe would be stimulated by the metabolic acidosis that develops with 
hypotensive hemorrhage and, as a consequence, would release serotonin into 
the NTS and activate 5-HT1A receptors to facilitate peripheral chemoreflex 
responses.  However, 5-HT1A receptors are negatively coupled to signaling 
pathways that excite cells (Fargin et al., 1989).  Therefore, in our model we 
predicted that 5-HT1A receptors involved in the response to hemorrhage would be 
expressed by inhibitory GABAergic interneurons that are activated during 
prolonged hypoxia and mediate the decrease in sympathetic activity and 
ventilation that accompany hypoxic ventilatory decline.  As such, 5-HT1A receptor 
activation was speculated to reverse the decline in ventilation that develops with 
sustained peripheral chemoreceptor activation.  Hypoxic ventilatory decline is 
accompanied by reductions in sympathetic drive as well.  Therefore, reversal of 
this GABA-mediated response would be expected to increase ventilation and 
sympathetic activation.      
To address this hypothesis, we examined whether acidosis stimulates 
serotonin neurons in the caudal raphe, and whether acidosis would further 
augment peripheral chemoreflex responses to hypoxia.  Contrary to our working 
model, hyperoxic hypercapnia did not reliably activate serotonin neurons in the 
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caudal raphe despite causing an acidosis comparable to that seen in severe 
hemorrhage.  Instead, we noted that hypoxic hypercapnia caused more 
activation of serotonin neurons of the RO and RM than did hypercapnia alone.  
Our results are incongruent with evidence that serotonin neurons are intrinsically 
sensitive to changes in arterial blood pH and PaCO2.  We utilized hyperoxic 
conditions in the presence of hypercapnia in order to prevent the activation of 
peripheral chemoreceptors which are also sensitive to pH.  However, recent 
evidence has shown that in unanaesthetized dogs peripheral chemoreceptor 
input can sensitize the ventilatory response to central chemoreceptor activation 
(Blain et al., 2010).  Conversely, denervation of the carotid sinus nerve impairs 
the central chemoreceptor-induced increase in ventilation.  In light of the recent 
evidence that hyperoxia may reduce the sensitivity of central chemoreceptors, it 
is plausible that peripheral chemoreceptor activation may contribute to the 
excitability of serotonin neurons in the caudal raphe and this may contribute to 
the sensitization of central chemoreception.  This may explain why more caudal 
raphe serotonergic neurons were activated during hypoxic hypercapnia than 
hyperoxic hypercapnia.     
Nevertheless, our results indicate that acidosis did not appear to augment 
the chemoreflex ventilatory response to hypoxia, as indicated by the lack of 
consistent increase in minute ventilation over the course of the hypoxic 
hypercapnic challenge.  Interestingly, we instead observed increased sniffing 
during hypoxic hypercapnia that appeared to be attenuated in rats subjected to 5-
HT1A receptor knockdown.  Based on these final experiments, we deduced that 
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the sympathoexcitatory effect of 5-HT1A receptors in the caudal NTS was not due 
to augmentation of the peripheral chemoreceptor responses. 
Instead, we now propose that activation of 5-HT1A receptors in the caudal 
NTS may be an important signaling mechanism that stimulates arousal.  Several 
laboratories have documented sniffing as a measure of exploratory behavior as 
well as an arousal response (Carnevali et al., 2013).  High frequency ventilation 
or sniffing behavior is dramatically increased in response to novel stimuli such as 
odors and visual cues as well as in response to rewards (Freeman et al., 1983; 
Waranch and Terman, 1975; Wesson et al., 2009).  Therefore, increases in 
arousal may be demonstrated by increases in sniffing behavior such as that seen 
in our rats during exposure to hypercapnic gas mixtures.  We noted sniffing 
behavior during hypoxia and hyperoxic hypercapnia in both treatment groups.   
However, only sniffing in response to hypoxic hypercapnia was reduced by 5-
HT1A receptor knockdown.  These findings suggest that multiple mechanisms 
contribute to sniffing behavior, but that sniffing behavior and thus arousal during 
hypoxic hypercapnia requires activation of 5-HT1A receptors in the caudal NTS.         
Arousal responses require connections to the higher centers of the brain.  
One such pathway may be through the parabrachial nucleus (Kubo et al., 1998; 
Saper, 1982).  The lateral subnucleus of the parabrachial nucleus (LPBN) has 
reciprocal projections with the NTS (Herbert et al., 1990).  Lesion of the LPBN 
impairs sniffing behavior during chemoreceptor activation (Mizusawa et al., 
1995).  Interestingly, similar lesions impair the secondary compensatory 
response to hypotensive hemorrhage in rats.  (Blair et al., 2001; Blair and 
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Mickelsen, 2006).  Prior work has shown that the LPBN is activated in response 
to hypotensive hemorrhage, chemoreceptor activation, and peripheral tissue 
hypoxia (Chan and Sawchenko, 1994; Hirooka et al., 1997; Jaworski et al., 
2002).  Thus, it is tempting to speculate that 5-HT1A receptors in the NTS transmit 
arousal signals to higher-order centers through the LPBN.  This could also 
explain the inability of 8-OH-DPAT to raise sympathetic activity in anesthetized 
models of hemorrhage in which behavioral arousal is not expressed.     
Based on our findings from this project, we revised our working model to 
include a pathway through LPBN to higher-order centers.  It remains to be 
determined how this pathway participates in sympathetic and ventilatory 
activation.  However, it is recognized that 5-HT1A receptors expressed in the 
RVLM inhibit sympathetic activity (Bago et al., 1999).  Therefore, it seems less 
likely that 8-OH-DPAT (and therefore, endogenous serotonin) is able to mediate 
sympathetic excitation through a pathway that incorporates RVLM.   
Alternatively, it is possible that both sympathetic and ventilatory activation 
mediated by serotonin during hemorrhage are due to downstream activation of 
the paraventricular nucleus of the hypothalamus (PVN).  The PVN is recognized 
as an integration site of higher-order sensory and central inputs with autonomic 
functions and provides direct excitatory projections to the intermediolateral cell 
column containing pre-ganglionic sympathetic fibers as well as to the RVLM 
(Badoer, 2001; Coote et al., 1998).  Moreover, the PVN has direct projections to 
PreBötC and phrenic nuclei in the spinal cord and electrical stimulation of these 
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projections can augment ventilation, HR and BP (Duan et al., 1997; Kc et al., 
2002a).   
Even more interesting, several investigators have shown that electrical or 
chemical activation of the PVN results in increased BP and HR as a result of 
increased sympathetic activation (Chen et al., 2003; Kenney et al., 2003; Martin 
et al., 1991).  Since larger venules and veins have extensive sympathetic 
innervations, it is plausible that PVN-mediated increases in sympathetic drive can 
augment CO and venous tone (Furness and Marshall, 1974).  In fact, studies 
performed by Martin et al. demonstrated that disinhibition of the PVN results in 
an increase in CO, without altering TPR in a conscious rat (Martin and Haywood, 
1993).  Since 8-OH-DPAT administration during hemorrhagic shock and 
disinhibition of the PVN both result in similar hemodynamic effects, it is tempting 
to speculate that PVN-mediated increases in venous tone may be disinhibited by 
5-HT1A receptor activation during hemorrhage, but the exact mechanisms require 
further investigation. Moreover, the PVN is also activated in response to hypoxia, 
hypercapnia, and hemorrhage (Badoer and Merolli, 1998; Kc et al., 2002b; King 
et al., 2012).  Thus, it is plausible that PVN-mediated increases in sympathetic 
drive could augment venous tone and promote peripheral tissue perfusion during 
blood loss. 
The LPBN also has direct projections to the central nucleus of the 
amygdala (CeA), a region also important in regulating arousal responses and 
cardiovascular control (Dampney, 1994; Davis and Whalen, 2001; Saha, 2005; 
Saha et al., 2005; Saper, 1982; Saper and Loewy, 1980). Electrical stimulation of 
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the CeA produces increases in HR and BP in conscious animals, but produces 
the opposite effect when stimulated in an anesthetized animal (Iwata et al., 
1987).  Furthermore, hypotension produced by hydralazine infusions causes c-
Fos activation of neurons within the CeA.  Electron microscopy studies confirmed 
that these same neurons that are activated by hypotension in the CeA, receive 
innervation from the LBPN (Takeuchi et al., 2004). Therefore, activation of the 
CeA may be contributing to the arousal responses seen during hypoxic 
hypercapnic gas exposure.  Taken together, we revised our model to incorporate 
the projections from the NTS to the LPBN, CeA, and PVN which we now believe 
to be components of the pathways involved in compensation from hypotensive 
hemorrhage. 
In our revised model (Figure 30) we speculate that some pathway that is 
initiated by peripheral chemoreceptor afferents contributes to increased 
excitability of serotonin neurons of the caudal raphe, such that they become 
more responsive to acidosis.  Thus, the combination of peripheral and central 
chemoreflex stimulation increases serotonin release in the NTS.  Subsequent 
activation of 5-HT1A receptors stimulates excitatory projections to higher-order 
centers, possibly through connections in the LPBN that contribute to a 
combination of effects that include arousal via the CeA, and parallel increases in 
sympathetic activity and ventilation possibly mediated by PVN.  We further 
predict that this promotes increased tissue perfusion by stimulating increased 
venoconstriction.   
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Figure 31.  Revised working model.  Based on our most recent conclusions 
from this dissertation, we hypothesized that in our revised working model, 
serotonin neurons become more sensitive to metabolic acidosis during 
hemorrhage with concurrent activation of the peripheral chemoreceptors.  In turn, 
serotonin activates 5-HT1A receptors in the caudal NTS that project directly to the 
lateral parabrachial nucleus (LPBN).  The LPBN signals arousal to hemorrhage 
via projections to the amygdala and promotes sympathetic and ventilatory drive 
by downstream activation of the paraventricular nucleus of the hypothalamus 
(PVN).  Once activated, the PVN promotes sympathoexcitatory activation via 
IML.   
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